<SEC-DOCUMENT>0000950159-23-000019.txt : 20230213
<SEC-HEADER>0000950159-23-000019.hdr.sgml : 20230213
<ACCEPTANCE-DATETIME>20230213061518
ACCESSION NUMBER:		0000950159-23-000019
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20230213
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230213
DATE AS OF CHANGE:		20230213

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cigna Group
		CENTRAL INDEX KEY:			0001739940
		STANDARD INDUSTRIAL CLASSIFICATION:	HOSPITAL & MEDICAL SERVICE PLANS [6324]
		IRS NUMBER:				824991898
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38769
		FILM NUMBER:		23614487

	BUSINESS ADDRESS:	
		STREET 1:		900 COTTAGE GROVE ROAD
		CITY:			BLOOMFIELD
		STATE:			CT
		ZIP:			06002
		BUSINESS PHONE:		8602266000

	MAIL ADDRESS:	
		STREET 1:		900 COTTAGE GROVE ROAD
		CITY:			BLOOMFIELD
		STATE:			CT
		ZIP:			06002

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cigna Corp
		DATE OF NAME CHANGE:	20181221

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Halfmoon Parent, Inc.
		DATE OF NAME CHANGE:	20180508
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>cigna8k.htm
<DESCRIPTION>THE CIGNA GROUP FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-gaap-supplement="http://fasb.org/us-gaap-sup/2022q3" xmlns:srt-supplement="http://fasb.org/srt-sup/2022q3" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:CI="http://cigna.com/20230213">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_US%2DGAAP%2D2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_033_CI_cigna.com_20230213 -->
<!-- Field: Set; Name: xdx; ID: xdx_04D_20230213_20230213 -->
<!-- Field: Set; Name: xdx; ID: xdx_058_edei%2D%2DEntityCentralIndexKey_0001739940 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0xMi0zMQ== -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-02-13to2023-02-13" name="dei:EntityCentralIndexKey">0001739940</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-02-13to2023-02-13" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-02-13to2023-02-13" name="dei:CurrentFiscalYearEndDate">--12-31</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="ci-20230213.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-02-13to2023-02-13">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001739940</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-13</xbrli:startDate>
        <xbrli:endDate>2023-02-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt/0.05pt Times New Roman, Times, Serif; margin: 0.8pt 0 0; text-align: center">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 2.7pt 0 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Washington, D.C. 20549</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>FORM <span id="xdx_901_edei--DocumentType_c20230213__20230213_zbduEDGuUHLk"><ix:nonNumeric contextRef="From2023-02-13to2023-02-13" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">CURRENT REPORT</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Pursuant to Section 13 or 15(d) of the</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Securities Exchange Act of 1934</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 9.7pt 0 0; text-align: center">Date of Report (Date of earliest event reported)
<b><span id="xdx_90D_edei--DocumentPeriodEndDate_c20230213__20230213_zVtxxAZu71U"><ix:nonNumeric contextRef="From2023-02-13to2023-02-13" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">February 13, 2023</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 9.7pt 0 0; text-align: center"><b><span id="xdx_90C_edei--EntityRegistrantName_c20230213__20230213_z7YKTnIlUkb7"><ix:nonNumeric contextRef="From2023-02-13to2023-02-13" name="dei:EntityRegistrantName">The Cigna Group</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 30%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.8pt 0 4.35pt; text-align: center"><b><span id="xdx_900_edei--EntityIncorporationStateCountryCode_c20230213__20230213_zQO2pKXbwr3f"><ix:nonNumeric contextRef="From2023-02-13to2023-02-13" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.8pt 0 4.35pt; text-align: center">(State or other jurisdiction of incorporation)</p></td>
    <td style="width: 39%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.8pt 0 4.35pt; text-align: center"><b><span id="xdx_909_edei--EntityFileNumber_c20230213__20230213_zT7S4MbmhoQk"><ix:nonNumeric contextRef="From2023-02-13to2023-02-13" name="dei:EntityFileNumber">001-38769</ix:nonNumeric></span></b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.8pt 0 4.35pt; text-align: center">(Commission File Number)</p></td>
    <td style="width: 31%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.8pt 0 4.35pt; text-align: center"><b><span id="xdx_900_edei--EntityTaxIdentificationNumber_c20230213__20230213_zHOb5VbIWih1"><ix:nonNumeric contextRef="From2023-02-13to2023-02-13" name="dei:EntityTaxIdentificationNumber">82-4991898</ix:nonNumeric></span></b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.8pt 0 4.35pt; text-align: center">(IRS Employer</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.8pt 0 4.35pt; text-align: center">Identification No.)</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><span id="xdx_907_edei--EntityAddressAddressLine1_c20230213__20230213_zWu6MgNgvOnb"><ix:nonNumeric contextRef="From2023-02-13to2023-02-13" name="dei:EntityAddressAddressLine1">900 Cottage Grove Road</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><span id="xdx_900_edei--EntityAddressCityOrTown_c20230213__20230213_z4YapK46AMmg"><ix:nonNumeric contextRef="From2023-02-13to2023-02-13" name="dei:EntityAddressCityOrTown">Bloomfield</ix:nonNumeric></span>, <span id="xdx_905_edei--EntityAddressStateOrProvince_c20230213__20230213_zZNQervZR3rh"><ix:nonNumeric contextRef="From2023-02-13to2023-02-13" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Connecticut</ix:nonNumeric></span> <span id="xdx_90F_edei--EntityAddressPostalZipCode_c20230213__20230213_zm8XjHMLbuJ6"><ix:nonNumeric contextRef="From2023-02-13to2023-02-13" name="dei:EntityAddressPostalZipCode">06002</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Address of principal executive offices) (Zip Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 9.7pt 0 0; text-align: center">Registrant&#8217;s telephone number, including
area code:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>(<span id="xdx_909_edei--CityAreaCode_c20230213__20230213_znrTXA3SQdzk"><ix:nonNumeric contextRef="From2023-02-13to2023-02-13" name="dei:CityAreaCode">860</ix:nonNumeric></span>) <span id="xdx_900_edei--LocalPhoneNumber_c20230213__20230213_z3SeIRwxz0D3"><ix:nonNumeric contextRef="From2023-02-13to2023-02-13" name="dei:LocalPhoneNumber">226-6000</ix:nonNumeric></span> </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 9.7pt 0 0; text-align: center"><b><span id="xdx_90F_edei--EntityInformationFormerLegalOrRegisteredName_c20230213__20230213_zotIoHUGaBkb"><ix:nonNumeric contextRef="From2023-02-13to2023-02-13" name="dei:EntityInformationFormerLegalOrRegisteredName">Cigna Corporation</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Former name or former address, if changed since last
report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 9.7pt 0 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 9.7pt 0 0"><span id="xdx_90C_edei--WrittenCommunications_c20230213__20230213_z93VBz3170gf"><ix:nonNumeric contextRef="From2023-02-13to2023-02-13" format="ixt:booleanfalse" name="dei:WrittenCommunications">[_]</ix:nonNumeric></span> Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_90D_edei--SolicitingMaterial_c20230213__20230213_zR4EBKLoNuH8"><ix:nonNumeric contextRef="From2023-02-13to2023-02-13" format="ixt:booleanfalse" name="dei:SolicitingMaterial">[_]</ix:nonNumeric></span> Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 14.55pt; text-indent: -14.6pt"><span id="xdx_906_edei--PreCommencementTenderOffer_c20230213__20230213_zjkPgpIc2ur1"><ix:nonNumeric contextRef="From2023-02-13to2023-02-13" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">[_]</ix:nonNumeric></span> Pre-commencement communications pursuant
to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 14.55pt; text-indent: -14.6pt"><span id="xdx_906_edei--PreCommencementIssuerTenderOffer_c20230213__20230213_zZifkFROitl"><ix:nonNumeric contextRef="From2023-02-13to2023-02-13" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">[_]</ix:nonNumeric></span> Pre-commencement communications pursuant
to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 9.7pt 0 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; width: 32%; padding-left: 6.05pt; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title of each class</span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; width: 24%; padding-left: 4.35pt; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading Symbol(s)</span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; width: 44%; padding-left: 5.25pt; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of each exchange on which registered</span></td></tr>
  <tr>
    <td style="border-bottom: black 1pt solid; padding-left: 6.05pt; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--Security12bTitle_c20230213__20230213_zipzTsKRdTF5"><ix:nonNumeric contextRef="From2023-02-13to2023-02-13" name="dei:Security12bTitle">Common Stock, Par Value $0.01</ix:nonNumeric></span></span></td>
    <td style="border-bottom: black 1pt solid; padding-left: 4.35pt; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--TradingSymbol_c20230213__20230213_zTSKJukCcCd8"><ix:nonNumeric contextRef="From2023-02-13to2023-02-13" name="dei:TradingSymbol">CI</ix:nonNumeric></span></span></td>
    <td style="border-bottom: black 1pt solid; padding-left: 5.25pt; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--SecurityExchangeName_c20230213__20230213_zhG8q2kOHud9"><ix:nonNumeric contextRef="From2023-02-13to2023-02-13" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonNumeric></span>, Inc.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule 12b-2 of the Securities
Exchange Act of 1934 (17 CFR &#167;240.12b-2).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">Emerging growth company <span id="xdx_905_edei--EntityEmergingGrowthCompany_c20230213__20230213_zPK8CpX26I7d"><ix:nonNumeric contextRef="From2023-02-13to2023-02-13" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. &#9744;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt/0.05pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: black 0.75pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0.15in 0 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 100%; padding-right: 0.8pt; text-align: center; font-size: 10pt">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 100%; padding-right: 0.8pt; text-align: center; font-size: 10pt">&#160;</td></tr>
  </table>
<p style="font: 10pt/5.4pt Times New Roman, Times, Serif; margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 1 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt/0.05pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 11%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 5.03</b></span></td>
    <td style="width: 89%; padding-right: 0.8pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amendments to Articles of Incorporation or By-laws; Change in Fiscal Year.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 8.1pt 0 0; text-align: justify">Effective February 13, 2023, Cigna Corporation
(the &#8220;Company&#8221;) changed its corporate name to The Cigna Group (the &#8220;Name Change&#8221;) pursuant to a certificate of
amendment to the Company&#8217;s restated certificate of incorporation (the &#8220;Charter Amendment&#8221;) previously filed with the
Delaware Secretary of State. The Company also amended and restated its by-laws (the &#8220;Amended and Restated By-laws&#8221;) on February
13, 2023 to reflect the Name Change. Pursuant to Delaware law, a shareholder vote was not necessary to effectuate the Name Change and
the Name Change does not affect the rights of the Company&#8217;s shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 8.1pt 0 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also filed a restated certificate of incorporation (the &#8220;Restated Charter&#8221;) that combined into one document the Company&#8217;s
prior restated certificate of incorporation, as amended by the Charter Amendment to reflect the Name Change. The Cigna Group&#8217;s common
stock will continue to trade under its former name, Cigna Corporation, through February 22, 2023 and will begin trading under its new
name, The Cigna Group, on February 23, 2023.&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s common stock will continue to trade on the New York Stock Exchange under the ticker symbol &#34;CI&#34;. The Name Change
does not affect the Company&#8217;s trading symbol, its CUSIP, nor the rights of its security holders, creditors, customers or suppliers.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 8.1pt 0 0; text-align: justify">Copies of the Charter Amendment, Restated
Charter and Amended and Restated By-laws are filed as Exhibit 3.1, Exhibit 3.2 and Exhibit 3.3, respectively, with this Current Report
on Form 8-K and are incorporated herein by reference. Other than the Name Change, the Company did not make any changes to its certificate
of incorporation or by-laws.</p>

<p style="font: 10pt/110% Times New Roman, Times, Serif; margin: 0 0.7pt 0 0; text-align: justify">&#160;</p>

<p style="font: 10pt/7.9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 11%; padding-right: 0.8pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 9.01</b></span></td>
    <td style="width: 89%; padding-right: 0.8pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial Statements and Exhibits.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 0.8pt; font-size: 10pt">&#160;</td>
    <td style="padding-right: 0.8pt; font-size: 10pt">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">(d) Exhibits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="text-decoration: underline">Exhibit No. Description</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 58.3pt; text-indent: -58.35pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 58.3pt; text-indent: -58.35pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 11%; padding-right: 0.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td style="width: 89%; padding-right: 0.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex3-1.htm">Certificate of Amendment of Restated Certificate of Incorporation of Cigna Corporation</a>.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 0.8pt">&#160;</td>
    <td style="padding-right: 0.8pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 0.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</span></td>
    <td style="padding-right: 0.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex3-2.htm">Restated Certificate of Incorporation of The Cigna Group</a>.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 0.8pt">&#160;</td>
    <td style="padding-right: 0.8pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 0.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</span></td>
    <td style="padding-right: 0.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex3-3.htm">Amended and Restated By-laws of The Cigna Group</a>.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 0.8pt">&#160;</td>
    <td style="padding-right: 0.8pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 0.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.8pt 0 0">Cover Page Interactive Data File (embedded within the Inline
    XBRL).</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.8pt 0 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 0.8pt">&#160;</td>
    <td style="padding-right: 0.8pt">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 58.3pt; text-indent: -58.35pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 9.7pt 0 0; text-align: center"><b>SIGNATURE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 9.7pt 0 0; text-indent: 29.15pt">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-left: 4.35pt">&#160;</td>
    <td colspan="2" style="padding-left: 4.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE CIGNA GROUP<br />
<br />
</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 57%; padding-left: 4.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:&#160;&#160;February 13, 2023</span></td>
    <td style="width: 8%; padding-left: 4.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:&#160;&#160;</span></td>
    <td style="width: 35%; padding-left: 4.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">/s/ Brian C. Evanko</span></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 4.35pt">&#160;</td>
    <td style="padding-left: 4.35pt">&#160;</td>
    <td style="padding-left: 4.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian C. Evanko</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 4.35pt">&#160;</td>
    <td style="padding-left: 4.35pt">&#160;</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.8pt 0 4.35pt">Executive Vice President and</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.8pt 0 4.35pt">Chief Financial Officer</p></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 4.35pt">&#160;</td>
    <td style="padding-left: 4.35pt">&#160;</td>
    <td style="padding-left: 4.35pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 4.35pt">&#160;</td>
    <td style="padding-left: 4.35pt">&#160;</td>
    <td style="padding-left: 4.35pt">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 100%; padding-right: 0.8pt; text-align: center">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 4.85pt 0 0">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjV0KwjAQhE/QOyx5Fk1TROijRUWsIkXE12i3EmyzZZP6cyRvaWwRl4Flmfl2hBiJFS1NjQyneZHDAZu21h6hwAoZ7QVDIltvUgi7wKtxnrX1/fkDMwoMBmY6jmfnYPTRu3FYpiDVJEglIJNUKthvRfT1M7KVKdF6o2vQtoQ9U8sGvebX8OGgn2SpefVVR2RnyKYQj+Vgv0HJWMGO7vpBfHOQ55mIRv1EYsXUtd+aznlqYFFjE7rcgP4VfQAUrklD -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>ex3-1.htm
<DESCRIPTION>EXHIBIT 3.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0">Exhibit 3.1</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 3.75pt 146.35pt 0 146.25pt; text-align: center"><B>CERTIFICATE OF AMENDMENT
<FONT STYLE="letter-spacing: -0.3pt">OF</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 100.75pt 0 1.4in; text-align: center"><B>RESTATED CERTIFICATE OF INCORPORATION
<FONT STYLE="letter-spacing: -0.3pt">OF</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 146.25pt; text-align: center"><B>CIGNA <FONT STYLE="letter-spacing: -0.1pt">CORPORATION</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.5pt 0 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 41.85pt; text-align: center">(Pursuant to Section 242 of the General Corporation
Law of the State of <FONT STYLE="letter-spacing: -0.1pt">Delaware)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10.85pt 0 0 5.95pt; text-indent: 1in">Cigna Corporation, a corporation duly
organized and existing under the General Corporation Law of the State of Delaware (the &ldquo;Corporation&rdquo;), does hereby certify
that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.5pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 5.85pt 0 5.95pt; text-align: justify; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">1.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The Restated Certificate of Incorporation of the Corporation is hereby amended solely to reflect a change in the name of the Corporation
by deleting Article FIRST thereof and inserting the following in lieu thereof:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.5pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 77.95pt">&ldquo;<U>First</U>: The name of the Corporation is The Cigna
<FONT STYLE="letter-spacing: -0.1pt">Group&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.5pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 5.7pt 0 6pt; text-align: justify; text-indent: 71.95pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">2.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The Board of Directors of the Corporation has adopted a resolution approving and declaring advisable the amendment described herein
in accordance with the provisions of Sections 141(f) and 242(b)(1) of the General Corporation Law of the State of <FONT STYLE="letter-spacing: -0.1pt">Delaware.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.05pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 4.5pt 5.95pt 0; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">3.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The amendment described herein has been duly adopted in accordance with Section 242 of the General Corporation Law of the State
of Delaware.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.5pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 5.85pt 0 5.95pt; text-indent: 1in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>This Certificate of Amendment shall become effective at 8:00 a.m. Eastern Time on February 13, 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.5pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 5.95pt; text-indent: 1in">IN WITNESS WHEREOF, the Corporation has caused
this Certificate to be executed by its duly authorized officer on this 8th day of February, 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 5.95pt; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 5.95pt; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 33%">&nbsp;</TD>
  <TD STYLE="width: 34%">&nbsp;</TD>
  <TD STYLE="width: 33%">&nbsp;<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"><B>CIGNA
<FONT STYLE="letter-spacing: -0.1pt">CORPORATION</FONT></B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-bottom: 0; margin-top: 0; margin-left: 0; text-indent: 0pt; text-align: justify"><FONT STYLE="letter-spacing: 0">By:
<U>/s/ Kari K. Stevens</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-bottom: 0; margin-top: 0; margin-left: 0pt; text-indent: 0pt; text-align: justify">Name:
Kari K. Stevens</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-left: 0pt; text-indent: 0pt; text-align: justify">Title:
<FONT STYLE="letter-spacing: -0.1pt">Secretary</FONT></P>

</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.2
<SEQUENCE>3
<FILENAME>ex3-2.htm
<DESCRIPTION>EXHIBIT 3.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0">Exhibit 3.2</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; color: #0A0A0A; margin-top: 0; margin-bottom: 6pt; text-align: center"><FONT STYLE="letter-spacing: -0.1pt"><B>RESTATED
CERTIFICATE OF INCORPORATION OF THE CIGNA</B></FONT><B> <FONT STYLE="letter-spacing: -0.2pt">GROUP</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.2pt 0 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 41pt; text-align: left; color: #0A0A0A">The undersigned hereby certifies
on behalf of The Cigna Group as <FONT STYLE="letter-spacing: -0.1pt">follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 7.85pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 22.95pt"></TD><TD STYLE="width: 18pt">1.</TD><TD STYLE="text-align: justify; padding-right: 5.95pt">The present name of the corporation is The Cigna Group. The corporation was incorporated
under the name &quot;Halfmoon Parent, Inc.&quot; by the filing of its original Certificate of Incorporation with the Secretary of State
of the State of Delaware on March 6, 2018.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 7.9pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 22.95pt"></TD><TD STYLE="width: 18pt">2.</TD><TD STYLE="text-align: justify; padding-right: 5.85pt">This Restated Certificate of Incorporation was duly adopted in accordance with
the provisions of Section 245 of the Delaware General Corporation Law.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.45pt 0 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 22.95pt"></TD><TD STYLE="width: 18pt">3.</TD><TD STYLE="text-align: justify; padding-right: 5.9pt">This Restated Certificate of Incorporation shall become effective at 8:01 a.m. Eastern
Time on the 13<SUP>th</SUP> day of February, 2023.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.35pt 0 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/100% Times New Roman, Times, Serif; margin-top: 0.05pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 22.95pt"></TD><TD STYLE="width: 18pt">4.</TD><TD STYLE="text-align: justify; padding-right: 5.85pt">The Certificate of Incorporation of the corporation is hereby integrated and restated
to read in its entirety as follows:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 7.55pt 0 0 46.95pt; text-align: left; color: #0A0A0A"><U>First:</U> The name
of the Corporation is The Cigna <FONT STYLE="letter-spacing: -0.1pt">Group.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.4pt 0 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt/101% Times New Roman, Times, Serif; margin: 0 24.5pt 0 10.85pt; text-align: justify; text-indent: 36.35pt; color: #0A0A0A"><U>Second:</U>
The address of the Corporation's registered office in the State of Delaware is 1209 Orange Street in the City of Wilmington, County of
New Castle, Delaware 19801. The name of its registered agent at such address is The Corporation Trust Company.</P>

<P STYLE="font: 10pt/100% Times New Roman, Times, Serif; margin: 11.4pt 24.4pt 0 10.6pt; text-align: justify; text-indent: 36.2pt; color: #0A0A0A"><U>Third:</U>
The nature of the business or purposes to be conducted or promoted is to engage in any lawful act or activity for which corporations may
be organized under the General Corporation Law of the State of Delaware.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.35pt 0 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 24.7pt 0 10.5pt; text-align: justify; text-indent: 36.45pt"><FONT STYLE="color: #0A0A0A"><U>Fourth:</U>
The total number of shares of all classes of capital stock which the Corporation shall have the authority to issue is 625,000,000 shares
divided into two classes as follows: 600,000,000 shares of Common Stock of the par value of $0.01 per share and </FONT><FONT STYLE="color: #1C1C1D">25,000</FONT><FONT STYLE="color: #464249">,</FONT><FONT STYLE="color: #0A0A0A">000
shares of Preferred Stock of the par value of $1.00 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.05pt 0 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; color: #0A0A0A"><TR STYLE="vertical-align: top">
<TD STYLE="width: 11pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="letter-spacing: -0.05pt"><B>A.</B></FONT></TD><TD STYLE="text-align: left"><FONT STYLE="letter-spacing: -0.1pt"><B>PREFERRED STOCK</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.5pt 0 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 23.95pt 0 10.5pt; text-align: justify; text-indent: 36.35pt"><FONT STYLE="color: #0A0A0A">The
Board of Directors is expressly authorized to provide for the issue of all or any shares of the Preferred Stock, in one or more series,
and to fix for each </FONT><FONT STYLE="color: #1C1C1D">such </FONT><FONT STYLE="color: #0A0A0A">series </FONT><FONT STYLE="color: #1C1C1D">such
</FONT><FONT STYLE="color: #0A0A0A">voting powers, full or limited, or no voting powers, and such designations, preferences and relative,
participating, optional or other special rights and </FONT><FONT STYLE="color: #2D2836">s</FONT><FONT STYLE="color: #0A0A0A">uch qualifications,
limitations or restrictions thereof, as shall be stated and expressed</FONT> <FONT STYLE="color: #1C1C1D">in</FONT> <FONT STYLE="color: #0A0A0A">the
resolution or resolutions adopted by the Board</FONT> <FONT STYLE="color: #1C1C1D">of</FONT> <FONT STYLE="color: #0A0A0A">Directors providing
for the issue of such series and as may be permitted by the General Corporation Law of the State of Delaware, including, without limitation,
the authority to provide that any such series may be (i) subject to redemption at such time or times and at such price or prices; (ii)
entitled to receive dividends (which may be cumulative or non-cumulative) at </FONT><FONT STYLE="color: #1C1C1D">such </FONT><FONT STYLE="color: #0A0A0A">rates,
on </FONT><FONT STYLE="color: #1C1C1D">such </FONT><FONT STYLE="color: #0A0A0A">conditions, and at such times, and payable in preference</FONT>
<FONT STYLE="color: #1C1C1D">to,</FONT> <FONT STYLE="color: #0A0A0A">or in</FONT> <FONT STYLE="color: #1C1C1D">such</FONT> <FONT STYLE="color: #0A0A0A">relation</FONT>
<FONT STYLE="color: #1C1C1D">to,</FONT> <FONT STYLE="color: #0A0A0A">the dividends payable on any other class or classes or any other
series; (iii) entitled</FONT> <FONT STYLE="color: #1C1C1D">to</FONT> <FONT STYLE="color: #0A0A0A">such rights upon the dissolution of,
or upon <FONT STYLE="letter-spacing: -0.25pt">any</FONT></FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 3.95pt 24.05pt 0 10.5pt; text-align: justify"><FONT STYLE="color: #0A0A0A">distribution
of the assets </FONT><FONT STYLE="color: #1C1C1D">of, </FONT><FONT STYLE="color: #0A0A0A">the Corporation; or </FONT><FONT STYLE="color: #1C1C1D">(iv)
</FONT><FONT STYLE="color: #0A0A0A">convertible into, or </FONT><FONT STYLE="color: #1C1C1D">exchangeable </FONT><FONT STYLE="color: #0A0A0A">for,
shares of any other class or classes of</FONT> <FONT STYLE="color: #1C1C1D">stock, or</FONT> <FONT STYLE="color: #0A0A0A">of</FONT> <FONT STYLE="color: #1C1C1D">any
other</FONT> <FONT STYLE="color: #0A0A0A">series of the same or any other class or classes of stock, of the Corporation at such price
or prices or at such rates of exchange and with such adjustments; all </FONT><FONT STYLE="color: #1C1C1D">as </FONT><FONT STYLE="color: #0A0A0A">may
be stated in such resolution or resolutions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.05pt 0 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; color: #0A0A0A"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10.8pt"></TD><TD STYLE="width: 35.95pt"><FONT STYLE="letter-spacing: -0.05pt"><B>B.</B></FONT></TD><TD STYLE="text-align: left"><FONT STYLE="letter-spacing: -0.1pt"><B>COMMON STOCK</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.5pt 0 0; text-align: left"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/100% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 46.8pt"></TD><TD STYLE="width: 35.8pt"><FONT STYLE="color: #0A0A0A">1.</FONT></TD><TD STYLE="text-align: justify; padding-right: 24.2pt"><FONT STYLE="color: #0A0A0A"><U>Voting Rights.</U> Except as provided by law or
this Certificate of Incorporation, each holder of Common Stock</FONT> <FONT STYLE="color: #1C1C1D">shall</FONT> <FONT STYLE="color: #0A0A0A">have
one vote in respect of each share of stock held by him of record on the books of the Corporation for the election of directors and on
all matters </FONT><FONT STYLE="color: #1C1C1D">submitted</FONT> <FONT STYLE="color: #0A0A0A">to</FONT> <FONT STYLE="color: #1C1C1D">a</FONT>
<FONT STYLE="color: #0A0A0A">vote of </FONT><FONT STYLE="color: #1C1C1D">stockholders of </FONT><FONT STYLE="color: #0A0A0A">the </FONT><FONT STYLE="color: #1C1C1D">Corporation.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/100% Times New Roman, Times, Serif; margin-top: 3.55pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 47.3pt"></TD><TD STYLE="width: 35.8pt">2.</TD><TD STYLE="text-align: justify; padding-right: 24pt"><U>Dividends.</U> Subject to the preferential rights of the Preferred Stock, the
holders of shares of Common Stock shall be entitled to receive, when and if declared by the Board of Directors, out of the assets of the
Corporation which are by law available therefor, dividends payable either in cash, in property, or in shares of capital stock.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 11.3pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 47.1pt"></TD><TD STYLE="width: 36pt">3.</TD><TD STYLE="text-align: justify; padding-right: 23.65pt"><U>Dissolution, Liquidation or Winding Up.</U> In the event of any dissolution,
liquidation or winding up of the affairs of the Corporation, after distribution in full of the preferential amounts, if any, to be distributed
to the holders of shares of Preferred Stock, holders of Common Stock shall be entitled to receive all of the remaining assets of the Corporation
of whatever kind available for distribution to stockholders ratably in proportion to the number of shares of Common Stock held by them
respectively. The Board of Directors may distribute in kind to the holders of Common Stock such remaining assets of the Corporation or
may sell, transfer or otherwise dispose of all or any part of such remaining assets to any other corporation, trust or other entity and
receive payment therefor in cash, stock or obligations of such other corporation, trust or entity, or any combination thereof, and may
sell all or any part of the consideration so received and distribute any balance thereof in kind to holders of Common Stock. Neither the
merger or consolidation of the Corporation into or with any other corporation, nor the merger of any other corporation into it, nor any
purchase or redemption of shares of stock of the Corporation of any class, shall be deemed to be a dissolution, liquidation or winding
up of the Corporation for the purpose of this paragraph.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.45pt 0 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt/100% Times New Roman, Times, Serif; margin: 0 24pt 0 11pt; text-align: justify; text-indent: 0.5in"><U>Fifth:</U>
The By-Laws of the Corporation may be adopted, amended or repealed by the affirmative vote of the holders of a majority of the voting
power of the capital stock of the Corporation outstanding and entitled to vote thereon. The Board of Directors shall also have the power
to adopt, amend or repeal any provision of the By-Laws of the Corporation without any vote of the stockholders of the Corporation.</P>

<P STYLE="font: 10pt/101% Times New Roman, Times, Serif; margin: 11.3pt 24.5pt 0 11pt; text-align: justify; text-indent: 36.1pt"><U>Sixth</U>:
Elections of directors need not be by written ballot unless the By-Laws of the Corporation shall otherwise provide.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 11.45pt 24pt 0 11pt; text-align: justify; text-indent: 36.2pt"><U>Seventh:</U>
Notwithstanding any provision of the General Corporation Law of the State of Delaware, no action may be taken by stockholders without
a meeting, without prior notice and without a vote, unless a consent in writing setting forth the action so taken shall be signed by the
holders of all the outstanding stock who would be entitled to vote thereon.</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 3.95pt 23.7pt 0 10.75pt; text-align: justify; text-indent: 34.8pt"><U>Eighth:</U>
Whenever a compromise or arrangement is proposed between this Corporation and its creditors or any class of them and/or between this Corporation
and its stockholders or any class of them, any court of equitable jurisdiction within the State of Delaware may, on the application in
a summary way of this Corporation or of any creditor or stockholder thereof or on the application of any receiver or receivers appointed
for this Corporation under the provisions of Section 291 of Title 8 of the Delaware Code or on the application of trustees in dissolution
or of any receiver or receivers appointed for this Corporation under the provisions of Section 279 of Title 8 of the Delaware Code order
a meeting of the creditors or class of creditors, and/or of the stockholders or class of stockholders of this Corporation, as the case
may be, to be summoned in such manner as the said court directs. <FONT STYLE="font-size: 10pt">If</FONT> a majority in number representing
three-fourths in value of the creditors or class of creditors, and/or of the stockholders or class of stockholders of this Corporation,
as the case may be, agree to any compromise or arrangement and to any reorganization of this Corporation as consequence of such compromise
or arrangement, the said compromise or arrangement and the said reorganization shall, if sanctioned by the court to which the said application
has been made, be binding on all the creditors or class of creditors, and/or on all of the stockholders or class of stockholders, of this
Corporation, as the case may be, and also on this Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.15pt 0 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt/100% Times New Roman, Times, Serif; margin: 0.05pt 24.2pt 0 10.85pt; text-align: justify; text-indent: 36.1pt"><U>Ninth:</U>
The Corporation reserves the right to amend, alter, change or repeal any provision contained in this Certificate of Incorporation, in
the manner now or hereafter prescribed by statute, and all rights conferred upon stockholders herein are granted subject to this reservation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.3pt 0 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 23.9pt 0 10.85pt; text-align: justify; text-indent: 36.35pt"><U>Tenth:</U>
1. <U>Vote for Certain Business Combinations.</U> In addition to any affirmative vote of holders of a class or series of capital stock
of the Corporation required by law or this Certificate, a Business Combination (as hereinafter defined) with or upon a proposal by a Related
Person (as hereinafter defined) shall require the affirmative vote of the holders of at least a majority of the voting power of all outstanding
Voting Stock (as hereinafter defined) of the Corporation, voting together as a single class. Such affirmative votes shall be required
notwithstanding the fact that no vote may be required, or that a lesser percentage may be specified, by law or the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.15pt 0 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0.05pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 47.3pt"></TD><TD STYLE="width: 35.8pt"><FONT STYLE="letter-spacing: -0.05pt">2.</FONT></TD><TD STYLE="text-align: justify; padding-right: 24.05pt"><U>When Vote Is Not Required.</U> The provisions of this Article shall not be
applicable to a particular Business Combination, and such Business Combination shall require only such affirmative vote as is required
by law and any other provision of this Certificate or the By-Laws of the Corporation, if all of the conditions specified in any one of
the following Paragraphs (A), (B) or (C) are met:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0.05pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 83.1pt"></TD><TD STYLE="width: 36.25pt"><FONT STYLE="letter-spacing: -0.05pt">(A)</FONT></TD><TD STYLE="text-align: justify; padding-right: 24.1pt"><U>Approval by Directors.</U> The Business Combination has been approved by a vote
of a majority of all the Continuing Directors (as hereinafter defined); <FONT STYLE="letter-spacing: -0.3pt">or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.5pt 0 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 83.05pt"></TD><TD STYLE="width: 36.15pt"><FONT STYLE="letter-spacing: -0.05pt">(B)</FONT></TD><TD STYLE="text-align: justify; padding-right: 23.85pt"><U>Combination with Subsidiary.</U> The Business Combination is solely between
the Corporation and a subsidiary of the Corporation and such Business Combination does not have the direct or indirect effect set forth
in Paragraph 3(B)(v) of this Article Tenth; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.15pt 0 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 83.1pt"></TD><TD STYLE="width: 36.25pt"><FONT STYLE="letter-spacing: -0.05pt">(C)</FONT></TD><TD STYLE="text-align: justify; padding-right: 24.35pt"><U>Price and Procedural Conditions.</U> The proposed Business Combination will
be consummated within three years after the date the Related Person became a Related Person (the &quot;Determination Date&quot;) and all
of the following conditions have been met:</TD></TR></TABLE>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/100% Times New Roman, Times, Serif; margin-top: 3.45pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 119.2pt"></TD><TD STYLE="width: 36.15pt"><FONT STYLE="letter-spacing: -0.05pt">(i)</FONT></TD><TD STYLE="text-align: justify; padding-right: 24pt">The aggregate amount of (x) cash and (y) fair market value (as of the date of the
consummation of the Business Combination) of consideration other than cash, to be received per share of Common or Preferred Stock of the
Corporation in such Business Combination by holders thereof shall be at least equal to the</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 3.4pt 23.85pt 0 155.2pt; text-align: justify">highest per share price (including
any brokerage commissions, transfer taxes and soliciting dealers' fees) paid by the Related Person for any shares of such class or series
of stock acquired by it; provided, that if either (a) the highest preferential amount per share of a series of Preferred Stock to which
the holders thereof would be entitled in the event of any voluntary or involuntary liquidation, dissolution or winding-up of the affairs
of the Corporation <FONT STYLE="letter-spacing: -0.1pt">(regardless of whether the Business Combination to be consummated </FONT>constitutes
such an event) or (b) the highest reported sales price per share for any shares of such series of Preferred Stock on any national securities
exchange on which such series is traded and if not traded on any such exchange, the highest reported closing bid quotation per share with
respect to shares of such series on the National Association of Securities Dealers, Inc. Automated Quotation System or on any system then
in use, at any time after the Related Person became a holder of any shares of Common Stock, is greater than such aggregate amount, holders
of such series of Preferred Stock shall receive an amount for each such share at least equal to the greater of (a) or (b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.55pt 0 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 119.2pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt">(ii)</FONT></TD><TD STYLE="text-align: justify; padding-right: 24pt"><FONT STYLE="font-size: 10pt">The consideration to be received by holders of a particular
class or series of outstanding Common or Preferred Stock shall be in cash or in the same form as the Related Person has previously paid
for shares of such class or series of stock.</FONT> If <FONT STYLE="font-size: 10pt">the Related Person has paid for shares of any class
or series of stock with varying forms of consideration, the form of consideration given for such class or series of stock in the Business
Combination shall be either cash or the form used to acquire the largest number of shares of such class or series of stock previously
acquired by it.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.05pt 0 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/100% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 119.2pt"></TD><TD STYLE="width: 36.15pt"><FONT STYLE="letter-spacing: -0.05pt">(iii)</FONT></TD><TD STYLE="text-align: justify; padding-right: 24.4pt">No Extraordinary Event (as hereinafter defined) occurs after the Determination
Date and prior to the consummation of the Business <FONT STYLE="letter-spacing: -0.1pt">Combination.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.45pt 0 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 119.2pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-size: 10pt; letter-spacing: -0.05pt">(iv)</FONT></TD><TD STYLE="text-align: justify; padding-right: 24.1pt"><FONT STYLE="font-size: 10pt">A proxy or information statement describing the proposed
Business Combination and complying with the requirements of the Securities Exchange Act of </FONT>1934, <FONT STYLE="font-size: 10pt">as
amended, and the rules and regulations thereunder (or any subsequent provisions replacing such Act, rules or regulations) is mailed to
public stockholders of the Corporation at least 30 days prior to the consummation of such Business Combination (whether or not such proxy
or information statement is required pursuant to such Act or subsequent provisions).</FONT></TD></TR></TABLE>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 3.05pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 46.95pt"></TD><TD STYLE="width: 36.25pt"><FONT STYLE="letter-spacing: -0.05pt">3.</FONT></TD><TD STYLE="text-align: justify"><U>Certain Definitions.</U> For purposes of this Article <FONT STYLE="letter-spacing: -0.1pt">Tenth:</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 3.5pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 83.1pt"></TD><TD STYLE="width: 36.25pt"><FONT STYLE="letter-spacing: -0.05pt">(A)</FONT></TD><TD STYLE="text-align: justify; padding-right: 23.9pt">A &quot;person&quot; shall mean any individual, firm, corporation or other entity,
or a group of &quot;persons&quot; acting or agreeing to act together in the manner set forth in Rule 13d-5 under the Securities Exchange
Act of 1934, as in effect on April 24, 1985.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.15pt 0 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/100% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 83.2pt"></TD><TD STYLE="width: 36.15pt"><FONT STYLE="letter-spacing: -0.05pt">(B)</FONT></TD><TD STYLE="text-align: justify; padding-right: 24.15pt">The term &quot;Business Combination&quot; shall mean any of the following transactions,
when entered into by the Corporation or a subsidiary of the Corporation with, or upon a proposal by, a Related Person:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/101% Times New Roman, Times, Serif; margin-top: 11.5pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 119.2pt"></TD><TD STYLE="width: 36.15pt"><FONT STYLE="letter-spacing: -0.05pt">(i)</FONT></TD><TD STYLE="text-align: justify; padding-right: 24.15pt">the merger or consolidation of the Corporation or any subsidiary of the Corporation;
or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 11.45pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 119.45pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="letter-spacing: -0.05pt">(ii)</FONT></TD><TD STYLE="text-align: justify; padding-right: 24.6pt">the sale, lease, exchange, mortgage, pledge, transfer or other disposition (in
one or a series of transactions) of any assets of the Corporation or any subsidiary of the Corporation having an aggregate fair market
value of $100 million or more; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.15pt 0 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 119.2pt"></TD><TD STYLE="width: 36.15pt"><FONT STYLE="letter-spacing: -0.05pt">(iii)</FONT></TD><TD STYLE="text-align: justify; padding-right: 24.4pt">the issuance or transfer by the Corporation or any subsidiary of the Corporation
(in one or a series of transactions) of securities of the Corporation or any subsidiary having an aggregate fair market value of $50 million
or more; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.15pt 0 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/100% Times New Roman, Times, Serif; margin-top: 0.05pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 119.2pt"></TD><TD STYLE="width: 36.15pt"><FONT STYLE="letter-spacing: -0.05pt">(iv)</FONT></TD><TD STYLE="text-align: justify; padding-right: 24.8pt">the adoption of a plan or proposal for the liquidation or dissolution of the Corporation;
or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.3pt 0 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 119.2pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="letter-spacing: -0.05pt">(v)</FONT></TD><TD STYLE="text-align: justify; padding-right: 24.05pt">the reclassification of securities (including a reverse stock split), recapitalization,
consolidation or any other transaction (whether or not involving a Related Person) which has the direct or indirect effect of increasing
the voting power, whether or not then exercisable, of a Related Person in any class or series of capital stock of the Corporation or any
subsidiary of the Corporation; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.05pt 0 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0.05pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 119.2pt"></TD><TD STYLE="width: 36.25pt"><FONT STYLE="letter-spacing: -0.05pt">(vi)</FONT></TD><TD STYLE="text-align: justify; padding-right: 24.05pt">any agreement, contract or other arrangement providing directly or indirectly
for any of the foregoing.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.45pt 0 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0.05pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 83.1pt"></TD><TD STYLE="width: 36.25pt"><FONT STYLE="letter-spacing: -0.05pt">(C)</FONT></TD><TD STYLE="text-align: justify; padding-right: 23.9pt">The term &quot;Related Person&quot; shall mean any person (other than the Corporation,
a subsidiary of the Corporation or any profit sharing, employee stock ownership or other employee benefit plan of the Corporation or of
a subsidiary of the Corporation or any trustee of or fiduciary with respect to any such plan acting in such capacity) that is the direct
or indirect beneficial owner (as defined in Rule 13d-3 and Rule 13d-5 under the Securities Exchange Act of 1934) of more than ten percent
(10%) of the outstanding Voting Stock of the Corporation, and any Affiliate or Associate of any such <FONT STYLE="letter-spacing: -0.1pt">person.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.05pt 0 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.05pt 0 0; text-align: left"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.05pt 0 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.05pt 0 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/100% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 83.05pt"></TD><TD STYLE="width: 36.15pt"><FONT STYLE="letter-spacing: -0.05pt">(D)</FONT></TD><TD STYLE="text-align: justify; padding-right: 24.05pt">The term &quot;Continuing Director&quot; shall mean any member of the Board of
Directors who is not affiliated with a Related Person and who was a member of the Board of Directors
immediately prior to the time that the Related Person became a Related Person, and any
successor to a Continuing Director who is not affiliated with the Related Person and is recommended to succeed a Continuing Director
by a majority of Continuing Directors who are then members of the Board of Directors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 3.95pt 0 0 119.2pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.15pt 0 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0.05pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 83.05pt"></TD><TD STYLE="width: 36.05pt"><FONT STYLE="letter-spacing: -0.05pt">(E)</FONT></TD><TD STYLE="text-align: justify; padding-right: 24.3pt">&quot;Affiliate&quot; and &quot;Associate&quot; shall have the respective meanings
ascribed to such terms in Rule 12b-2 under the Securities Exchange Act of 1934.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.5pt 0 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/100% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 83.1pt"></TD><TD STYLE="width: 36.25pt"><FONT STYLE="letter-spacing: -0.05pt">(F)</FONT></TD><TD STYLE="text-align: justify; padding-right: 24.2pt">The term &quot;Extraordinary Event&quot; shall mean, as to any Business Combination
and Related Person, any of the following events that is not approved by a majority of all Continuing Directors:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/100% Times New Roman, Times, Serif; margin-top: 11.45pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 119.2pt"></TD><TD STYLE="width: 36.15pt"><FONT STYLE="letter-spacing: -0.05pt">(i)</FONT></TD><TD STYLE="text-align: justify; padding-right: 24.55pt">any failure to declare and pay at the regular date therefor any full quarterly
dividend (whether or not cumulative) on outstanding Preferred Stock; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.45pt 0 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 119.2pt"></TD><TD STYLE="width: 36.15pt"><FONT STYLE="letter-spacing: -0.05pt">(ii)</FONT></TD><TD STYLE="text-align: justify; padding-right: 24.3pt">any reduction in the annual rate of dividends paid on the Common Stock (except
as necessary to reflect any subdivision of the Common Stock); or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.4pt 0 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 119.2pt"></TD><TD STYLE="width: 36.15pt"><FONT STYLE="letter-spacing: -0.05pt">(iii)</FONT></TD><TD STYLE="text-align: justify; padding-right: 23.95pt">any failure to increase the annual rate of dividends paid on the Common Stock
as necessary to reflect any reclassification (including any reverse stock split), recapitalization, reorganization or any similar transaction
that has the effect of reducing the number of outstanding shares of the Common Stock; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.15pt 0 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 119.2pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="letter-spacing: -0.05pt">(iv)</FONT></TD><TD STYLE="text-align: justify; padding-right: 23.95pt">the receipt by the Related Person, after the Determination Date, of a direct or
indirect benefit (except proportionately as a stockholder) from any loans, advances, guarantees, pledges or other financial assistance
or any tax credits or other tax advantages provided by the Corporation or any subsidiary of the Corporation, whether in anticipation of
or in connection with the Business Combination or <FONT STYLE="letter-spacing: -0.1pt">otherwise.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.1pt 0 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 83.05pt"></TD><TD STYLE="width: 36.15pt"><FONT STYLE="letter-spacing: -0.05pt">(G)</FONT></TD><TD STYLE="text-align: justify; padding-right: 23.95pt">A majority of all Continuing Directors shall have the power to make all determinations
with respect to this Article Tenth, including, without limitation, the transactions that are Business Combinations, the persons who are
Related Persons, the time at which a Related Person became a Related Person, and the fair market value of any assets, securities or other
property, and any such determinations of such directors shall be conclusive and <FONT STYLE="letter-spacing: -0.1pt">binding.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/100% Times New Roman, Times, Serif; margin-top: 0.05in; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 83.1pt"></TD><TD STYLE="width: 36.25pt"><FONT STYLE="letter-spacing: -0.05pt">(H)</FONT></TD><TD STYLE="text-align: justify; padding-right: 23.95pt">The term &quot;Voting Stock&quot; shall mean all outstanding shares of the Common
or Preferred Stock of the Corporation entitled to vote generally and each reference to a proportion of Voting Stock shall refer to shares
having such proportion of the number of shares entitled to be cast.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/100% Times New Roman, Times, Serif; margin-top: 3.95pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 47.2pt"></TD><TD STYLE="width: 35.9pt"><FONT STYLE="letter-spacing: -0.05pt">4.</FONT></TD><TD STYLE="text-align: justify; padding-right: 29.95pt"><U>No Effect on Fiduciary Obligations of Related Persons.</U> Nothing contained
in this Article Tenth shall be construed to relieve any Related Person from any fiduciary obligation imposed by law.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.3pt 0 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 23.85pt 0 11pt; text-align: justify; text-indent: 0.5in"><U>Eleventh:</U>
To the fullest extent permitted by the General Corporation Law of the State of Delaware as the same exists or may hereafter be amended,
no director of the Corporation shall be liable to the Corporation or its stockholders for monetary damages for breach of fiduciary duty
as a director. Any repeal or modification of the preceding sentence shall not adversely affect any right or protection of a director existing
at the time of such repeal or modification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.1pt 0 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 200.75pt 0 186.25pt; text-align: center"><I>[Signature page <FONT STYLE="letter-spacing: -0.1pt">follows]</FONT></I></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 3.95pt 0 0 5pt; text-align: left; text-indent: 0.5in">IN WITNESS WHEREOF,
the Corporation has caused this Restated Certificate of Incorporation to be signed in its name by the undersigned officer on the 8th day
of February, 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 3.95pt 0 0 5pt; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 33%">&nbsp;</TD>
  <TD STYLE="width: 34%">&nbsp;</TD>
  <TD STYLE="width: 33%">&nbsp;<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"><B>THE
CIGNA <FONT STYLE="letter-spacing: -0.2pt">GROUP</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"><B></B></P>

<P STYLE="margin-bottom: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-left: 0; text-indent: 0pt; text-align: justify"><FONT STYLE="letter-spacing: 0">By:
<U>/s/ Kari K. Stevens</U></FONT></P>

<P STYLE="margin-bottom: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-left: 0pt; text-indent: 0pt; text-align: justify">Name:
Kari K. Stevens</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-left: 0pt; text-indent: 0pt; text-align: justify">Title:
<FONT STYLE="letter-spacing: -0.1pt">Secretary</FONT></P>

</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.1pt 0 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.3
<SEQUENCE>4
<FILENAME>ex3-3.htm
<DESCRIPTION>EXHIBIT 3.3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0">Exhibit 3.3</P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">AMENDED AND RESTATED BY-LAWS OF<BR>
<BR>
THE CIGNA GROUP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 24pt; text-align: center">(A Delaware Corporation)</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">Article&nbsp;I</FONT><BR>
<BR>
Offices</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Registered Office</U>. The registered office of The Cigna Group (hereinafter, the &ldquo;Corporation&rdquo;) within the State
of Delaware shall be in the City of Wilmington, County of New Castle.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Other Offices</U>. The Corporation may also have offices at such other places, both within and without the State of Delaware,
as the Board of Directors shall from time to time determine or the business of the Corporation may require.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">Article&nbsp;II</FONT><BR>
<BR>
Meetings of Shareholders</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Place of Meetings</U>. All meetings of the shareholders for the election of directors or for any other purpose shall be held
at any such place, either within or without the State of Delaware, or by means of remote communication pursuant to the Delaware General
Corporation Law (the &ldquo;DGCL&rdquo;), as shall be designated from time to time by the Board of Directors and stated in the notice
of the meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Annual Meeting</U>. The annual meeting of shareholders shall be held on such date and at such time as shall be designated from
time to time by the Board of Directors and stated in the notice of the meeting. At such annual meeting, the shareholders shall elect directors
to the Board of Directors and transact such other business as may properly be brought before the meeting. The Board of Directors may postpone,
reschedule or cancel any previously scheduled annual meeting of shareholders for any reason. A nominee for director shall be elected to
the Board of Directors if the votes cast for such nominee&rsquo;s election exceed the votes cast against such nominee&rsquo;s election;
provided, however, that directors shall be elected by a plurality of the votes cast at any meeting of shareholders for which the number
of director nominees exceeds the number of directors to be elected (a &ldquo;contested election&rdquo;). A contested election shall be
deemed to exist at any meeting of shareholders for which (a)&nbsp;the Corporate Secretary of the Corporation receives a notice that a
shareholder has nominated a person for election to the Board of Directors in compliance with Section&nbsp;11 or Section&nbsp;13 of this
Article&nbsp;II and (b)&nbsp;such nomination has not been withdrawn by such shareholder on or prior to the day next preceding the date
the Corporation first mails its notice of meeting for such meeting to the shareholders. If directors are to be elected in a contested
election, shareholders shall not be permitted to vote against a nominee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Special Meetings</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Special meetings of shareholders, unless otherwise prescribed by statute, may only be called (i)&nbsp;at any time by the Board
of Directors, the Chief Executive Officer or the Chair of the Board or (ii)&nbsp;pursuant to the procedures set forth in Section&nbsp;3(b)
of this Article&nbsp;II. The Board of Directors may postpone, reschedule or cancel any previously scheduled special meeting of shareholders
called pursuant to the foregoing clause (i) for any reason.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>A special meeting of the shareholders shall be called by the Corporate Secretary of the Corporation upon the request in proper
written form (a &ldquo;Special Meeting Request&rdquo;) of one or more shareholders that have Net Long Beneficial Ownership, and will have
had continuous Net Long Beneficial Ownership for a period of at least one full year prior to the date of such request, of capital stock
of the Corporation representing at least 25% of the voting power of the issued and outstanding capital stock of the Corporation entitled
to vote on matters to be presented at the special meeting (the &ldquo;Requisite Percentage&rdquo;). The Board of Directors may submit
its own proposal or proposals for consideration at a special meeting called at the request of one or more shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>A Special Meeting Request must be delivered to or mailed and received by the Corporate Secretary of the Corporation at the principal
executive offices of the Corporation, in accordance with the terms of this Section&nbsp;3(b). A Special Meeting Request shall be valid
only if it is signed and dated by each shareholder of record submitting the Special Meeting Request and each beneficial owner, if any,
on whose behalf the Special Meeting Request is being made, or such shareholder&rsquo;s or beneficial owner&rsquo;s duly authorized agent
(each, a &ldquo;Requesting Shareholder&rdquo;). Any beneficial owner who wishes to deliver a Special Meeting Request must cause the nominee
or other person who serves as the record shareholder of such beneficial owner&rsquo;s stock to sign such Special Meeting Request. If a
record shareholder is the nominee for more than one beneficial owner of stock, the record shareholder may deliver a Special Meeting Request
solely with respect to the common stock of the Corporation owned by the beneficial owner who is directing the record shareholder to sign
such Special Meeting Request. The term &ldquo;Requesting Shareholder&rdquo; shall not include any shareholder that has provided a request
to call a special meeting in response to a solicitation made pursuant to, and in accordance with, Section 14 of the Securities Exchange
Act of 1934, as amended (together with the rules and regulations promulgated thereunder, the &ldquo;Exchange Act&rdquo;) by way of a definitive
consent solicitation statement filed with the U.S. Securities and Exchange Commission (the &ldquo;SEC&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; width: 34%; vertical-align: middle">-&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>To be in proper written form, a Special Meeting Request must include the following information: (1) in the case of any director
nominations proposed to be presented at the special meeting, all of the information, statements, questionnaires and representations required
by Section&nbsp;11(c) of this Article&nbsp;II; (2) in the case of any shareholder proposals proposed to be presented at the special meeting,
all of the information, statements and representations required by Section&nbsp;12(c) of this Article&nbsp;II; (3)&nbsp;an agreement by
the Requesting Shareholder to notify the Corporation promptly in the event of (A)&nbsp;any disposition prior to the time of the special
meeting of any shares included within any Requesting Shareholder&rsquo;s Net Long Beneficial Ownership as of the date on which the Special
Meeting Request was delivered to the Corporate Secretary of the Corporation and (B)&nbsp;any other material change prior to the time of
the special meeting in any Requesting Shareholder&rsquo;s Net Long Beneficial Ownership; (4)&nbsp;an acknowledgement that (A)&nbsp;any
disposition prior to the date of the special meeting of any capital stock of the Corporation included in any Requesting Shareholder&rsquo;s
Net Long Beneficial Ownership as of the date on which the Special Meeting Request was delivered to the Corporate Secretary of the Corporation
shall be deemed to be a revocation of such Special Meeting Request with respect to such disposed shares and (B)&nbsp;that any decrease
in the Requesting Shareholders&rsquo; aggregate Net Long Beneficial Ownership to less than the Requisite Percentage shall be deemed to
be an absolute revocation of such Special Meeting Request; and (5)&nbsp;documentary evidence that the Requesting Shareholders had Net
Long Beneficial Ownership of at least the Requisite Percentage as of the date of delivery of the Special Meeting Request to the Corporate
Secretary of the Corporation and for a period of at least one full year prior to the date of delivery of such Special Meeting Request;
provided, however, that if any of the Requesting Shareholders are not the beneficial owners of the shares representing the Requisite Percentage,
then to be valid, the Special Meeting Request must also include documentary evidence that the beneficial owners on whose behalf the Special
Meeting Request is made had, together with any Requesting Shareholders who are beneficial owners, Net Long Beneficial Ownership of the
Requisite Percentage as of the date of delivery of such Special Meeting Request to the Corporate Secretary of the Corporation and for
a period of at least one full year prior to the date of delivery of such Special Meeting Request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In addition, the Requesting Shareholders on whose behalf the Special Meeting Request is being made shall (1)&nbsp;update the information
provided in the Special Meeting Request, if necessary, so that the information provided or required to be provided therein shall be true
and correct as of the record date for the special meeting (with such information to be delivered no later than five business days after
such record date) and as of the date that is 10 business days prior to the date of the special meeting or any adjournment, postponement
or rescheduling thereof, or, if there are fewer than 10 business days between the date of the special meeting and any such adjourned,
postponed or rescheduled meeting, then as of the date of such adjourned, postponed or rescheduled meeting (with such information to be
delivered no later than five business days prior to the date of such meeting) and (2)&nbsp;promptly provide any other information reasonably
requested by the Corporation. Information provided pursuant to the preceding sentence shall be delivered to the Corporate Secretary of
the Corporation at the principal executive offices of the Corporation as set forth in the immediately preceding sentence or as promptly
as practicable following the applicable request. A failure to deliver such information as required shall constitute a revocation of the
applicable Special Meeting Request by the applicable Requesting Shareholder(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; width: 34%; vertical-align: middle">-&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If any information submitted pursuant to this Section&nbsp;3(b) is inaccurate or incomplete in any material respect, such information
shall be deemed not to have been provided in accordance with these By-Laws. The Requesting Shareholder shall notify the Corporate Secretary
in writing at the principal executive offices of the Corporation of any inaccuracy or change in any information submitted pursuant to
this Section&nbsp;3(b) within two business days after becoming aware of such inaccuracy or change. Upon written request of the Corporate
Secretary on behalf of the Board of Directors (or a duly authorized committee thereof), the Requesting Shareholder shall provide, within
seven business days after delivery of such request (or such longer period as may be specified in such request), (1)&nbsp;written verification,
reasonably satisfactory to the Board of Directors, any committee thereof or any authorized officer of the Corporation, to demonstrate
the accuracy of any information submitted by the Requesting Shareholder pursuant to this Section&nbsp;3(b), and (2) a written affirmation
of any information submitted by the Requesting Shareholder pursuant to this Section&nbsp;3(b) as of an earlier date. If the Requesting
Shareholder fails to provide such written verification or affirmation within such period, the information as to which written verification
or affirmation was requested may be deemed not to have been provided in accordance with these By-Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>A Special Meeting Request shall not be valid, and a special meeting requested by shareholders shall not be held, if (1)&nbsp;the
Special Meeting Request does not comply with this Section&nbsp;3(b); (2)&nbsp;the Special Meeting Request relates to an item of business
that is not a proper subject for shareholder action under the DGCL; (3)&nbsp;the Special Meeting Request is delivered during the period
commencing 120 days prior to the first anniversary of the date of the immediately preceding annual meeting of shareholders and ending
on the earlier of (A)&nbsp;the date of the next annual meeting or (B)&nbsp;120 days after the first anniversary of the date of the previous
annual meeting; (4)&nbsp;an identical or substantially similar item (as determined in good faith by the Board of Directors), other than
the election of directors, (A)&nbsp;was presented at an annual or special meeting of shareholders held not more than 12 months before
delivery of the Special Meeting Request or (B)&nbsp;is included in the Corporation&rsquo;s notice of meeting as an item of business to
be brought before an annual or special meeting of shareholders that has been called but not yet held or that is called for a date within
120 days of the receipt by the Corporation of a Special Meeting Request; or (5)&nbsp;the Special Meeting Request was made in a manner
that involved a violation of the Exchange Act or other applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(vi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Special meetings of shareholders validly requested pursuant to this Section&nbsp;3(b) shall be held not more than 120 days after
receipt by the Corporation of a valid Special Meeting Request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(vii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Requesting Shareholders (or any of them) may revoke a Special Meeting Request by written revocation delivered to the Corporate
Secretary of the Corporation at the principal executive offices of the Corporation at any time prior to the special meeting. If, following
such revocation (or any deemed revocation pursuant to clause&nbsp;(4) of Section&nbsp;3(b)(ii)), there are unrevoked requests from Requesting
Shareholders holding in the aggregate less than the Requisite Percentage (or there are no unrevoked requests at all), the Board of Directors,
in its discretion, may cancel the special meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(viii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If none of the Requesting Shareholders (or any Qualified Representative thereof) appears (including virtually, in the case of a
meeting held solely by means of remote communication) to present the business specified in the Special Meeting Request to be presented
for consideration, the Corporation need not present such business for a vote at the special meeting, notwithstanding that proxies in respect
of such business may have been received by the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; width: 34%; vertical-align: middle">-&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(ix)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Business transacted at any special meeting called pursuant to this Section&nbsp;3(b) shall be limited to (1)&nbsp;the purpose(s)
stated in a valid Special Meeting Request received from the Requesting Shareholders holding in the aggregate the Requisite Percentage
and (2)&nbsp;any additional matters that the Board of Directors determines to include in the Corporation&rsquo;s notice of the special
meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(x)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Board of Directors shall determine in good faith whether all requirements set forth in this Section&nbsp;3(b) have been satisfied
and such determination shall be binding on the Corporation and its shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Notice of Meetings</U>. Except as otherwise expressly required by statute, written notice, or notice in the form of electronic
transmission to shareholders who have consented to receive notice in such form, of each annual and special meeting of shareholders stating
the place, date and time of the meeting, the means of remote communication (if any) by which shareholders and proxyholders may be deemed
present in person and may vote at the meeting and, in the case of a special meeting, the purpose or purposes for which the meeting is
called, shall be given, as permitted by applicable law, to each shareholder of record entitled to notice of the meeting not less than
10 days nor more than 60 days before the date of such meeting. Business transacted at any special meeting of shareholders shall be limited
to the purposes stated in the notice. If mailed, such notice shall be sent in a postage prepaid envelope, addressed to the shareholder
at his or her address as it appears on the records of the Corporation. Such notice shall be deemed given (a)&nbsp;if by mail, at the time
when the same shall be deposited in the United States mail, postage prepaid; (b)&nbsp;if by facsimile telecommunication, when directed
to a number at which the shareholder has consented to receive notice; (c)&nbsp;if by electronic mail, when directed to an electronic mail
address at which the shareholder has consented to receive such notice; (d)&nbsp;if by a posting on an electronic network together with
a separate notice to the shareholder of such specific posting, upon the later to occur of (i)&nbsp;such posting, or (ii)&nbsp;the giving
of the separate notice of such posting; or (e)&nbsp;if by any other form of electronic communication, when directed to the shareholder
in the manner consented to by the shareholder. Any such consent shall be revocable by the shareholder by written notice to the Corporation.
Any such consent shall be deemed revoked if (1)&nbsp;the Corporation is unable to deliver by electronic transmission two consecutive notices
given by the Corporation in accordance with such consent and (2)&nbsp;such inability becomes known to the Corporate Secretary or Assistant
Corporate Secretary of the Corporation or to the transfer agent or other person responsible for giving notice; provided, however, that
inadvertent failure to treat such inability as a revocation shall not invalidate any meeting or other action. Notice of any meeting shall
not be required to be given to any person who attends such meeting, except when such person attends the meeting in person or by proxy
for the express purpose of objecting, at the beginning of the meeting, to the transaction of any business because the meeting is not lawfully
called or convened, or who, either before or after the meeting, shall submit a signed written waiver of notice, or a waiver by electronic
transmission, in person or by proxy. Neither the business to be transacted at, nor the purpose of, an annual or special meeting of shareholders
need be specified in any written waiver of notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; width: 34%; vertical-align: middle">-&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>List of Shareholders</U>. The Corporate Secretary of the Corporation, or such other person who has charge of the stock ledger
of the Corporation shall prepare and make, at least 10 days before each meeting of shareholders, a complete list of the shareholders entitled
to vote at the meeting, arranged in alphabetical order, showing the address of and the number of shares registered in the name of each
shareholder. Such list shall be open to the examination of any shareholder, for any purpose germane to the meeting, during ordinary business
hours, for a period of at least 10 days ending on the day before the meeting date, in the manner provided by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Quorum, Adjournments</U>. The holders of at least two-fifths of the issued and outstanding stock of the Corporation entitled
to vote thereat, present in person or represented by proxy, shall constitute a quorum for the transaction of business at all meetings
of shareholders, except as otherwise required by statute or by the Certificate of Incorporation. If, however, such quorum shall not be
present or represented by proxy at any meeting of shareholders, a majority of the voting power entitled to vote thereon, present in person
or represented by proxy, shall have the power to adjourn the meeting from time to time, without notice other than announcement at the
meeting, until a quorum shall be present or represented by proxy. The chair of the meeting shall have the power to adjourn the meeting
from time to time, without notice other than announcement at the meeting, regardless of quorum. No notice of the time and place of the
adjourned meeting (including an adjournment taken to address a technical failure to convene or continue a meeting using remote communication)
and means of remote communication (if any) by which shareholders and proxyholders may be deemed present in person and vote at such adjourned
meeting need be given if the time and place, if any, thereof, and the means of remote communication, if any, by which stockholders and
proxy holders may be deemed to be present in person and vote at such adjourned meeting, are (a) announced at the meeting at which the
adjournment taken, (b) displayed during the time scheduled for the meeting, on the same electronic network used to enable stockholders
and proxy holders to participate in the meeting by means of remote communication or (c) set forth in the notice of meeting given in accordance
with these By-Laws. At such adjourned meeting at which a quorum shall be present or represented by proxy, any business may be transacted
which might have been transacted at the meeting as originally called. If the adjournment is for more than 30 days, or, if after adjournment
a new record date is set, a notice of the adjourned meeting shall be given to each shareholder of record entitled to vote at the meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Organization</U>. At each meeting of shareholders, the Chair of the Board or, in the Chair&rsquo;s absence, the Lead Independent
Director (if one has been appointed) or, in the Lead Independent Director&rsquo;s absence, a director or officer of the Corporation chosen
by the Board of Directors at the meeting, shall act as chair of the meeting. The Corporate Secretary or, in the Corporate Secretary&rsquo;s
absence or inability to act, the person whom the chair of the meeting shall appoint secretary of the meeting shall act as secretary of
the meeting and keep the minutes thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; width: 34%; vertical-align: middle">-&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;8.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Order of and Rules for Conducting Business</U>. The order of and the rules, regulations and procedures for conducting business
at all meetings of the shareholders shall be as determined by the chair of the meeting or the Board of Directors. Such rules, regulations
or procedures, whether adopted by the chair of the meeting or the Board of Directors, may include, without limitation, the following:
(a) the establishment of an agenda for the meeting; (b)&nbsp;rules and procedures for maintaining order at the meeting and the safety
of those present at the meeting; (c) limitations on attendance at or participation in the meeting to shareholders of record of the Corporation,
their duly authorized and constituted proxies or such other persons as the chair of the meeting shall determine; (d) restrictions on entry
to the meeting after the time fixed for the commencement thereof; (e) limitations on the time allotted to questions or comments by participants;
(f) the determination of when the polls shall open and close for any given matter to be voted on at the meeting; (g) removal of any shareholder
or any other individual who refuses to comply with meeting rules, regulations or procedures; (h) restrictions on the use of audio and
video recording devices, cell phones and other electronic devices; (i)&nbsp;rules, regulations and procedures for compliance with any
federal, state or local laws or regulations including those concerning safety, health or security; (j) procedures (if any) requiring attendees
to provide the Corporation advance notice of their intent to attend the meeting; and (k)&nbsp;any rules, regulations or procedures as
the chair of the meeting may deem appropriate regarding the participation by means of remote communication of shareholders and proxyholders
not physically present at a meeting, whether such meeting is to be held at a designated place or solely by means of remote communication.
Unless and to the extent determined by the chair of the meeting or the Board of Directors, meetings of shareholders shall not be required
to be held in accordance with the rules of parliamentary procedure. The chair of the meeting, in addition to making any other determinations
that may be appropriate to the conduct of the meeting, shall, if the facts warrant, determine and declare to the meeting that a matter
or business was not properly brought before the meeting and if the chair of the meeting should so determine, he or she shall so declare
to the meeting and any such matter or business not properly brought before the meeting shall not be transacted or considered.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;9.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Voting</U>. Except as otherwise provided by statute, the Certificate of Incorporation, or any resolution or resolutions adopted
by the Board of Directors pursuant to the authority vested in it by the Certificate of Incorporation, each shareholder of the Corporation
shall be entitled at each meeting of shareholders to one vote for each share of capital stock of the Corporation standing in such shareholder&rsquo;s
name on the record of shareholders of the Corporation:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>on the date fixed pursuant to the provisions of Section&nbsp;7 of Article&nbsp;V as the record date for the determination of the
shareholders who shall be entitled to vote at such meeting; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>if no such record date shall have been fixed, then at 5:00 p.m. Eastern Time (the &ldquo;close of business&rdquo;) on the day next
preceding the day on which notice thereof shall be given, or, if notice is waived by all shareholders, at the close of business on the
day next preceding the day on which the meeting is held.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Each shareholder entitled to vote at any meeting
of shareholders may vote in person or may authorize another person or persons to act for such shareholder by a proxy authorized by an
instrument in writing or by a transmission permitted by law delivered to the Inspectors of Election, but no such proxy shall be voted
after three years from its date, unless the proxy provides for a longer period. Any copy, facsimile telecommunication or other reliable
reproduction of the writing or transmission created pursuant to this paragraph may be substituted or used in lieu of the original writing
or transmission for any and all purposes for which the original writing or transmission could be used; provided that such copy, facsimile
telecommunication or other reproduction shall be a complete reproduction of the entire original writing or transmission. A duly executed
proxy shall be irrevocable if it states that it is irrevocable and if, and only as long as, it is coupled with an interest sufficient
in law to support an irrevocable power. A shareholder may revoke any proxy which is not irrevocable by attending the meeting and voting
in person or by delivering an instrument in writing or a transmission permitted by law revoking the proxy or constituting another valid
proxy bearing a later date to the Inspectors. Any such proxy shall be delivered to the Inspectors, or such other person so designated
to receive proxies, at or prior to the time designated in the order of business for so delivering such proxies. When a quorum is present
at any meeting, the affirmative vote of the holders of a majority of the voting power of the Corporation present in person or by proxy
at such meeting and entitled to vote on the subject matter, shall decide any question brought before such meeting, unless the question
is one upon which by express provision of statute or of the Certificate of Incorporation or of these By-Laws, a different vote is required,
in which case such express provision shall govern and control the decision of such question. Unless required by statute, or determined
by the chair of the meeting to be advisable, the vote on any question need not be by ballot. On a vote by ballot, each ballot shall be
signed by the shareholder voting, or by the shareholder&rsquo;s proxy, if there be such proxy, and shall state the number of shares voted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; width: 34%; vertical-align: middle">-&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;10.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Inspectors of Election</U>. The Board of Directors, the Chair of the Board or the Chief Executive Officer shall, in advance
of any meeting of shareholders, appoint one or more Inspectors of Election to act at the meeting or at any adjournment and make a written
report thereof, and may designate one or more persons as alternate Inspectors to replace any Inspectors who fail to act. If no Inspector
or alternate is able to act at a meeting of shareholders, the chair of the meeting shall appoint one or more Inspectors to act at the
meeting. Each Inspector, before entering upon the discharge of his or her duties, shall take and sign an oath faithfully to execute the
duties of Inspector at such meeting with strict impartiality and according to the Inspector&rsquo;s best ability. The Inspectors shall
determine the number of shares outstanding and the voting power of each, the number of shares represented at the meeting and the validity
of proxies and ballots, receive and count all votes and ballots, determine all challenges and questions arising in connection with the
right to vote, retain for a reasonable period a record of the disposition of any challenges made to any determination by the Inspectors,
and certify their determination of the number of shares represented at the meeting, and their count of all votes and ballots and report
the same to the chair of the meeting, and do such acts as are proper to conduct the election or vote with fairness to all shareholders.
The Inspectors may appoint or retain other persons or entities to assist the Inspectors in the performance of the duties of the Inspectors.
The date and time of the opening and the closing of the polls for each matter upon which the shareholders will vote at a meeting shall
be announced at the meeting by the chair of the meeting. No ballot, proxies or votes, nor any revocations thereof or changes thereto,
shall be accepted by the Inspectors after the closing of the polls unless the Court of Chancery upon application by a shareholder shall
determine otherwise. On request of the chair of the meeting, the Inspectors shall make a report in writing of any challenge, request or
matter determined by them and shall execute a certificate of any fact found by them. No director or candidate for the office of director
shall act as an Inspector of an election of directors. Inspectors need not be shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; width: 34%; vertical-align: middle">-&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;11.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Nomination of Directors</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Nominations of persons for election to the Board of Directors of the Corporation may be made at an annual meeting of shareholders
(i) by or at the direction of the Board of Directors or (ii)&nbsp;by any shareholder of the Corporation who is a shareholder of record
at the time of giving of notice provided for in this Section&nbsp;11&nbsp;and through the time of the annual meeting, who shall be entitled
to vote for the election of directors at the annual meeting and who complies with the notice procedures set forth in this Section&nbsp;11,
or (iii)&nbsp;pursuant to and in compliance with the procedures set forth in Section&nbsp;13 of this Article&nbsp;II. For nominations
to be properly brought before an annual meeting by a Noticing Shareholder pursuant to clause (ii) of the preceding sentence, (A)&nbsp;the
Noticing Shareholder must have given timely notice thereof (meeting the requirements hereinafter set forth) in proper written form to
the Corporate Secretary of the Corporation, (B) the Noticing Shareholder must provide to the Corporate Secretary any updates to such notice
at the times and in the forms specified in this Section&nbsp;11 and (C)&nbsp;the Noticing Shareholder and any beneficial owner on whose
behalf a nomination is made must comply with the representation set forth in such Noticing Shareholder&rsquo;s Shareholder Solicitation
Statement (as defined below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>To be timely, a shareholder&rsquo;s notice for an annual meeting pursuant to clause&nbsp;(ii)&nbsp;of Section&nbsp;11(a) of this
Article&nbsp;II shall be received by the Corporate Secretary of the Corporation at the principal executive offices of the Corporation
not later than the close of business on the day that is 90 days, nor earlier than the close of business on the day that is 120 days, prior
to the first anniversary of the date of the preceding year&rsquo;s annual meeting of shareholders; provided, however, that in the event
that the annual meeting of shareholders is more than 30 days before or 60 days after such anniversary date or if no such meeting was held
in the preceding year, notice by a shareholder shall be timely only if received (i)&nbsp;not earlier than the close of business on the
day that is 120 days prior to such annual meeting and (ii)&nbsp;not later than the close of business on the day that is 90 days before
such annual meeting or, if later, no later than the close of business on the day that is 10 days after the first Public Announcement of
the date of such annual meeting. The number of nominees a shareholder may nominate for election at an annual meeting of shareholders shall
not exceed the number of directors to be elected at such annual meeting. In no event shall any adjournment, postponement or rescheduling
of an annual meeting or the announcement thereof commence a new time period (or extend any time period) for the giving of a shareholder&rsquo;s
notice as described above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>A Noticing Shareholder&rsquo;s notice shall set forth:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>as to each person whom the Noticing Shareholder proposes to nominate for election or reelection as a director (each, a &ldquo;Proposed
Nominee&rdquo;):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(1)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>all information relating to such person that is required to be disclosed in a proxy statement or other filing made by any Proponent
Person in connection with the contested solicitations of proxies for election of directors, or is otherwise required, in each case pursuant
to Regulation&nbsp;14A under the Exchange Act (including such person&rsquo;s written consent to being named in the proxy statement as
a nominee and to serving as a director if elected), whether or not such Proponent Person intends to deliver a proxy statement or conduct
its own proxy solicitation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; width: 34%; vertical-align: middle">-&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(2)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a commitment that such person, if elected, will tender, promptly following such person&rsquo;s election, an irrevocable resignation
effective upon such person&rsquo;s failure to receive the required vote for reelection at any future meeting at which such person would
face reelection and upon acceptance of such resignation by the Board of Directors, in accordance with the Corporation&rsquo;s Board Corporate
Governance Guidelines;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(3)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>identification of the names and addresses of other shareholder(s) (including beneficial owner(s)) known by such Proposed Nominee
to support a nomination or proposal of business by the Noticing Shareholder, and to the extent known, the class and number of all shares
of the Corporation&rsquo;s capital stock owned beneficially or of record by such other shareholder(s) (or other beneficial owner(s)) (the
information described in the foregoing clauses (1) and (2) and this clause (3), the &ldquo;Shareholder Nominee Information&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(4)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a description of all direct and indirect compensation or other material monetary agreements, arrangements and understandings during
the past three years, and any other material relationships, between or among any Proponent Person, on the one hand, and each Proposed
Nominee and such Proposed Nominee&rsquo;s respective Affiliates and Associates, on the other hand, including all information that would
be required to be disclosed pursuant to Item&nbsp;404 of Regulation S-K as if any Proponent Person were the &ldquo;registrant&rdquo; for
purposes of such rule and such Proposed Nominee were a director or executive officer of such registrant;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(5)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a description of (A)&nbsp;any agreement, arrangement or understanding with, or any commitment or assurance to, any person or entity
as to how such nominee, if elected as a director of the Corporation, will act or vote on any issue or question to be decided by the Board
of Directors or that otherwise relates to the Corporation or such persons&rsquo; service on the Board of Directors (a &ldquo;Voting Commitment&rdquo;),
(B)&nbsp;any compensatory, payment or other financial agreement, arrangement or understanding with any person other than with the Corporation,
including any agreement to indemnify such person for obligations arising as a result of his or her service as a director of the Corporation,
in connection with such nominee&rsquo;s nomination, service or action as a director of the Corporation (a &ldquo;Third Party Compensation
Arrangement&rdquo;) and (C) any business or personal interests that could place such Proposed Nominee in a potential conflict of interest
with the Corporation or any of its subsidiaries;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(6)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a written questionnaire with respect to the background and qualification of such Proposed Nominee, completed by such Proposed Nominee
in the form required by the Corporation (which form such Noticing Shareholder shall request in writing from the Corporate Secretary prior
to submitting notice and which the Corporate Secretary shall provide to such Noticing Shareholder within 10 days after receiving such
request); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; width: 34%; vertical-align: middle">-&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(7)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a written representation and agreement completed by such Proposed Nominee in the form required by the Corporation (which form such
Noticing Shareholder shall request in writing from the Corporate Secretary prior to submitting notice and which the Corporate Secretary
shall provide to such Noticing Shareholder within 10 days after receiving such request), providing, among other things, that such Proposed
Nominee: (1) is not and will not become a party to any Voting Commitment that has not been disclosed to the Corporation or any Voting
Commitment that could limit or interfere with such Proposed Nominee&rsquo;s ability to comply, if elected as a director of the Corporation,
with such Proposed Nominee&rsquo;s fiduciary duties under applicable law; (2) is not and will not become a party to any Third Party Compensation
Agreement that has not been disclosed to the Corporation; (3) will, if elected as a director of the Corporation, comply with all applicable
laws and stock exchange listing standards and the Corporation&rsquo;s policies, guidelines and principles applicable to directors, including,
without limitation, the Corporation&rsquo;s Board Corporate Governance Guidelines, Code of Ethics and Principles of Conduct, the Director
Code of Business Conduct and Ethics, confidentiality, share ownership and trading policies and guidelines, and any other codes, policies
and guidelines or any rules, regulations and listing standards, in each case as applicable to directors, and all applicable fiduciary
duties under state law; (4) intends to serve a full term as a director of the Corporation, if elected; and (5) will provide facts, statements
and other information in all communications with the Corporation and its shareholders that are or will be true and correct in all material
respects, and that do not and will not omit to state a material fact necessary in order to make the statements made, in light of the circumstances
under which they are made, not misleading;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>as to each Noticing Shareholder:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(1)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the name and address, as they appear on the Corporation&rsquo;s stock ledger, of such Noticing Shareholder; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(2)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a representation that the Noticing Shareholder is a shareholder of record of stock of the Corporation at the time of the giving
of notice provided for in these By-Laws, is entitled to vote at such meeting and that the Noticing Shareholder (or a Qualified Representative
thereof) intends to appear in person at the meeting to present such nominee for election or to bring such business before the meeting
and an acknowledgement that, if such Noticing Shareholder (or a Qualified Representative thereof) does not appear at such meeting (including
virtually in the case of a meeting held solely by means of remote communication) to present the Noticing Shareholder&rsquo;s Proposed
Nominee(s) for election or proposed business, as applicable, the Corporation need not present the Noticing Shareholder&rsquo;s nominee
for election or business for a vote at such meeting, notwithstanding that proxies in respect of such vote may have been received by the
Corporation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; width: 34%; vertical-align: middle">-&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>as to each Noticing Shareholder and the beneficial owner(s), if different from such Noticing Shareholder, on whose behalf the notice
is given, (1) a description of all agreements, arrangements or understandings between or among the Noticing Shareholder, beneficial owner(s)
and/or any other person(s) (including any Proposed Nominee(s)) (naming such person(s)) pursuant to which a nomination is to be made or
business is to be proposed by the Noticing Shareholder and/or (2) identification of the names and addresses of such other shareholder(s)
(including beneficial owner(s)) known by such Noticing Shareholder or beneficial owner(s) to support such nomination or proposed business,
and to the extent known, the class and number of all shares of the Corporation&rsquo;s capital stock owned beneficially or of record by
such other shareholder(s) (or other beneficial owner(s));</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>as to each Proponent Person:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(1)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>(A)&nbsp;the class, series and number of shares of the Corporation that are, directly or indirectly, beneficially owned or owned
of record by such Proponent Person (including any class or series of shares of capital stock of the Corporation as to which such Proponent
Person has a right to acquire beneficial ownership at any time in the future), the date or dates such shares were acquired, the investment
intent of such acquisition and any pledge by such Proponent Person with respect to any of such shares, (B)&nbsp;any Derivative Instrument
owned beneficially, directly or indirectly, by any such Proponent Person or to which any such Proponent Person is a party, all of which
Derivative Instruments shall be disclosed without regard to whether (x) any such Derivative Instrument conveys any voting rights in shares
of any class or series of capital stock of the Corporation to such Proponent Person, (y) any such Derivative Instrument is required to
be, or is capable of being, settled through delivery of shares of any class or series of capital stock of the Corporation or (z) such
Proponent Person may have entered into other transactions that hedge or mitigate the economic effect of such Derivative Instrument, (C)&nbsp;a
description of any proxy (other than a revocable proxy given in response to a solicitation made pursuant to, and in accordance with, Section&nbsp;14(a)
of the Exchange Act by way of a solicitation statement filed on Schedule 14A), contract, arrangement, understanding or relationship pursuant
to which any such Proponent Person has a right to vote, directly or indirectly, any shares of the Corporation or influence the voting
over any such shares, (D)&nbsp;any rights to dividends on the shares of the Corporation owned beneficially, directly or indirectly, by
any such Proponent Person that are separated or separable from the underlying shares of the Corporation, (E)&nbsp;any proportionate interest
in shares of the Corporation or Derivative Instruments held, directly or indirectly, by a general or limited partnership limited liability
company or similar entity in which any such Proponent Person is (x) a general partner or, directly or indirectly, beneficially owns an
interest in a general partner or (y) the manager, managing member or, directly or indirectly, beneficially owns an interest in the manager
or managing member of such limited liability company or similar entity, (F)&nbsp;any performance-related fees (other than an asset-based
fee) that any such Proponent Person is directly or indirectly entitled to based on any increase or decrease in the value of shares of
the Corporation or Derivative Instruments, including, without limitation, any such interests held by members of any such Proponent Person&rsquo;s
immediate family sharing the same household and (G) any direct or indirect interest of such Proponent Person in any contract with the
Corporation or any Affiliate of the Corporation (including any employment agreement, collective bargaining agreement or consulting agreement);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; width: 34%; vertical-align: middle">-&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(2)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a complete and accurate description of any pending, or to such Proponent Person&rsquo;s knowledge, threatened, legal proceeding
in which such Proponent Person is a party or participant involving the Corporation or, to such Proponent Person&rsquo;s knowledge, any
current or former officer, director, Affiliate or Associate of the Corporation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(3)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a complete and accurate description of any violations by such Proponent Person of federal or state securities laws relating to
the disclosure of information (and supplemental disclosure that, if had been provided, would have cured such violation) and of any breach
of a contract with the Corporation by such Proponent Person;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(4)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>all other information relating to such Proponent Person which would be required to be included in a proxy statement or other filing
required to be filed with the SEC if, with respect to any such nomination or item of business, such Proponent Persons were a participant
in a contested solicitation subject to Regulation&nbsp;14A under the Exchange Act, whether or not any such Proponent Person intends to
deliver a proxy statement or conduct its own proxy solicitation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(5)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any other information about any Derivative Instrument that would be required to be disclosed in a proxy statement or other filing
required to be filed with the SEC if, with respect to any such nomination or item of business, such Proponent Persons were a participant
in a solicitation subject to Regulation&nbsp;14A under the Exchange Act, as if such Derivative Instrument was treated the same as securities
of the Corporation under such requirements;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(6)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>all information that would be required to be disclosed in a Schedule 13D in respect of the Corporation pursuant to the Exchange
Act and the rules and regulations promulgated thereunder (or any successor provision of law) (regardless of whether the requirement to
file a Schedule 13D is applicable to the Proponent Person);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(7)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a statement whether or not such Proponent Person intends to, or is part of a group that intends to, (A) deliver a proxy statement
and form of proxy to a sufficient number of holders of the Corporation&rsquo;s voting shares reasonably believed by such shareholder or
beneficial owner to elect such Proposed Nominee(s) or to carry such proposal under applicable law or (B)&nbsp;otherwise engage in a solicitation
(within the meaning of Rule 14a-1(l) under the Exchange Act) with respect to the nomination or proposal, and if so, the name of each participant
(as defined in Item 4 of Schedule 14A under the Exchange Act) in such solicitation (such statement, a &ldquo;Shareholder Solicitation
Statement&rdquo;); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; width: 34%; vertical-align: middle">-&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(8)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a representation regarding whether such Proponent Person intends to solicit proxies in support of director nominees other than
the Corporation&rsquo;s nominees in accordance with Rule 14a-19 promulgated under the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Corporation may request any Proponent Person and any Proposed Nominee to furnish such additional information as may be reasonably
required by the Board of Directors. Such Proponent Person and/or Proposed Nominee shall provide such additional information within 10
days after it has been requested by the Corporation. The Board of Directors may require any Proposed Nominee to submit to interviews with
the Board of Directors or any committee thereof to determine the eligibility, suitability or qualifications of such Proposed Nominee to
serve as a director, and such Proposed Nominee shall make himself or herself available for any such interviews within no less than 10
business days following the date of such request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>A Noticing Shareholder providing notice pursuant to this Section&nbsp;11 or Section&nbsp;12 of this Article&nbsp;II shall update
such notice and other information provided to the Corporation so that the information provided or required to be provided in such notice
shall be true and correct as of the record date for the meeting and as of the date that is 10 business days prior to the meeting or any
adjournment, postponement or rescheduling thereof, and such update shall be delivered in writing to the Corporate Secretary at the principal
executive offices of the Corporation not later than 10 days after the record date of the meeting (in the case of the update required to
be made as of the record date), and not later than eight business days prior to the date for the meeting or any adjournment, postponement
or rescheduling thereof (in the case of the update required to be made as of 10 business days prior to the meeting or any adjournment,
postponement or rescheduling thereof). For the avoidance of doubt, the obligation to update as set forth in this Section&nbsp;11(e) or
in any other Section&nbsp;of these By-Laws shall not limit the Corporation&rsquo;s rights with respect to any deficiencies in any notice
provided by a shareholder, extend any applicable deadlines hereunder or under any other provisions of these By-Laws or enable or be deemed
to permit a shareholder who has previously submitted a notice hereunder or under any other provision of these By-Laws to amend or update
any proposal or to submit any new proposal, including by changing or adding nominees, matters, business and/or resolutions proposed to
be brought before a meeting of the shareholders. If a Noticing Shareholder fails to provide any written update in accordance with this
Section&nbsp;11(e), the information as to which such written update relates may be deemed not to have been provided in accordance with
these By-Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If any information submitted pursuant to this Section&nbsp;11 or Section&nbsp;12 of this Article&nbsp;II, as applicable, is inaccurate
or incomplete in any material respect, such information shall be deemed not to have been provided in accordance with these By-Laws. The
Noticing Shareholder shall notify the Corporate Secretary in writing at the principal executive offices of the Corporation of any inaccuracy
or change in any information submitted pursuant to this Section&nbsp;11 or Section&nbsp;12 of this Article&nbsp;II, as applicable, within
two business days after becoming aware of such inaccuracy or change. Upon written request of the Corporate Secretary on behalf of the
Board of Directors (or a duly authorized committee thereof), the Noticing Shareholder shall provide, within seven business days after
delivery of such request (or such longer period as may be specified in such request), (i)&nbsp;written verification, reasonably satisfactory
to the Board of Directors, any committee thereof or any authorized officer of the Corporation, to demonstrate the accuracy of any information
submitted by the Noticing Shareholder pursuant to this Section&nbsp;11 or Section&nbsp;12 of this Article&nbsp;II, as applicable, and
(ii) a written affirmation of any information submitted by the Noticing Shareholder pursuant to this Section&nbsp;11 or Section&nbsp;12
of this Article&nbsp;II, as applicable, as of an earlier date. If the Noticing Shareholder fails to provide such written verification
or affirmation within such period, the information as to which written verification or affirmation was requested may be deemed not to
have been provided in accordance with these By-Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; width: 34%; vertical-align: middle">-&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>At the request of the Board of Directors, any person nominated by the Board of Directors for election as a director shall furnish
to the Corporate Secretary of the Corporation that information required to be set forth in a Noticing Shareholder&rsquo;s notice of nomination
which pertains to a Proposed Nominee. No person shall be eligible for election at any meeting of shareholders as a director of the Corporation
unless nominated by the Board or in compliance with the procedures set forth in this Section&nbsp;11 or pursuant to and in compliance
with the procedures set forth in Section&nbsp;3(b) of this Article&nbsp;II or Section&nbsp;13 of this Article&nbsp;II. The chair of the
meeting shall, if the facts warrant, determine and declare to the meeting that a nomination was not made in compliance with the procedures
prescribed by these By-Laws, and if the chair of the meeting should so determine, he or she shall so declare to the meeting and the defective
nominations shall be disregarded. If the Noticing Shareholder (or a Qualified Representative thereof) does not appear (including virtually,
in the case of a meeting held solely by means of remote communication) at a meeting of shareholders to present the Noticing Shareholder&rsquo;s
Proposed Nominee(s), the nomination of such Proposed Nominee(s) shall be disregarded, notwithstanding that proxies in favor thereof may
have been received by the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Notwithstanding anything in this Section&nbsp;11 to the contrary, in the event that the number of directors to be elected to the
Board of Directors is increased, a shareholder&rsquo;s notice required by this Section&nbsp;11 shall also be considered timely, but only
with respect to nominees for any new positions created by such increase, if it shall be delivered to the Corporate Secretary of the Corporation
at the principal executive offices of the Corporation not later than the close of business on the 10th day following the day on which
such public disclosure is first made by the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Nominations of persons for election to the Board of Directors may be made at a special meeting of shareholders at which directors
are to be elected pursuant to the Corporation&rsquo;s notice of meeting (i) by or at the direction of the Board of Directors or any duly
authorized committee thereof, (ii) by shareholders pursuant to Section&nbsp;3(b) of this Article&nbsp;II or (iii)&nbsp;provided that the
Board of Directors has determined that directors shall be elected at such meeting, by any shareholder of the Corporation who is a shareholder
of record at the time the notice provided for in this Section&nbsp;11 is delivered to the Corporate Secretary, who is entitled to vote
at the meeting and upon such election and who complies with the notice procedures set forth in this Section&nbsp;11. For nominations to
be properly brought before a special meeting by a Noticing Shareholder pursuant to clause (iii) of the preceding sentence, (1)&nbsp;the
Noticing Shareholder must have given timely notice thereof (meeting the requirements hereinafter set forth) in proper written form to
the Corporate Secretary of the Corporation, (2) the Noticing Shareholder must provide to the Corporate Secretary any updates to such notice
at the times and in the forms specified in this Section&nbsp;11 and (3)&nbsp;the Noticing Shareholder and any beneficial owner on whose
behalf a nomination is made must comply with the representation set forth in such Noticing Shareholder&rsquo;s Shareholder Solicitation
Statement. In the event the Corporation calls a special meeting of shareholders for the purpose of electing one or more directors to the
Board of Directors, any such shareholder entitled to vote in such election of directors may nominate a person or persons (as the case
may be) for election to such position(s) as specified in the Corporation&rsquo;s notice of meeting, if the shareholder&rsquo;s notice
required by this Section&nbsp;11 shall be received by the Corporate Secretary at the principal executive offices of the Corporation not
earlier than the close of business on the day that is 120 days before such special meeting and not later than the close of business on
the day that is the later of (A) 90 days before such special meeting or (B) 10 days following the day on which Public Announcement of
the date of the special meeting and of the nominees proposed by the Board of Directors to be elected at such meeting. To be in proper
written form, such notice must include all of the information, statements, questionnaires and representations required by Section&nbsp;11(c)
of this Article&nbsp;II. The number of nominees a shareholder may nominate for election at a special meeting shall not exceed the number
of directors to be elected at such special meeting. In no event shall the adjournment, postponement or rescheduling of a special meeting
commence a new time period (or extend any time period) for the giving of a shareholder&rsquo;s notice as described above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; width: 34%; vertical-align: middle">-&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Notwithstanding the foregoing provisions of this Section&nbsp;11, a Noticing Shareholder shall also comply with all applicable
requirements of state law and the Exchange Act with respect to the matters set forth in this Section&nbsp;11. Nothing in this Section&nbsp;11
shall be deemed to affect any rights of the holders of any series of preferred stock to elect directors pursuant to any applicable provisions
of the Certificate of Incorporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Notwithstanding the foregoing provisions of this Section&nbsp;11, unless otherwise required by law, if any Proponent Person (i)
provides notice pursuant to Rule 14a-19(a)(1)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>[1]</SUP></FONT>
promulgated under the Exchange Act and (ii) subsequently fails to comply with the requirements of Rule 14a-19(a)(2) and Rule 14a-19(a)(3)
promulgated under the Exchange Act, then the Corporation shall disregard any proxies or votes solicited for the Proposed Nominees. Upon
request by the Corporation, if any Proponent Person provides notice pursuant to Rule 14a-19(a)(1) promulgated under the Exchange Act,
such Proponent Person shall deliver to the Corporation, no later than five business days prior to the applicable meeting, reasonable evidence
that it has met the requirements of Rule 14a-19(a)(3) promulgated under the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;12.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Notice of Shareholder Business</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>At the annual meeting of shareholders, only such business shall be conducted as shall have been properly brought before the meeting.
To be properly brought before an annual meeting, business (other than nominations for election to the Board of Directors of the Corporation,
which are governed by Section&nbsp;11 and Section&nbsp;13 of this Article&nbsp;II) must be a proper subject for shareholder action under
the DGCL and must be (a)&nbsp;specified in the notice of meeting (or any supplement thereto) given by the Corporation; (b)&nbsp;brought
before the meeting by or at the direction of the Board of Directors or (c)&nbsp;otherwise properly brought before the meeting by a shareholder
of the Corporation who is a shareholder of record at the time of giving of notice provided for in this Section&nbsp;12 and through the
time of the annual meeting, who has complied with the notice procedures set forth in this Section&nbsp;12, and who shall be entitled to
vote on such business. For business (other than nominations for election to the Board of Directors of the Corporation, which are governed
by Section&nbsp;11 and Section&nbsp;13 of this Article&nbsp;II) to be properly brought before an annual meeting by a Noticing Shareholder,
(i)&nbsp;the Noticing Shareholder must have given timely notice thereof (meeting the requirements hereinafter set forth) in proper written
form to the Corporate Secretary of the Corporation, (ii)&nbsp;such business must be a proper matter for shareholder action under the DGCL
and (iii)&nbsp;the Noticing Shareholder and any beneficial owner on whose behalf such business is proposed must comply with the representation
set forth in such Noticing Shareholder&rsquo;s Shareholder Solicitation Statement. To be timely, a Noticing Shareholder&rsquo;s notice
for an annual meeting pursuant to this Section&nbsp;12 must be delivered to or mailed and received by the Corporate Secretary of the Corporation
at the principal executive offices of the Corporation, not later than the close of business on the day that is 90 days, nor earlier than
the close of business on the day that is 120 days, prior to the first anniversary of the date of the preceding year&rsquo;s annual meeting
of shareholders; provided, however, that in the event that the annual meeting of shareholders is more than 30 days before or 60 days after
such anniversary date or if no such meeting was held in the preceding year, notice by a shareholder shall be timely only if received (1)&nbsp;not
earlier than the close of business on the day that is 120 days prior to such annual meeting and (2)&nbsp;not later than the close of business
on the day that is 90&nbsp;days before such annual meeting or, if later, not later than the close of business on the day that is 10 days
after the first Public Announcement of the date of such annual meeting. In no event shall any adjournment, postponement or rescheduling
of an annual meeting or the announcement thereof commence a new time period (or extend any time period) for the giving of a shareholder&rsquo;s
notice as described above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; width: 34%; vertical-align: middle">-&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>At a special meeting of shareholders, only such business shall be conducted at a special meeting of shareholders as shall have
been brought before the meeting pursuant to the Corporation&rsquo;s notice of meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>A Noticing Shareholder&rsquo;s notice to the Corporate Secretary pursuant to this Section&nbsp;12 shall set forth as to each matter
the Noticing Shareholder proposes to bring before the meeting (A)&nbsp;a brief description of the business desired to be brought before
the meeting, the reasons for conducting such business at the meeting and any material interest in such business of any Proponent Person;
(B) the text of the proposal or business (including the text of any resolutions proposed for consideration and, in the event that such
business includes a proposal to amend the Certificate of Incorporate or these By-Laws, the text of the proposed amendment); (C)&nbsp;a
description of all agreements, arrangements or understandings between or among any of the Proponent Persons or between or among any Proponent
Person and any other person or persons (including their names) in connection with the proposal of such business by such Noticing Shareholder;
(D) all other information relating to such business that would be required to be included in a proxy statement or other filing required
to be filed with the SEC if, with respect to any such item of business, the Proponent Persons were participants in a contested solicitation
subject to Regulation&nbsp;14A under the Exchange Act (whether or not any such Proponent Person intends to deliver a proxy statement or
conduct its own proxy solicitation); and (E) the information required by Section&nbsp;11(c)(ii) through Section&nbsp;11(c)(iv) of this
Article&nbsp;II. All of the information, statements and representations provided pursuant to this Section&nbsp;12(c) shall be updated
or corrected as required by Section&nbsp;11(e) and Section&nbsp;11(f) of this Article&nbsp;II).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; width: 34%; vertical-align: middle">-&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Notwithstanding anything in these By-Laws to the contrary, no business (other than nominations for election to the Board of Directors
of the Corporation, which are governed by Section&nbsp;11 and Section&nbsp;13 of this Article&nbsp;II) shall be conducted at an annual
meeting except in compliance with the procedures set forth in this Section&nbsp;12. If the Noticing Shareholder (or a Qualified Representative
thereof) does not appear (including virtually, in the case of a meeting held solely by means of remote communication) at an annual meeting
of shareholders to present the Noticing Shareholder&rsquo;s proposed business, such proposed business shall not be conducted, notwithstanding
that proxies in favor thereof may have been received by the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Notwithstanding the foregoing provisions of this Section&nbsp;12, a Noticing Shareholder shall also comply with all applicable
requirements of state law and the Exchange Act with respect to the matters set forth in this Section&nbsp;12. Nothing in this Section&nbsp;12
shall be deemed to affect any rights of shareholders to request inclusion of proposals in the Corporation's proxy statement pursuant to
Rule 14a-8 under the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;13.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Proxy Access for Director Nominations</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Whenever the Board of Directors solicits proxies with respect to the election of directors at an annual meeting, in addition to
any persons nominated for election to the Board of Directors by or at the direction of the Board of Directors, subject to the provisions
of this Section&nbsp;13, the Corporation shall:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>include in its notice of meeting and proxy materials, as applicable, for any annual meeting of shareholders (1)&nbsp;the name of
any person nominated for election (the &ldquo;Shareholder Nominee&rdquo;) by a shareholder as of the date that the Notice of Proxy Access
Nomination (as defined below) is received by the Corporation in accordance with this Section&nbsp;13 who is entitled to vote for the election
of directors at the annual meeting and who satisfies the notice, ownership and other requirements of this Section&nbsp;13 (such shareholder,
together with the beneficial owner of such shares, a &ldquo;Nominator&rdquo;) or by a group of no more than 20 such shareholders (such
shareholders, together with the beneficial owners of such shares, a &ldquo;Nominator Group&rdquo;) that, collectively as a Nominator Group,
satisfies the notice, ownership and other requirements of this Section&nbsp;13 applicable to a Nominator Group; provided that, in the
case of a Nominator Group, each member thereof (each a &ldquo;Group Member&rdquo;) shall have satisfied the notice, ownership and other
requirements of this Section&nbsp;13 applicable to Group Members, and (2)&nbsp;if the Nominator or the Nominator Group, as applicable,
so elects, the Nomination Statement (as defined below) furnished by such Nominator or Nominator Group; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>include such Shareholder Nominee&rsquo;s name on any ballot distributed at such annual meeting and on the Corporation&rsquo;s proxy
card (or any other format through which the Corporation permits proxies to be submitted) distributed in connection with such annual meeting.
Nothing in this Section&nbsp;13 shall limit the Corporation&rsquo;s ability to solicit against, and include in its proxy materials its
own statements relating to, any Shareholder Nominee, Nominator or Nominator Group, or to include such Shareholder Nominee as a nominee
of the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; width: 34%; vertical-align: middle">-&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>At each annual meeting, a Nominator or Nominator Group may nominate one or more Shareholder Nominees for election at such meeting
pursuant to this Section&nbsp;13; provided that the maximum number of Shareholder Nominees nominated by all Nominators and Nominator Groups
(including Shareholder Nominees that were submitted by a Nominator or Nominator Group for inclusion in the Corporation&rsquo;s proxy materials
pursuant to this Section&nbsp;13 but either are subsequently withdrawn, disregarded, declared invalid or ineligible pursuant to this Section&nbsp;13)
to appear in the Corporation&rsquo;s proxy materials with respect to an annual meeting shall not exceed the greater of (i)&nbsp;two nominees
and (ii)&nbsp;20% of the total number of directors in office as of the Final Proxy Access Deadline (as defined below), or if such number
is not a whole number, the closest whole number below 20% (the &ldquo;Maximum Number&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The Maximum Number shall be reduced, but not
below zero, by the sum of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
number of persons that the Board of Directors decides to nominate pursuant to an agreement, arrangement or other understanding with one
or more shareholders or beneficial owners, as the case may be, in lieu of such person being formally nominated as a director pursuant
to this Section&nbsp;13 or Section&nbsp;11 of this Article&nbsp;II; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
number of persons that the Board decides to nominate for re-election who were previously elected to the Board based on a nomination made
pursuant to this Section&nbsp;13 or Section&nbsp;11 of this Article&nbsp;II or pursuant to an agreement, arrangement or other understanding
with one or more shareholders or beneficial owners, as the case may be, in lieu of such person being formally nominated as a director
pursuant to this Section&nbsp;13 or Section&nbsp;11 of this Article&nbsp;II, in each case, at one of the previous two annual meetings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">If one or more vacancies for any reason occurs
on the Board of Directors at any time after the Final Proxy Access Deadline but before the date of the applicable annual meeting and the
Board of Directors determines to reduce the size of the Board of Directors in connection therewith, the Maximum Number shall be calculated
based on the number of directors in office as so reduced.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Any Nominator or Nominator Group submitting
more than one Shareholder Nominee for inclusion in the Corporation&rsquo;s proxy materials pursuant to this Section&nbsp;13 shall rank
in its Notice of Proxy Access Nomination such Shareholder Nominees based on the order that the Nominator or Nominator Group desires such
Shareholder Nominees to be selected for inclusion in the Corporation&rsquo;s proxy materials in the event that the total number of Shareholder
Nominees submitted by Nominators or Nominator Groups pursuant to this Section&nbsp;13 exceeds the Maximum Number. In the event that the
number of Shareholder Nominees submitted by Nominators or Nominator Groups pursuant to this Section&nbsp;13 exceeds the Maximum Number,
the highest ranking Shareholder Nominee who meets the requirements of this Section&nbsp;13 from each Nominator and Nominator Group will
be selected for inclusion in the Corporation&rsquo;s proxy materials until the Maximum Number is reached, beginning with the Nominator
or Nominator Group with the largest number of shares disclosed as owned (as defined below) in its respective Notice of Proxy Access Nomination
submitted to the Corporation and proceeding through each Nominator or Nominator Group in descending order of ownership. If the Maximum
Number is not reached after the highest ranking Shareholder Nominee who meets the requirements of this Section&nbsp;13 from each Nominator
and Nominator Group has been selected, this process will continue as many times as necessary, following the same order each time, until
the Maximum Number is reached.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; width: 34%; vertical-align: middle">-&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">If, after the Final Proxy Access Deadline, whether
before or after the mailing of the Corporation&rsquo;s definitive proxy statement, (A)&nbsp;a Shareholder Nominee who satisfies the requirements
of this Section&nbsp;13 becomes ineligible for inclusion in the Corporation&rsquo;s proxy materials pursuant to this Section&nbsp;13,
becomes unwilling to serve on the Board of Directors, dies, becomes disabled or is otherwise disqualified from being nominated for election
or serving as a director of the Corporation or (B)&nbsp;a Nominator or Nominator Group withdraws its nomination or becomes ineligible,
in each case as determined by the Board of Directors or the chair of the meeting, then the Board of Directors or the chair of the meeting
shall declare each nomination by such Nominator or Nominator Group to be invalid, and each such nomination shall be disregarded, no replacement
nominee(s) shall be included in the Corporation&rsquo;s proxy materials or otherwise submitted for election as a director in substitution
thereof and the Corporation (x)&nbsp;may omit from its proxy materials information concerning such Shareholder Nominee and (y)&nbsp;may
otherwise communicate to its shareholders, including, without limitation, by amending or supplementing its proxy materials, that the Shareholder
Nominee will not be eligible for election at the annual meeting and will not be included as a Shareholder Nominee in the proxy materials.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>To nominate a Shareholder Nominee, the Nominator or Nominator Group shall submit to the Corporate Secretary of the Corporation
the information required by this Section&nbsp;13 on a timely basis. To be timely, the Notice of Proxy Access Nomination must be addressed
to and received by the Corporate Secretary of the Corporation not less than 120&nbsp;days nor more than 150 days prior to the first anniversary
of the date on which the Corporation&rsquo;s definitive proxy statement was released to shareholders in connection with the prior year&rsquo;s
annual meeting; provided, however, that if the annual meeting is convened more than 30 days prior to or delayed by more than 60 days after
the first anniversary of the date of the preceding year&rsquo;s annual meeting, the information must be so received not earlier than 120&nbsp;days
prior to such annual meeting and not later than the close of business on the later of (x)&nbsp;the 90th day prior to such annual meeting
or (y)&nbsp;the 10th day following the day on which a Public Announcement of the date of the annual meeting is first made (the last day
on which a Notice of Proxy Access Nomination may be delivered pursuant to and in accordance with this Section&nbsp;13, the &ldquo;Final
Proxy Access Deadline&rdquo;); provided further that in no event shall any adjournment, postponement or rescheduling of an annual meeting,
or the Public Announcement thereof, commence a new time period or extend any time period for the receipt of the information required by
this Section&nbsp;13. The written notice required by this Section&nbsp;13 (the &ldquo;Notice of Proxy Access Nomination&rdquo;) shall
include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a written notice of the nomination by such Nominator or Nominator Group expressly requesting to have its Shareholder Nominee included
in the Corporation&rsquo;s proxy materials pursuant to this Section&nbsp;13 that includes, with respect to the Shareholder Nominee and
the Nominator (including any beneficial owner on whose behalf the nomination is made) or, in the case of a Nominator Group, with respect
to each Group Member (including any beneficial owner on whose behalf the nomination is made) all of the representations, agreements and
other information required in the Shareholder Nominee Information and by Section&nbsp;11(c)(ii), Section&nbsp;11(c)(iii) and clauses (1)
and (4) of Section&nbsp;11(c)(iv) of this Article&nbsp;II;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; width: 34%; vertical-align: middle">-&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>if the Nominator or Nominator Group so elects, a written statement of the Nominator or Nominator Group for inclusion in the Corporation&rsquo;s
proxy statement in support of the election of the Shareholder Nominee(s) to the Board of Directors, which statement shall not exceed 500
words with respect to each Shareholder Nominee (the &ldquo;Nomination Statement&rdquo;) and for the avoidance of doubt, the Nomination
Statement shall be limited to 500 words and shall not include any images, charts, pictures, graphic presentations or similar items;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>in the case of a nomination by a Nominator Group, the designation by all Group Members of one specified Group Member (or a Qualified
Representative thereof) that is authorized to act on behalf of all Group Members with respect to the nomination and matters related thereto,
including withdrawal of the nomination;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a representation by the Shareholder Nominee and the Nominator or Nominator Group (including each Group Member) and any beneficial
owner on whose behalf the nomination is made that each such person has provided and will provide facts, statements and other information
in all communications with the Corporation and its shareholders and beneficial owners, including, without limitation, the Notice of Proxy
Access Nomination and the Nomination Statement, that are and will be true and correct in all material respects and do not and will not
omit to state a material fact necessary in order to make the statements made in light of the circumstances under which they were made,
not misleading;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a statement of the Nominator or Nominator Group (including each Group Member) and any beneficial owner on whose behalf the nomination
is made, setting forth and certifying the number of shares such Nominator or Nominator Group is deemed to own (as determined in accordance
with sub-paragraph&nbsp;(d) of this Section&nbsp;13) continuously for at least three years as of the date of the Notice of Proxy Access
Nomination and one or more written statements from the shareholder of the Required Shares (as defined below), and from each intermediary
through which such shares are or have been held during the requisite three-year holding period, verifying that, as of a date within seven
days prior to the date that the Notice of Proxy Access Nomination is received by the Corporate Secretary of the Corporation, the Nominator
or the Nominator Group, as the case may be, owns, and has owned continuously for the preceding three years, the Required Shares, and the
Nominator&rsquo;s or, in the case of a Nominator Group, each Group Member&rsquo;s agreement to provide (1)&nbsp;within seven days after
the record date for the applicable annual meeting, written statements from the shareholder and intermediaries verifying the Nominator&rsquo;s
or the Nominator Group&rsquo;s, as the case may be, continuous ownership of the Required Shares through the record date; provided that
if and to the extent that a shareholder is acting on behalf of one or more beneficial owners, such written statements shall also be submitted
by any such beneficial owner or owners, and (2)&nbsp;immediate notice if the Nominator or the Nominator Group, as the case may be, ceases
to own the Required Shares prior to the date of the applicable annual meeting;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; width: 34%; vertical-align: middle">-&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(vi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a copy of any Schedule&nbsp;14N that has been filed with the SEC as required by Rule&nbsp;14a-18 under the Exchange Act;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(vii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a representation by the Nominator (including any beneficial owner on whose behalf the nomination is made), or, in the case of a
Nominator Group, each Group Member (including any beneficial owner on whose behalf the nomination is made) that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(1)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the Required Shares were acquired in the ordinary course of business and not with intent to change or influence control of the
Corporation, and each such person does not presently have such intent;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(2)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>each such person will maintain ownership (as defined in this Section&nbsp;13) of the Required Shares through the date of the applicable
annual meeting along with a further statement as to whether or not such person has the intention to hold the Required Shares for at least
one year thereafter (which statement the Nominator or Nominator Group shall include in its Nomination Statement, it being understood that
the inclusion of such statement shall not count towards the Nomination Statement&rsquo;s 500-word limit);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(3)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>each such person has not nominated, and will not nominate, for election to the Board of Directors at the applicable annual meeting
any person other than its Shareholder Nominee(s) pursuant to this Section&nbsp;13;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(4)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>each such person has not distributed, and will not distribute, to any shareholders or beneficial owners any form of proxy for the
applicable annual meeting other than the form distributed by the Corporation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(5)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>each such person has not engaged in, and will not directly or indirectly engage in, and has not been and will not be a participant
(as defined in Schedule&nbsp;14A of the Exchange Act) in, a &ldquo;solicitation&rdquo; within the meaning of Rule&nbsp;14a-1(1) under
the Exchange Act in support of the election of any individual as a director at the applicable annual meeting other than with respect to
such Nominator or Nominator Group&rsquo;s Shareholder Nominee(s) or a nominee of the Board of Directors; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(6)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>each such person consents to the public disclosure of the information provided pursuant to this Section&nbsp;13;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(viii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>an executed agreement, in a form deemed satisfactory by the Board of Directors or any committee thereof, pursuant to which the
Nominator (including any beneficial owner on whose behalf the nomination is made) or, in the case of a Nominator Group, each Group Member
(including any beneficial owner on whose behalf the nomination is made) agrees to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(1)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>comply with all applicable laws, rules and regulations arising out of or relating to the nomination of each Shareholder Nominee
pursuant to this Section&nbsp;13;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; width: 34%; vertical-align: middle">-&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(2)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>assume all liability stemming from any legal or regulatory violation arising out of the communications and information provided
by such person(s) to the Corporation and its shareholders and beneficial owners, including, without limitation, the Notice of Proxy Access
Nomination and Nomination Statement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(3)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>indemnify and hold harmless the Corporation and each of its directors, officers, employees, agents and affiliates individually
against any liability, loss or damages in connection with any threatened or pending action, suit or proceeding, whether legal, administrative
or investigative, against the Corporation or any of its directors, officers, employees, agents and affiliates arising out of or relating
to any nomination submitted by such person(s) pursuant to this Section&nbsp;13;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(4)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>file with the SEC any solicitation or other communication with the Corporation&rsquo;s shareholders and beneficial owners relating
to the meeting at which the Shareholder Nominee will be nominated, regardless of whether any such filing is required under Regulation&nbsp;14A
of the Exchange Act or whether any exemption from filing is available for such solicitation or other communication under Regulation&nbsp;14A
of the Exchange Act;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(5)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>furnish to the Corporation all notifications and updated information required by this Section&nbsp;13, including, without limitation,
the information required by sub-paragraph&nbsp;(e) of this Section&nbsp;13; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in; text-indent: 0.5in">(6)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>upon request, provide to the Corporation within five business days after such request, but in any event prior to the day of the
annual meeting, such additional information as reasonably requested by the Corporation; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(ix)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a letter of resignation signed by each Shareholder Nominee, which letter shall specify that such Shareholder Nominee&rsquo;s resignation
is irrevocable and that it shall become effective upon a determination by the Board of Directors or any committee thereof that (1)&nbsp;any
of the information provided to the Corporation by the Nominator, the Nominator Group, any Group Member (including, in each case, any beneficial
owner on whose behalf the nomination is made) or the Shareholder Nominee in respect of the nomination of such Shareholder Nominee pursuant
to this Section&nbsp;13 is or was untrue in any material respect (or omitted to state a material fact necessary in order to make the statements
made, in light of the circumstances under which they were made, not misleading) or (2)&nbsp;the Shareholder Nominee, the Nominator, the
Nominator Group or any Group Member (including, in each case, any beneficial owner on whose behalf the nomination is made) or any affiliate
thereof shall have breached any of its representations, obligations or agreements under this Section&nbsp;13.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I>Ownership Requirements</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>To nominate a Shareholder Nominee pursuant to this Section&nbsp;13, the Nominator or Nominator Group shall have owned shares representing
3% or more of the</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; width: 34%; vertical-align: middle">-&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0">voting power entitled to vote generally in the election of directors (the &ldquo;Required Shares&rdquo;) continuously
for at least three years as of both the date the Notice of Proxy Access Nomination is submitted to the Corporation and the record date
for determining shareholders eligible to vote at the applicable annual meeting and must continue to own the Required Shares at all times
between and including the date the Notice of Proxy Access Nomination is submitted to the Corporation and the date of the applicable annual
meeting; provided that if and to the extent a shareholder is acting on behalf of one or more beneficial owners only the shares owned by
such beneficial owner or owners, and not any other shares owned by any such shareholder, shall be counted for purposes of satisfying the
foregoing ownership requirement, and&nbsp;the aggregate number of shareholders and all such beneficial owners whose share ownership is
counted for the purposes of satisfying the foregoing ownership requirement shall not exceed 20. Two or more funds that are (1)&nbsp;under
common management and investment control, (2)&nbsp;under common management and funded primarily by the same employer or (3)&nbsp;a &ldquo;group
of investment companies,&rdquo; as such term is defined in the Investment Company Act of 1940, as amended, shall be treated as one shareholder
or beneficial owner, as the case may be, for the purpose of satisfying the foregoing ownership requirements; provided that each fund otherwise
meets the requirements set forth in this Section&nbsp;13; and provided further that any such funds for which shares are aggregated for
the purpose of satisfying the foregoing ownership requirements provide documentation reasonably satisfactory to the Corporation that demonstrates
that the funds satisfy the criteria for being treated as one shareholder within seven days after the Notice of Proxy Access Nomination
is delivered to the Corporate Secretary. No shares may be attributed to more than one Nominator or Nominator Group, and no shareholder
or beneficial owner may be a member of more than one Nominator Group (other than a shareholder directed to act by more than one beneficial
owner) for the purposes of this Section&nbsp;13.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>For purposes of this Section&nbsp;13, &ldquo;ownership&rdquo; shall be deemed to consist of and include only the outstanding shares
as to which a person possesses both (1)&nbsp;the full voting and investment rights pertaining to such shares and (2)&nbsp;the full economic
interest in (including the opportunity for profit and risk of loss on) such shares; provided that the ownership of shares calculated in
accordance with clauses&nbsp;(1) and (2)&nbsp;shall not include any shares (A)&nbsp;that a person or any of its affiliates has sold in
any transaction that has not been settled or closed, including any short sale, (B)&nbsp;that a person or any of its affiliates has borrowed
for any purposes or purchased pursuant to an agreement to resell or (C)&nbsp;that are subject to any Derivative Instrument or similar
agreement entered into by a person or any of its affiliates, whether any such security, instrument or agreement is to be settled with
shares or with cash based on the notional amount or value of shares, in any case in which such security, instrument or agreement has,
or is intended to have, or if exercised by either party would have, the purpose or effect of (x)&nbsp;reducing in any manner, to any extent
or at any time in the future, the person&rsquo;s or such person&rsquo;s affiliates&rsquo; full right to vote or direct the voting of any
such shares, and/or (y)&nbsp;hedging, offsetting or altering to any degree any gain or loss arising from the full economic ownership of
such person&rsquo;s or such person&rsquo;s affiliates&rsquo; shares. &ldquo;Ownership&rdquo; shall include shares held in the name of
a nominee or other intermediary so long as the person claiming ownership of such shares retains the right to instruct how the shares are
voted with respect to the election of directors and possesses the full economic interest in the shares. A person&rsquo;s ownership of
shares shall be deemed to continue during any period in which the person has delegated any voting power by means of a proxy, power of
attorney or other instrument or arrangement that is revocable at any time by the person. A person&rsquo;s ownership of shares shall be
deemed to continue during any period in which the person has loaned such shares provided that the person has the power to recall such
loaned shares on five business days&rsquo; notice, will vote such shares at the annual meeting and will hold such shares through the date
of the annual meeting. For the purposes of this Section&nbsp;13, the terms &ldquo;owned,&rdquo; &ldquo;owning&rdquo; and other variations
of the word &ldquo;own&rdquo; shall have correlative meanings. For the purposes of this Section&nbsp;13, the term &ldquo;affiliate&rdquo;
or &ldquo;affiliates&rdquo; shall have the meaning ascribed thereto under the rules and regulations of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; width: 34%; vertical-align: middle">-&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>For the avoidance of doubt, with respect to any nomination submitted by a Nominator Group pursuant to this Section&nbsp;13, the
information required by sub-paragraph&nbsp;(c) of this Section&nbsp;13 to be included in the Notice of Proxy Access Nomination shall be
provided by each Group Member (including any beneficial owner on whose behalf the nomination is made), and each such Group Member (including
any beneficial owner on whose behalf the nomination is made) shall execute and deliver to the Corporate Secretary of the Corporation the
representations and agreements required under sub-paragraph&nbsp;(c) of this Section&nbsp;13 at the time the Notice of Proxy Access Nomination
is submitted to the Corporation. In the event that the Nominator, Nominator Group or any Group Member shall have breached any of their
agreements with the Corporation or any information included in the Nomination Statement or the Notice of Proxy Access Nomination, or any
other communications by the Nominator, Nominator Group or any Group Member (including any beneficial owner on whose behalf the nomination
is made) with the Corporation or its shareholders and beneficial owners, ceases to be true and correct in all material respects (or omits
a material fact necessary to make the statements made, in light of the circumstances under which they were made and as of such later date,
not misleading), each Nominator, Nominator Group or Group Member (including any beneficial owner on whose behalf the nomination is made),
as the case may be, shall promptly (and in any event within 48 hours of discovering such breach or that such information has ceased to
be true and correct in all material respects (or omits a material fact necessary to make the statements made, in light of the circumstances
under which they were made and as of such later date, not misleading)) notify the Corporate Secretary of the Corporation of any such breach,
inaccuracy or omission in such previously provided information and shall provide the information that is required to correct any such
defect, if applicable, it being understood that providing any such notification shall not be deemed to cure any defect or limit the Corporation&rsquo;s
rights to omit a Shareholder Nominee from its proxy materials as provided in this Section&nbsp;13.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I>Shareholder Nominee Requirements</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Within the time period specified in this Section&nbsp;13 for delivering the Notice of Proxy Access Nomination, each Shareholder
Nominee must deliver to the Corporate Secretary of the Corporation a written representation and agreement, which shall be deemed a part
of the Notice of Proxy Access Nomination for purposes of this Section&nbsp;13, that such person: (1)&nbsp;consents to be named in the
proxy statement as a nominee, to serve as a director if elected and to the public disclosure of the information provided pursuant to this
Section&nbsp;13; (2)&nbsp;understands his or her duties as a director under the DGCL and agrees to act in accordance with those duties
while serving as a director;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; width: 34%; vertical-align: middle">-&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0">(3)&nbsp;is not and will not become a party to (A)&nbsp;any Voting Commitment that has not been disclosed
to the Corporation or (B)&nbsp;any Voting Commitment that could limit or interfere with such person&rsquo;s ability to comply, if elected
as a director of the Corporation, with such person&rsquo;s fiduciary duties under applicable law; (4)&nbsp;is not and will not become
a party to any Third Party Compensation Arrangement that has not been disclosed to the Corporation, and has not and will not receive any
such Third Party Compensation Arrangement that has not been disclosed to the Corporation; (5)&nbsp;if elected as a director of the Corporation,
will comply with all applicable laws and stock exchange listing standards and the Corporation&rsquo;s policies, guidelines and principles
applicable to directors, including, without limitation, the Corporation&rsquo;s Board Corporate Governance Guidelines, Code of Ethics
and Principles of Conduct, the Director Code of Business Conduct and Ethics, confidentiality, share ownership and trading policies and
guidelines, and any other codes, policies and guidelines or any rules, regulations and listing standards, in each case as applicable to
directors; (6)&nbsp;agrees to meet with the Board of Directors or any committee or delegate thereof to discuss matters relating to the
nomination of the Shareholder Nominee, including information in the Notice of Proxy Access Nomination and such Shareholder Nominee&rsquo;s
eligibility to serve as a member of the Board of Directors; and (7)&nbsp;will provide facts, statements and other information in all communications
with the Corporation and its shareholders and beneficial owners that are and will be true and correct in all material respects and do
not and will not omit to state a material fact necessary in order to make the statements made, in light of the circumstances under which
they were made, not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>At the request of the Corporation, each Shareholder Nominee must promptly submit (but in no event later than seven days after receipt
of the request) to the Corporate Secretary of the Corporation all completed and signed questionnaires required of directors. The Corporation
may request such additional information as necessary to permit the Board of Directors to determine if each nominee is independent, including
for purposes of serving on the committees of the Board of Directors, under the listing standards of each principal securities exchange
upon which the shares are listed, any applicable rules of the SEC and any publicly disclosed standards used by the Board of Directors
in determining and disclosing the independence of the Corporation&rsquo;s directors and to determine whether the nominee otherwise meets
all other publicly disclosed standards applicable to directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In the event that a Shareholder Nominee shall have breached any of their agreements with the Corporation or any information or
communications provided by a Shareholder Nominee to the Corporation or its shareholders and beneficial owners ceases to be true and correct
in any respect or omits a fact necessary to make the statements made, in light of the circumstances under which they were made, not misleading,
such nominee shall promptly (and in any event within 48 hours of discovering such breach or that such information has ceased to be true
and correct in all material respects (or omits a material fact necessary to make the statements made, in light of the circumstances under
which they were made and as of such later date, not misleading)) notify the Corporate Secretary of the Corporation of any such breach,
inaccuracy or omission in such previously provided information and shall provide the information that is required to make such information
or communication true and correct, if applicable, it being understood that providing any such notification shall not be deemed to cure
any defect or limit the Corporation&rsquo;s rights to omit a Shareholder Nominee from its proxy materials as provided in this Section&nbsp;13.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; width: 34%; vertical-align: middle">-&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In the event any Nominator or Nominator Group (including any beneficial owner on whose behalf the nomination is made) submits a
nomination at an annual general meeting pursuant to this Section&nbsp;13 and such Shareholder Nominee shall have been nominated for election
at any of the previous two annual meetings and such Shareholder Nominee shall not have received at least 25% of the votes cast in favor
of such nominee&rsquo;s election or such nominee withdrew from or became ineligible or unavailable for election to the Board of Directors,
then such nomination shall be disregarded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Notwithstanding anything to the contrary contained in this Section&nbsp;13, the Corporation shall not be required to include, pursuant
to this Section&nbsp;13, a Shareholder Nominee in its proxy materials for any annual meeting, or, if the proxy statement already has been
filed, to submit the nomination of a Shareholder Nominee to a vote at the annual meeting, notwithstanding that proxies in respect of such
vote may have been received by the Corporation:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>for any meeting for which the Corporate Secretary of the Corporation receives notice that any shareholder or beneficial owner,
as the case may be, intends to nominate one or more persons for election to the Board of Directors pursuant to Section&nbsp;11 of this
Article&nbsp;II;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>who is not determined by the Board of Directors in its sole discretion to be independent under the listing standards of each principal
securities exchange upon which the shares of the Corporation are listed, any applicable rules of the SEC and any publicly disclosed standards
used by the Board of Directors in determining and disclosing the independence of the Corporation&rsquo;s directors, including those applicable
to a director&rsquo;s service on any of the committees of the Board of Directors, in each case as determined by the Board of Directors
or any committee thereof, in its sole discretion;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>whose election as a member of the Board of Directors would cause the Corporation to be in violation of these By-Laws, the Certificate
of Incorporation, the rules and listing standards of the principal securities exchanges upon which the shares of the Corporation are listed,
or any applicable law, rule or regulation or of any publicly disclosed standards of the Corporation applicable to directors, in each case
as determined by the Board of Directors or any committee thereof, in its sole discretion;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>who is or has been, within the past three years, an officer or director of a competitor, as defined in Section&nbsp;8 of the Clayton
Antitrust Act of 1914, as amended;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>whose business or personal interests place such Shareholder Nominee in a conflict of interest with the Corporation or any of its
subsidiaries, as determined by the Board of Directors or any committee thereof, in its sole discretion;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(vi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>who is a named subject of a pending criminal proceeding (excluding traffic violations and other minor offenses) or has been convicted
in such a criminal proceeding within the past ten years;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; width: 34%; vertical-align: middle">-&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(vii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>who is subject to any order of the type specified in Rule&nbsp;506(d) of Regulation&nbsp;D under the Securities Act of 1933, as
amended (together with the rules and regulations promulgated thereunder, the &ldquo;Securities Act&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(viii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>if the Shareholder Nominee or Nominator (including any beneficial owner on whose behalf the nomination is made), or, in the case
of a Nominator Group, any Group Member (including any beneficial owner on whose behalf the nomination is made) shall have provided information
to the Corporation in connection with such nomination that was untrue in any material respect or omitted to state a material fact necessary
in order to make any statement made, in light of the circumstances under which it was made, not misleading, as determined by the Board
of Directors or any committee thereof, in its sole discretion;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(ix)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>if the Nominator (or a Qualified Representative thereof) or, in the case of a Nominator Group, the representative designated by
the Nominator Group in accordance with sub-paragraph&nbsp;(c)(iii) of this Section&nbsp;13 (or a Qualified Representative thereof), or
the Shareholder Nominee does not appear (including virtually, in the case of a meeting held solely by means of remote communication) at
the applicable annual meeting to present the Shareholder Nominee for election;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(x)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>if the Nominator (including any beneficial owner on whose behalf the nomination is made), or, in the case of a Nominator Group,
any Group Member (including any beneficial owner on whose behalf the nomination is made) has engaged in or is currently engaged in, or
has been or is a participant (as defined in Schedule&nbsp;14A of the Exchange Act) in, a &ldquo;solicitation&rdquo; within the meaning
of Rule&nbsp;14a-1(1) under the Exchange Act in support of the election of any individual as a director at the applicable annual meeting
other than with respect to such Nominator or Nominator Group&rsquo;s Shareholder Nominee(s) or a nominee of the Board of Directors; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(xi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the Nominator or, in the case of a Nominator Group, any Group Member, or applicable Shareholder Nominee otherwise breaches or fails
to comply with its representations or obligations pursuant to these By-Laws, including, without limitation, this Section&nbsp;13.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">For the purpose of this sub-paragraph (h) of this Section&nbsp;13,
clauses&nbsp;(ii) through (xi)&nbsp;will result in the exclusion from the proxy materials pursuant to this Section&nbsp;13 of the specific
Shareholder Nominee(s) to whom the ineligibility applies, or, if the proxy statement has already been filed, the ineligibility of the
Shareholder Nominee(s) and, in either case, the inability of the Nominator or Nominator Group that nominated any such Shareholder Nominee
to substitute another Shareholder Nominee therefor; however, clause&nbsp;(i) will result in the exclusion from the proxy materials pursuant
to this Section&nbsp;13 of all Shareholder Nominees for the applicable annual meeting, or, if the proxy statement already has been filed,
the ineligibility of all Shareholder Nominees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; width: 34%; vertical-align: middle">-&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Notwithstanding anything to the contrary contained in this Section&nbsp;13:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the Corporation may omit from its proxy materials any information, including all or any portion of the Nomination Statement, if
the Board of Directors determines that the disclosure of such information would violate any applicable law or regulation or that such
information is not true and correct in all material respects or omits to state a material fact necessary in order to make the statements
made, in light of the circumstances under which they were made, not misleading; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in; text-indent: 0.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>if any Nominator, Nominator Group or Group Member (including any beneficial owner on whose behalf the nomination is made) or Shareholder
Nominee has failed to comply with the requirements of this Section&nbsp;13, the Board of Directors or the chair of the meeting shall declare
the nomination by such Nominator or Nominator Group to be invalid, and such nomination shall be disregarded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>This Section&nbsp;13 shall be the exclusive method for shareholders to include nominees for director in the Corporation&rsquo;s
proxy materials, except to the extent required by Rule 14a-19 promulgated under the Exchange Act.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">Article&nbsp;III</FONT><BR>
<BR>
Board of Directors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>General Powers</U>. The business and affairs of the Corporation shall be managed by or under the direction of the Board of Directors.
The Board of Directors may exercise all such authority and powers of the Corporation and do all such lawful acts and things as are not
by statute or the Certificate of Incorporation directed or required to be exercised or done by the shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Number, Qualifications, Election and Term of Office</U>. The Board of Directors shall consist of not less than eight nor more
than 16 directors. The number of directors may be fixed, from time to time, by the affirmative vote of a majority of the entire Board
of Directors. Any decrease in the number of directors shall be effective at the time of the next succeeding annual meeting of shareholders
unless there shall be vacancies in the Board of Directors, in which case such decrease may become effective at any time prior to the next
succeeding annual meeting to the extent of the number of such vacancies. Directors need not be shareholders. All directors shall be elected
to hold office for one-year terms expiring at the next annual meeting of shareholders. Each director shall hold office until his or her
successor shall have been elected and qualified, or until death, or until such director shall have resigned, or shall have been removed,
as hereinafter provided in these By-Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Chair of the Board</U>. The Board of Directors shall annually elect a Chair of the Board from among the members of the Board
of Directors, who shall perform all duties incident to the office of Chair of the Board and such other duties as may from time to time
be assigned by the Board of Directors, including presiding at all meetings of the shareholders of the Corporation and meetings of the
Board of Directors at which the Chair shall be present. The Chair of the Board shall serve until his or her successor shall have been
elected or until his or her earlier death, resignation or removal. The Chair of the Board may be removed, with or without cause, by a
majority of the Board of Directors. The Board may provide that the Chief Executive Officer of the Corporation shall serve as the Chair
of the Board. The Board of Directors shall fill any vacancy in the position of Chair of the Board of Directors at such time and in such
manner as the Board of Directors shall determine. In addition, the Board of Directors may appoint one or more directors to serve in roles
with such titles (including the titles of Vice Chair, Lead Director and Presiding Director), powers, duties and compensation as it may
approve.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; width: 34%; vertical-align: middle">-&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Lead Independent Director</U>. The Board of Directors may, at its discretion, appoint an independent director to serve as the
Lead Independent Director in order to coordinate the activities of the independent directors. The Lead Independent Director shall be appointed
annually by a majority vote of the independent directors and shall serve until his or her successor shall have been appointed or until
his or her earlier death, resignation, removal or disqualification as an independent director. The Lead Independent Director may be removed,
with or without cause, by a majority of the independent directors. The Lead Independent Director shall have such powers and perform such
duties as are assigned by these By-Laws and shall have such other powers and perform such other duties, not inconsistent with these By-Laws,
as from time to time may be assigned by the Board of Directors. A majority of the independent directors shall fill any vacancy in the
position of Lead Independent Director at such time and in such manner as such directors shall determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Place of Meetings</U>. Meetings of the Board of Directors shall be held at such place or places, within or without the State
of Delaware, as the Board of Directors may from time to time determine or as shall be specified in the notice of any such meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Regular Meetings</U>. Regular meetings of the Board of Directors shall be held at such time and place as the Board of Directors
may fix. If any day fixed for a regular meeting shall be a legal holiday at the place where the meeting is to be held, then the meeting
which would otherwise be held on that day shall be held at the same hour on the next succeeding business day. Notice of regular meetings
of the Board of Directors need not be given except as otherwise required by statute or these By-Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Special Meetings</U>. Special meetings of the Board of Directors may be called by the Chair of the Board, by the Lead Independent
Director (if one has been appointed) or by the Chair of the Board at the request of one-third of the members of the Board of Directors
of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;8.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Notice of Meetings</U>. Notice of each special meeting of the Board of Directors (and of each regular meeting for which notice
shall be required) shall be given by the Corporate Secretary as hereinafter provided in this Section&nbsp;8. Any such notice shall state
the place, date and time of the meeting. Except as otherwise required by these By-Laws, such notice need not state the purposes of such
meeting. Notice of each such meeting shall be mailed, postage prepaid, to each director, addressed to the director&rsquo;s residence or
usual place of business, by first-class mail, at least two days before the day on which such meeting is to be held, or shall be sent addressed
to the director at such place by telegraph, cable, telex, telecopier, electronic transmission or other similar means, or be delivered
to the director personally or be given to the director by telephone or other similar means, at least twelve hours before the time at which
such meeting is to be held or on such shorter notice as the person or persons calling the meeting may deem necessary or appropriate under
the circumstances. Notice of any such meeting need not be given to any director who shall, either before or after the meeting, submit
a signed waiver of notice, or waiver by electronic transmission or who shall attend such meeting, except when the director shall attend
for the express purpose of objecting, at the beginning of the meeting, to the transaction of any business because the meeting is not lawfully
called or convened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; width: 34%; vertical-align: middle">-&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;9.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Quorum and Manner of Acting</U>. A majority of the entire Board of Directors shall constitute a quorum for the transaction of
business at any meeting of the Board of Directors, and, except as otherwise expressly required by statute or the Certificate of Incorporation
or these By-Laws, the act of a majority of the directors present at any meeting at which a quorum is present shall be the act of the Board
of Directors. In the absence of a quorum at any meeting of the Board of Directors, a majority of the directors present thereat may adjourn
such meeting to another time and place. Notice of the time and place of any such adjourned meeting shall be given to all of the directors
unless such time and place were announced at the meeting at which the adjournment was taken, in which case such notice shall only be given
to the directors who were not present thereat. At any adjourned meeting at which a quorum is present, any business may be transacted which
might have been transacted at the meeting as originally called. The directors shall act only as a Board and the individual directors shall
have no power as such.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;10.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Organization</U>. At each meeting of the Board of Directors, the Chair of the Board, or, in the absence of the Chair of the
Board, the Lead Independent Director (if one has been appointed), or in the absence of the Lead Independent Director, another director
chosen by a majority of the directors present shall act as chair of the meeting and preside thereat. The Corporate Secretary or, in the
Corporate Secretary&rsquo;s absence, any person appointed by the chair of the meeting shall act as secretary of the meeting and keep the
minutes thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;11.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Resignations</U>. Any director of the Corporation may resign at any time by giving notice in writing or by electronic transmission
of his or her resignation to the Corporation. Any such resignation shall take effect at the time specified therein or, if the time when
it shall become effective is not specified therein, immediately upon its receipt. Unless otherwise specified therein, the acceptance of
such resignation shall not be necessary to make it effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;12.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Vacancies</U>. Any vacancy in the Board of Directors, whether arising from death, disqualification, resignation, removal, an
increase in the number of directors or any other cause, may be filled only by the vote of a majority of the directors then in office,
though less than a quorum, or by the sole remaining director. Each director so elected shall hold office for a term expiring at the next
annual meeting of shareholders and shall hold office until his or her successor shall have been elected and qualified, or until death,
or until such director shall have resigned, or shall have been removed, as provided in these By-Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;13.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Removal of Directors</U>. Any director may be removed, with or without cause, at any time, by the holders of a majority of the
voting power of the issued and outstanding capital stock of the Corporation entitled to vote at an election of directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;14.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Compensation</U>. The Board of Directors shall have authority to fix the compensation, including fees and reimbursement of expenses,
of directors, including the Chair of the Board and the Lead Independent Director (if one has been appointed), for services to the Corporation
in any capacity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; width: 34%; vertical-align: middle">-&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;15.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Committees</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Board shall create an Executive Committee, which shall consist of no less than two nor more than seven members of the Board
and which, to the extent provided in a resolution of the Board of Directors, shall have and may exercise all the powers and authority
of the Board of Directors, and may authorize the seal of the Corporation to be affixed to all papers which may require it, except the
Executive Committee shall not have the power or authority in reference to the following matters: (i)&nbsp;approving or adopting, or recommending
to the shareholders, any action or matter expressly required by the DGCL to be submitted to shareholders for approval, (ii)&nbsp;adopting,
amending or repealing any By-Law of the Corporation; or (iii)&nbsp;acting with respect to any matter restricted by statute, the Certificate
of Incorporation or these By-Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Board shall create an Audit Committee and a People Resources Committee, each of which shall consist of three&nbsp;or more members
of the Board of Directors of the Corporation, none of whom shall be employees of the Corporation or its subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Board may also create such other committees, with such authority and duties, as the Board may from time to time deem advisable,
and may authorize any of such committees to appoint one or more subcommittees. Each such committee or subcommittee, to the extent provided
in the resolution creating it, shall have and may exercise all the powers and authority of the Board of Directors except as restricted
by statute the Certificate of Incorporation or these By-Laws and may authorize the seal of the Corporation to be affixed to all papers
which require it. Each such committee or subcommittee shall serve at the pleasure of the Board of Directors or of the committee creating
it as the case may be, and have such name as may be determined from time to time by resolution adopted by the Board of Directors or by
the committee creating it. Each committee shall keep regular minutes of its meeting and report the same to the Board of Directors or the
committee creating it.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Board of Directors may designate one or more directors as alternate members of any committee, who may replace any absent or
disqualified member at any meeting of the committee. In addition, in the absence or disqualification of a member of a committee, the member
or members thereof present at any meeting and not disqualified from voting, whether or not the member or members constitute a quorum,
may unanimously appoint another member of the Board of Directors to act at the meeting in the place of any such absent or disqualified
member.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;16.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Action by Consent</U>. Unless restricted by the Certificate of Incorporation, any action required or permitted to be taken by
the Board of Directors or any committee thereof may be taken without a meeting if all members of the Board of Directors or such committee,
as the case may be, consent thereto in writing, or by electronic transmission and the writing or writings or electronic transmission or
transmissions are filed with the minutes of the proceedings of the Board of Directors or such committee, as the case may be. Such filing
shall be in paper form if the minutes are maintained in paper form and shall be in electronic form if the minutes are maintained in electronic
form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; width: 34%; vertical-align: middle">-&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;17.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Telephonic Meeting</U>. Unless restricted by the Certificate of Incorporation, any one or more members of the Board of Directors
or any committee thereof may participate in a meeting of the Board of Directors or such committee by means of a conference telephone or
other communications equipment by means of which all persons participating in the meeting can hear each other. Participation by such means
shall constitute presence in person at a meeting.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">Article&nbsp;IV</FONT><BR>
<BR>
Officers</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Selection and Qualifications</U>. The officers of the Corporation shall be elected by the Board of Directors except as otherwise
provided herein or in a resolution adopted by the Board of Directors and may include the President, the Chief Executive Officer, one or
more Vice Presidents, and such other officers as the Board of Directors may choose. The Board may authorize the Chief Executive Officer
to appoint one or more classes of officers with such titles (including the titles of Vice President, Corporate Secretary and Treasurer),
powers, duties and compensation as the Chief Executive Officer may approve. Any two or more offices may be held by the same person. Each
officer shall hold office until his or her successor shall have been duly elected or appointed and shall have qualified, or until death,
or until such officer shall have resigned or have been removed, as hereinafter provided in these By-Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Resignations</U>. Any officer of the Corporation may resign at any time by giving written notice of such resignation to the
Corporation. Any such resignation shall take effect at the time specified therein or, if the time when it shall become effective shall
not be specified therein, immediately upon receipt. Unless otherwise specified therein, the acceptance of any such resignation shall not
be necessary to make it effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Removal</U>. Any officer of the Corporation may be removed, either with or without cause, at any time, by the Board of Directors
at any meeting thereof. Any appointed officer of the Corporation may also be removed, either with or without cause, at any time, by the
Chief Executive Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Chief Executive Officer</U>. The Chief Executive Officer shall have responsibility for the general and active management of
the business, property and affairs of the Corporation, subject, to the control of the Board of Directors. The Chief Executive Officer
shall perform such other duties as may be specified in these By-Laws or assigned by the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>President</U>. The President shall perform all duties incident to the Office of President and such other duties as may from
time to time be assigned to the President by the Chief Executive Officer or the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Vice Presidents</U>. Each Vice President shall perform such duties as from time to time may be assigned to the Vice President
by the Board of Directors, the Chief Executive Officer, or such other officer as may be designated by one of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; width: 34%; vertical-align: middle">-&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Treasurer</U>. The Treasurer shall:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>have charge and custody of, and be responsible for, all the funds and securities of the Corporation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>keep full and accurate accounts of receipts and disbursements in books belonging to the Corporation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>deposit all moneys and other valuables to the credit of the Corporation in such depositories as may be designated by the Board
of Directors or pursuant to its direction;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>receive, and give receipts for, moneys due and payable to the Corporation from any source whatsoever;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>disburse the funds of the Corporation and supervise the investments of its funds, taking proper vouchers therefor;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>render to the Board of Directors, whenever the Board of Directors may require, an account of the Corporation&rsquo;s cash position;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>in general, perform all duties incident to the office of Treasurer and such other duties as from time to time may be assigned by
the Board of Directors, or the Chief Executive Officer, or such other officer as may be designated by one of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;8.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Corporate Secretary</U>. The Corporate Secretary shall:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>keep or cause to be kept in one or more books provided for the purpose, the minutes of all meetings of the Board of Directors,
the committees of the Board of Directors and the shareholders;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>see that all notices are duly given in accordance with the provisions of these By-Laws and as required by law;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>be custodian of the records and the seal of the Corporation and affix and attest the seal to all certificates for shares of the
Corporation (unless the seal of the Corporation on such certificates shall be a facsimile, as hereinafter provided) and affix and attest
the seal to all other documents to be executed on behalf of the Corporation under its seal;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>see that the books, reports, statements, certificates and other documents and records required by law to be kept and filed in order
to maintain the Corporation&rsquo;s legal existence are properly kept and filed; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>in general, perform all duties incident to the office of Corporate Secretary and such other duties as from time to time may be
assigned by the Board of Directors, the Chief Executive Officer, or such other officer as may be designated by one of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; width: 34%; vertical-align: middle">-&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;9.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>The Assistant Treasurer</U>. The Assistant Treasurer, or if there shall be more than one, the Assistant Treasurers in the order
determined by the Board of Directors (or if there be no such determination, then in the order of their seniority), shall, in the absence
of the Treasurer or in the event of the inability or refusal of the Treasurer to act, perform the duties and exercise the powers of the
Treasurer and shall perform such other duties as from time to time may be assigned by the Board of Directors, the Chief Executive Officer,
the Treasurer, or such other officer as may be designated by one of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;10.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>The Assistant Corporate Secretary</U>. The Assistant Corporate Secretary, or if there be more than one, the Assistant Corporate
Secretaries in the order determined by the Board of Directors (or if there be no such determination, then in the order of their seniority),
shall, in the absence of the Corporate Secretary or in the event of the inability or refusal of the Corporate Secretary to act, perform
the duties and exercise the powers of the Corporate Secretary and shall perform such other duties as from time to time may be assigned
by the Board of Directors, the Chair of the Board, the President and Chief Executive Officer, the Corporate Secretary, or such other officer
as may be designated by one of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;11.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Designation</U>. The Board of Directors may, by resolution, designate one or more officers to be any of the following: Chief
Operating Officer, President, Chief Financial Officer, General Counsel, or Chief Accounting Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;12.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Agents and Employees</U>. If authorized by the Board of Directors, the Chief Executive Officer or any officer or employee of
the Corporation designated by the Board or the Chief Executive Officer may appoint or employ such agents and employees as shall be requisite
for the proper conduct of the business of the Corporation, and may fix their compensation and the conditions of their employment, subject
to removal by the appointing or employing person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;13.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Officers&rsquo; Bonds or Other Security</U>. If required by the Board of Directors, any officer of the Corporation shall give
a bond or other security for the faithful performance of such officer&rsquo;s duties, in such amount and with such surety as the Board
of Directors may require.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;14.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Compensation</U>. The compensation of all officers of the Corporation for their services as such officers shall be fixed from
time to time by the Board of Directors unless by resolution of the Board that authority is delegated to a committee of the Board, the
Chief Executive Officer, or any other officer of the Corporation. An officer of the Corporation shall not be prevented from receiving
compensation by reason of the fact that such officer is also a director of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;15.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Terms</U>. Unless otherwise specified by the Board of Directors in any particular election or appointment, each officer shall
hold office, and be removable, at the pleasure of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; width: 34%; vertical-align: middle">-&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">Article&nbsp;V</FONT><BR>
<BR>
Stock Certificates and Their Transfer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Stock Certificates; Uncertificated Shares</U>. The shares of the Corporation shall be represented by certificates; provided
that the Board of Directors may provide by resolution or resolutions that some or all of any or all classes or series of stock shall be
uncertificated shares. Any such resolution shall not apply to shares represented by a certificate until such certificate is surrendered
to the Corporation. Notwithstanding the adoption of such resolution by the Board of Directors, every holder of stock represented by certificates
shall be entitled to have a certificate signed by, or in the name of the Corporation by the Chair of the Board, the Chief Executive Officer,
or the President or a Vice President, and by the Treasurer or an Assistant Treasurer, or the Corporate Secretary or an Assistant Corporate
Secretary, representing the number of shares registered in certificate form. If the Corporation shall be authorized to issue more than
one class of stock or more than one series of any class, the powers, designations, preferences and relative, participating, optional or
other special rights of each class of stock or series thereof and the qualifications, limitations or restriction of such preferences and/or
rights shall be set forth in full or summarized on the face or back of the certificate which the Corporation shall issue to represent
such class or series of stock; provided that, except as otherwise provided in Section&nbsp;202 of the DGCL, in lieu of the foregoing requirements,
there may be set forth on the face or back of the certificate which the Corporation shall issue to represent such class or series of stock,
a statement that the Corporation will furnish without charge to each shareholder who so requests the powers, designations, preferences
and relative, participating, optional or other special rights of each class of stock or series thereof and the qualifications, limitations
or restrictions of such preferences and/or rights. Within a reasonable time after the issuance or transfer of uncertificated stock, the
Corporation shall send to the registered owner thereof a written notice containing the information required or permitted to be set forth
or stated on certificates pursuant to this Section&nbsp;1 or otherwise pursuant to the DGCL. Except as otherwise expressly provided by
law, the rights and obligations of the holders of uncertificated stock and the rights and obligations of the holders of certificates representing
stock of the same class and series shall be identical.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Facsimile Signatures</U>. Any or all of the signatures on a certificate may be a facsimile. In case any officer, transfer agent
or registrar who has signed or whose facsimile signature has been placed upon a certificate shall have ceased to be such officer, transfer
agent or registrar before such certificate is issued, it may be issued by the Corporation with the same effect as if such person was such
officer, transfer agent or registrar at the date of issue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Lost Certificates</U>. The Corporation may issue a new certificate or certificates, or uncertificated shares, in the place of
any certificate or certificates theretofore issued by the Corporation alleged to have been lost, stolen, or destroyed. The Corporation
may, in its discretion and as a condition precedent to the issuance thereof, require the owner of such lost, stolen, or destroyed certificate
or certificates, or the owner&rsquo;s legal representative, to give the Corporation a bond in such sum as it may direct sufficient to
indemnify it against any claim that may be made against the Corporation on account of the alleged loss, theft or destruction of any such
certificate or the issuance of such new certificate or uncertificated shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Transfers of Stock</U>. Upon surrender to the Corporation or the transfer agent of the Corporation of a certificate for shares
duly endorsed or accompanied by proper evidence of succession, assignment or authority or transfer, or upon receipt by the transfer agent
of a proper instruction from the registered holder of uncertificated shares, it shall be the duty of the Corporation to transfer such
shares upon its records and, in connection with the transfer of a share that will be certificated, to issue a new certificate to the person
entitled thereto and to cancel the old certificate; provided, however, that the Corporation shall be entitled to recognize and enforce
any lawful restriction on transfer. Whenever any transfer of stock shall be made for collateral security, and not absolutely, it shall
be so expressed in the entry of transfer if, when the certificates are presented to the Corporation for transfer, or when proper instructions
with respect to the transfer of uncertificated shares are received, both the transferor and the transferee request the Corporation to
do so.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; width: 34%; vertical-align: middle">-&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Transfer Agents and Registrars</U>. The Board of Directors may appoint, or authorize any officer or officers to appoint, one
or more transfer agents and one or more registrars.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Regulations</U>. The Board of Directors may make such additional rules and regulations, not inconsistent with these By-Laws,
as it may deem expedient concerning the issue, transfer and registration of certificates for shares of stock of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Fixing the Record Date</U>. In order that the Corporation may determine the shareholders entitled to notice of or to vote at
any meeting of shareholders or any adjournment thereof, or entitled to receive payment of any dividend or other distribution or allotment
of any rights, or entitled to exercise any rights in respect of any change, conversion or exchange of stock or for the purpose of any
other lawful action, the Board of Directors may, except as otherwise required by law, fix a record date, which record date shall not precede
the date on which the resolution fixing the record date is adopted and which record date shall not be more than 60 nor less than 10 days
before the date of such meeting, nor more than 60 days prior to any other action; provided, however, that if no record date is fixed by
the Board of Directors, the record date for determining shareholders entitled to notice of or to vote at a meeting of shareholders shall
be at the close of business on the day next preceding the day on which notice is given or, if notice is waived, at the close of business
on the day next preceding the day on which the meeting is held, and, for determining shareholders entitled to receive payment of any dividend
or other distribution or allotment of rights or to exercise any rights of change, conversion or exchange of stock or for any other purpose,
the record date shall be at the close of business on the day on which the Board of Directors adopts a resolution relating thereto. A determination
of shareholders of record entitled to notice of or to vote at a meeting of shareholders shall apply to any adjournment of the meeting;
provided, however, that the Board of Directors may fix a new record date for the adjourned meeting. To the extent permitted by law, the
record date for determining the shareholders entitled to receive notice of a meeting may be different from the record date for determining
the shareholders entitled to vote at such meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">In order that the Corporation may determine
the shareholders entitled to consent to corporate action without a meeting, the Board of Directors may fix a record date, which shall
not precede the date upon which the resolution fixing the record date is adopted by the Board of Directors, and which record date shall
be not more than 10&nbsp;days after the date upon which the resolution fixing the record date is adopted. If no record date has been fixed
by the Board of Directors and no prior action by the Board of Directors is required by the DGCL, the record date shall be the first date
on which a consent setting forth the action taken or proposed to be taken is delivered to the Corporation in the manner prescribed by
the DGCL. If no record date has been fixed by the Board of Directors and prior action by the Board of Directors is required by the DGCL
with respect to the proposed action by consent of the shareholders without a meeting, the record date for determining shareholders entitled
to consent to corporate action without a meeting shall be at the close of business on the day on which the Board of Directors adopts the
resolution taking such prior action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; width: 34%; vertical-align: middle">-&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;8.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Registered Shareholders</U>. The Corporation shall be entitled to recognize the exclusive right of a person registered on its
records as the owner of shares of stock to receive dividends and to vote as such owner, shall be entitled to hold liable for calls and
assessments a person registered on its records as the owner of shares of stock, and shall not be bound to recognize any equitable or other
claim to or interest in such share or shares of stock on the part of any other person, whether or not it shall have express or other notice
thereof, except as otherwise provided by the laws of Delaware.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">Article&nbsp;VI</FONT><BR>
<BR>
Indemnification</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Right to Indemnification</U>. Each person who was or is made a party or is threatened to be made a party to or is otherwise
involved in any action, suit or proceeding, whether civil, criminal, administrative or investigative (for purposes of this Article&nbsp;VI,
a &ldquo;proceeding&rdquo;), by reason of the fact that he or she (a)&nbsp;is or was a director or an officer of the Corporation or (b)&nbsp;is
or was serving at the request of the Corporation as a director, officer, employee, agent, partner or trustee of another corporation or
of a partnership, joint venture, trust or other enterprise, including service with respect to an employee benefit plan (the persons in
clauses&nbsp;(a) and (b)&nbsp;hereinafter referred to as an &ldquo;indemnitee&rdquo;), shall be indemnified and held harmless by the Corporation
to the fullest extent permitted by Delaware law, as the same exists or may hereafter be amended (but, in the case of any such amendment,
only to the extent that such amendment permits the Corporation to provide broader indemnification rights than such law permitted the Corporation
to provide prior to such amendment), against all expense, liability and loss (including attorneys&rsquo; fees, judgments, fines, ERISA
excise taxes or penalties and amounts paid in settlement) reasonably incurred or suffered by such indemnitee in connection therewith;
provided, however, that, except as provided in Section&nbsp;3 of this Article&nbsp;VI with respect to proceedings to enforce rights to
indemnification, the Corporation shall indemnify any such indemnitee in connection with a proceeding (or part thereof) initiated by such
indemnitee only if such proceeding (or part thereof) was authorized by the Board of Directors of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Right to Advancement of Expenses</U>. In addition to the right to indemnification conferred in Section&nbsp;1 of this Article&nbsp;VI,
an indemnitee shall also have the right to be paid by the Corporation the expenses (including attorney&rsquo;s fees) incurred in defending
any such proceeding in advance of its final disposition (hereinafter an &ldquo;advancement of expenses&rdquo;); provided, however, that
if the DGCL requires, an advancement of expenses incurred by an indemnitee in his or her capacity as a director or officer (and not in
any other capacity in which service was or is rendered by such indemnitee, including, without limitation, service to an employee benefit
plan) shall be made only upon delivery to the Corporation of an undertaking (hereinafter an &ldquo;undertaking&rdquo;), by or on behalf
of such indemnitee, to repay all amounts so advanced if it shall ultimately be determined by final judicial decision from which there
is no further right to appeal (hereinafter a &ldquo;final adjudication&rdquo;) that such indemnitee is not entitled to be indemnified
for such expenses under this Section&nbsp;2 or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 38 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; width: 34%; vertical-align: middle">-&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Right of Indemnitee to Bring Suit</U>. If a claim under Section&nbsp;1 or Section&nbsp;2 of this Article&nbsp;VI is not paid
in full by the Corporation within 60&nbsp;days after a written claim has been received by the Corporation, except in the case of a claim
for an advancement of expenses, in which case the applicable period shall be 20&nbsp;days, the indemnitee may at any time thereafter bring
suit against the Corporation to recover the unpaid amount of the claim. If successful in whole or in part in any such suit, or in a suit
brought by the Corporation to recover an advancement of expenses pursuant to the terms of an undertaking, the indemnitee shall be entitled
to be paid also the expense of prosecuting or defending such suit. In (a)&nbsp;any suit brought by the indemnitee to enforce a right to
indemnification hereunder (but not in a suit brought by the indemnitee to enforce a right to an advancement of expenses) it shall be a
defense that, and (b)&nbsp;in any suit brought by the Corporation to recover an advancement of expenses pursuant to the terms of an undertaking,
the Corporation shall be entitled to recover such expenses upon a final adjudication that, the indemnitee has not met any applicable standard
for indemnification set forth in the DGCL. Neither the failure of the Corporation (including its directors who are not parties to such
action, a committee of such directors, independent legal counsel, or its shareholders) to have made a determination prior to the commencement
of such suit that indemnification of the indemnitee is proper in the circumstances because the indemnitee has met the applicable standard
of conduct set forth in the DGCL, nor an actual determination by the Corporation (including its directors who are not parties to such
action, a committee of such directors, independent legal counsel, or its shareholders) that the indemnitee has not met such applicable
standard of conduct, shall create a presumption that the indemnitee has not met the applicable standard of conduct or, in the case of
such a suit brought by the indemnitee, be a defense to such suit. In any suit brought by the indemnitee to enforce a right to indemnification
or to an advancement of expenses hereunder, or brought by the Corporation to recover an advancement of expenses pursuant to the terms
of an undertaking, the burden of proving that the indemnitee is not entitled to be indemnified, or to such advancement of expenses, under
this Article&nbsp;VI or otherwise shall be on the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Non-Exclusivity of Rights</U>. The rights to indemnification and to the advancement of expenses conferred in this Article&nbsp;VI
shall not be exclusive of any other right which any person may have or hereafter acquire under any statute, the Corporation&rsquo;s Certificate
of Incorporation, agreement, vote of shareholders or directors or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Insurance</U>. The Corporation may maintain insurance, at its expense, to protect itself and any director, officer, employee
or agent of the Corporation or another corporation, partnership, joint venture, trust or other enterprise against any expense, liability
or loss, whether or not the Corporation would have the power to indemnify such person against such expense, liability or loss under the
DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Indemnification of Employees and Agents of the Corporation</U>. The Corporation may, to the extent authorized from time to time
by the Board of Directors, grant rights to indemnification and to the advancement of expenses to any employee or agent of the Corporation
to the fullest extent of the provisions of this Article&nbsp;VI with respect to the indemnification and advancement of expenses of directors
and officers of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 39 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; width: 34%; vertical-align: middle">-&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Nature of Rights</U>. The rights conferred upon indemnitees in this Article&nbsp;VI shall be contract rights and such rights
shall continue as to an indemnitee who has ceased to be a director, officer, employee, agent, partner or trustee and shall inure to the
benefit of the indemnitee&rsquo;s heirs, executors and administrators. Any amendment, alteration or repeal of this Article&nbsp;VI that
adversely affects any right of an indemnitee or its successors shall be prospective only and shall not limit or eliminate any such right
with respect to any proceeding involving any occurrence or alleged occurrence of any action or omission to act that took place prior to
such amendment or repeal.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">Article&nbsp;VII</FONT><BR>
<BR>
General Provisions</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Dividends</U>. Subject to the provisions of statute and the Certificate of Incorporation, dividends upon the shares of capital
stock of the Corporation may be declared by the Board of Directors at any regular or special meeting. Dividends may be paid in cash, in
property or in shares of stock of the Corporation, unless otherwise provided by statute or the Certificate of Incorporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Seal</U>. The seal of the Corporation shall be in such form as shall be approved by the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Fiscal Year</U>. The fiscal year of the Corporation shall be fixed, and once fixed, may thereafter be changed, by resolution
of the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Contributions</U>. The Board of Directors shall have the authority from time to time to make such contributions as the Board
in its discretion shall determine, for public and charitable purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Borrowing, etc</U>. No officer, agent or employee of the Corporation shall have any power or authority to borrow money on its
behalf, to pledge its credit, or to mortgage or pledge its real or personal property, except within the scope and to the extent of the
authority delegated by resolution of the Board of Directors. Authority may be given by the Board for any of the above purposes and may
be general or limited to specific instances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Deposits</U>. All funds of the Corporation shall be deposited from time to time to the credit of the Corporation in such banks,
trust companies, or other depositories as the Board of Directors may approve or designate, and all such funds shall be withdrawn only
upon checks, drafts, notes or other orders for payment signed by such one or more officers, employees or other persons as the Board shall
from time to time determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Execution of Contracts, Deeds, etc</U>. The Board of Directors may authorize any officer or officers, agent or agents, in the
name and on behalf of the Corporation to enter into or execute and deliver any and all deeds, bonds, mortgages, contracts and other obligations
or instruments, and such authority may be general or confined to specific instances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;8.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Voting of Stock in Other Corporations</U>. If authorized by the Board of Directors, any officer of the Corporation may appoint
an attorney or attorneys (who may be or include such officer), in the name and on behalf of the Corporation, to cast the votes which the
Corporation may be entitled to cast as a shareholder or otherwise in any other corporation any of whose shares or other securities are
held by or for the Corporation, at meetings of the holders of the shares or other securities of such other corporation, or in connection
with the ownership of such shares or other securities, to consent in writing to any action by such other corporation, and may instruct
the person or persons so appointed as to the manner of casting such votes or giving such consent, and may execute or cause to be executed
in the name and on behalf of the Corporation and under its seal such written proxies or other instruments as such proxy may deem necessary
or proper in the circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 40 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; width: 34%; vertical-align: middle">-&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;9.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Form of Records</U>. Any records maintained by the Corporation in the regular course of its business, including its stock ledger,
books of account, and minute books, may be kept on, or be in the form of punch cards, magnetic tape, photographs, microphotographs, or
any other information storage device; provided that the records so kept can be converted into clearly legible form within a reasonable
time. The Corporation shall so convert any records so kept upon the request of any person entitled to inspect the same.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">Article&nbsp;VIII</FONT><BR>
<BR>
Amendments</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">These By-Laws may be adopted, amended or repealed
by the affirmative vote of the holders of a majority of the voting power of the capital stock of the Corporation outstanding and entitled
to vote thereon. The Board of Directors shall also have the power to adopt, amend or repeal any provision of these By-Laws of the Corporation
without any vote of the shareholders of the Corporation.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">Article&nbsp;IX</FONT><BR>
<BR>
Definitions</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<U>Affiliate</U>.&rdquo; The term &ldquo;Affiliate,&rdquo; as used herein, shall have the meaning set forth in Rule 12b-2
under the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<U>Associate</U>.&rdquo; The term &ldquo;Associate,&rdquo; as used herein, shall have the meaning set forth in Rule 12b-2
under the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<U>Beneficial Ownership; Beneficially Owned</U>.&rdquo; The terms &ldquo;beneficial ownership&rdquo; or &ldquo;beneficially
owned,&rdquo; as used herein, shall have the meanings set forth for such terms in Section 13(d) of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<U>Certificate of Incorporation</U>.&rdquo; The term &ldquo;Certificate of Incorporation,&rdquo; as used herein, includes
not only the original Certificate of Incorporation filed to create the Corporation but also all other certificates, agreements of merger
or consolidation, plans of reorganization, or other instruments, howsoever designated, which are filed pursuant to the DGCL, and which
have the effect of amending or supplementing in some respect this Corporation&rsquo;s original Certificate of Incorporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<U>Designated Officer</U>.&rdquo; The term &ldquo;Designated Officer,&rdquo; as used herein, shall mean an officer identified
on a numbered list of officers of the Corporation who shall be deemed to be, in the order in which they appear on the list up until a
quorum is obtained, directors of the Corporation, or members of a committee of the Board of Directors, as the case may be, for purposes
of obtaining a quorum during an Emergency (as defined below), if a quorum of directors or committee members, as the case may be, cannot
otherwise be obtained during such Emergency, which officers have been designated by the Board of Directors from time to time but in any
event prior to such time or times as an Emergency may have occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 41 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; width: 34%; vertical-align: middle">-&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<U>Derivative Instrument</U>.&rdquo; The term &ldquo;Derivative Instrument,&rdquo; as used herein, shall mean any agreement,
arrangement or understanding, written or oral, (including any derivative, long or short position, profit interest, forward, future, swap,
option, warrant, convertible security, stock appreciation right or similar right, hedging transaction, repurchase agreement or arrangement,
borrowed or loaned shares and so-called &ldquo;stock borrowing&rdquo; agreement or arrangement) with an exercise or conversion privilege
or a settlement payment or mechanism at a price related to any class or series of shares of capital stock of the Corporation or with a
value derived in whole or in part from the value of any class or series of shares of capital stock of the Corporation, the effect or intent
of which is to mitigate loss, manage risk or benefit from changes in the price of any securities of the Corporation, to transfer to or
from any person or entity, in whole or in part, any of the economic consequences of ownership of any security of the Corporation, to maintain,
increase or decrease the voting power of any person or entity with respect to securities of the Corporation or to provide any person or
entity, directly or indirectly, with the opportunity to profit or share in any profit derived from, or to otherwise benefit economically
from, any increase or decrease in the value of any security of the Corporation, without regard to whether such agreement, arrangement
or understanding is required to be reported on a Schedule 13D in accordance with the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<U>Electronic Transmission</U>.&rdquo; The term &ldquo;electronic transmission&rdquo; as used herein shall mean any form
of communication, not directly involving the physical transmission of paper, that creates a record that may be retained, retrieved, and
reviewed by a recipient thereof, and that may be directly reproduced in paper form by such recipient through an automated process or that
otherwise may be permitted as an electronic transmission by the DGCL, as amended from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;8.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<U>Net Long Beneficial Ownership</U>.&rdquo; The term &ldquo;Net Long Beneficial Ownership&rdquo; (and its correlative terms),
as used herein, when used to describe the nature of a person&rsquo;s ownership of capital stock of the Corporation, shall mean the capital
stock of the Corporation that such person or, if such person is a beneficial owner, that such beneficial owner would then be deemed to
own pursuant to the definition of &ldquo;net long position&rdquo; set forth in Rule 14e-4 under the Exchange Act, excluding, at any time,
(a)&nbsp;any capital stock as to which such shareholder or beneficial owner, as the case may be, does not then have the right to vote
or direct the vote and (b)&nbsp;any capital stock as to which such person or beneficial owner (or any Affiliate or Associate of such person
or beneficial owner), as the case may be, had directly or indirectly entered into (or caused to be entered into) and not yet terminated
a Derivative Instrument, and further subtracting from any person&rsquo;s ownership of capital stock at any time such person&rsquo;s (and
such person&rsquo;s Affiliates&rsquo; and Associates&rsquo;) &ldquo;short position&rdquo; (as defined pursuant to Rule&nbsp;14e-4(a) under
the Exchange Act), all as the Board of Directors shall determine in good faith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 42 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; width: 34%; vertical-align: middle">-&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;9.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<U>Noticing Shareholder</U>.&rdquo; The term &ldquo;Noticing Shareholder,&rdquo; as used herein, shall mean a shareholder
providing notice pursuant to Section&nbsp;11, Section&nbsp;12 or Section&nbsp;13 of Article&nbsp;II, as applicable; provided, however,
that (a) the term &ldquo;Noticing Shareholder&rdquo; as used in Section&nbsp;11(c) or Section&nbsp;12(c) of Article&nbsp;II, as applicable,
shall mean, with respect to a Requesting Shareholder submitting information pursuant to Section&nbsp;11(c) or Section&nbsp;12(c) of Article&nbsp;II,
as applicable, the Requesting Shareholder, and (b) the term &ldquo;Noticing Shareholder&rdquo; as used in Section&nbsp;11(c) of Article&nbsp;II
shall mean, with respect to each Nominator and Group Member submitting information pursuant to Section&nbsp;11(c) of Article&nbsp;II,
the Nominator or Nominator Group, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;10.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<U>Proponent Person</U>.&rdquo; The term &ldquo;Proponent Person,&rdquo; as used herein, shall mean, with respect to any
Noticing Shareholder or Requesting Shareholder: (a) such Noticing Shareholder or Requesting Shareholder; (b) the beneficial owner(s),
if different from such Noticing Shareholder or Requesting Shareholder, on whose behalf the notice is provided or the Special Meeting Request
is made; (c) any person directly or indirectly controlling, controlled by or under common control with such Noticing Shareholder or Requesting
Shareholder (or, if different from such Noticing Shareholder or Requesting Shareholder, the beneficial owner or beneficial owners on whose
behalf such notice or Special Meeting Request is made); (d) any member of the immediate family of any individual described in the foregoing
clause (a) or (b) sharing the same household; (e) any Affiliate or Associate of any person described in the foregoing clause (a), (b),
(c) or (d); (f) any person who is a member of a &ldquo;group&rdquo; (as such term is used in Rule 13d-5 under the Exchange Act) with such
Noticing Shareholder or Requesting Shareholder, or any other Proponent Person with respect to the stock of the Corporation, including
any Proposed Nominee; (g) any person with whom any person described in the foregoing clause (a), (b), (c) or (d) is knowingly acting in
concert with respect to the stock of the Corporation; and (h) any participant (as defined in paragraphs (a)(ii)-(vi) of Instruction 3
to Item 4 of Schedule 14A) with any person described in the foregoing clause (a), (b), (c) or (d) with respect to any proposed nomination
or business; provided, however, that the term &ldquo;Proponent Person,&rdquo; shall mean, with respect to each Nominator and Group Member
submitting information pursuant to Section&nbsp;11(c) of Article&nbsp;II, the Nominator or Nominator Group, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;11.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<U>Public Announcement</U>.&rdquo; The term &ldquo;Public Announcement,&rdquo; as used herein, shall mean disclosure (a)
in a press release issued by the Corporation in accordance with its customary press release procedures, that is reported by the Dow Jones
News Service, Associated Press or a comparable national news service or is generally available on internet news sites, or (b) in a document
publicly filed by the Corporation with the SEC pursuant to Section 13, 14 or 15(d) of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;12.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<U>Qualified Representative</U>.&rdquo; The term &ldquo;Qualified Representative,&rdquo; as used herein in relation to any
person, shall mean (a) a duly authorized officer, manager or partner of such person or (b) a person authorized by a writing executed by
such person (or a reliable reproduction or electronic transmission of such a writing) delivered by such person to the Corporate Secretary
at the principal executive offices of the Corporation prior to the making of any nomination or proposal at a shareholder meeting stating
that such person is authorized to act for such Noticing Shareholder or Requesting Shareholder as proxy at the meeting of shareholders,
which writing or electronic transmission, or a reliable reproduction of the writing or electronic transmission, must be produced at least
24 hours prior to the meeting of shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 43 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; width: 34%; vertical-align: middle">-&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">Article&nbsp;X</FONT><BR>
<BR>
Exclusive Forum</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Unless the Corporation consents in writing to
the selection of an alternative forum, the sole and exclusive forum for (a)&nbsp;any derivative action or proceeding brought on behalf
of the Corporation, (b)&nbsp;any action asserting a claim for or based on a breach of a fiduciary duty owed by any current or former director
or officer or other employee of the Corporation to the Corporation or the Corporation&rsquo;s shareholders, including a claim alleging
the aiding and abetting of such a breach of fiduciary duty, (c)&nbsp;any action asserting a claim against the Corporation or any current
or former director or officer or other employee of the Corporation arising pursuant to any provision of the DGCL or the Certificate of
Incorporation or these By-Laws (as either may be amended from time to time), (d)&nbsp;any action asserting a claim related to or involving
the Corporation that is governed by the internal affairs doctrine, or (e)&nbsp;any action asserting an &ldquo;internal corporate claim&rdquo;
as that term is defined in Section&nbsp;115 of the DGCL shall be a state court within the State of Delaware (or, if no state court located
within the State of Delaware has jurisdiction, the federal district court for the District of Delaware).</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">Article&nbsp;XI</FONT><BR>
<BR>
Emergency By-Laws</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Emergency By-Laws</U>. This Article&nbsp;XI shall be operative during any emergency, disaster or catastrophe, as referred to
in Section 110 of the DGCL or other similar emergency condition (including, without limitation, a pandemic), as a result of which a quorum
of the Board of Directors or a committee thereof cannot readily be convened for action (each, an &ldquo;Emergency&rdquo;), notwithstanding
any different or conflicting provision of the other Sections of these By-Laws or in the Certificate of Incorporation. To the extent not
inconsistent with the provisions of this Article&nbsp;XI, the other Sections of these By-Laws and the provisions of the Certificate of
Incorporation shall remain in effect during such Emergency, and upon termination of such Emergency, the provisions of this Article&nbsp;XI
shall cease to be operative unless and until another Emergency shall occur. To the extent that it considers it practical to do so, the
Board of Directors shall manage the business of the Corporation during an Emergency in a manner that is consistent with these By-Laws
and the Certificate of Incorporation. It is recognized, however, that in an Emergency, it may not always be practical to act in this manner
and this Article&nbsp;XI is intended to, and does hereby, empower the Board of Directors with the maximum authority possible under the
DGCL and all other applicable law to conduct the interim management of the affairs of the Corporation in an emergency in what it considers
to be in the best interests of the Corporation, including, without limitation, taking any action that it determines to be practical and
necessary to address the circumstances of the Emergency. Nothing contained in this Article&nbsp;XI shall be deemed exclusive of any other
provisions for emergency powers consistent with other sections of the DGCL that have been or may be adopted by corporations created under
the DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 44 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; width: 34%; vertical-align: middle">-&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Meetings; Notice</U><I>. </I>During any Emergency, a meeting of the Board of Directors or any committee thereof may be called
by any member of the Board of Directors or such committee or the Chair of the Board, the Lead Independent Director (if one has been appointed),
the Chief Executive Officer, the Corporate Secretary or any executive officer of the Corporation. Notice of the place, date and time of
the meeting shall be given by any available means of communication by the person calling the meeting to such of the directors or committee
members and Designated Officers as, in the judgment of the person calling the meeting, it may be feasible to reach. Such notice shall
be given at such time in advance of the meeting as, in the judgment of the person calling the meeting, circumstances permit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Quorum</U>. At any meeting of the Board of Directors called in accordance with Section&nbsp;2 of this Article&nbsp;XI, the presence
or participation of one director shall constitute a quorum for the transaction of business, and at any meeting of any committee of the
Board of Directors called in accordance with Section&nbsp;2 of this Article&nbsp;XI, the presence or participation of one committee member
shall constitute a quorum for the transaction of business. In the event that no directors are able to attend a meeting of the Board of
Directors or any committee thereof, the presence or participation of two Designated Officers shall constitute a quorum for the transaction
of business. The Designated Officers in attendance shall serve as directors, or committee members, as the case may be, for the meeting,
and will have full powers to act as directors, or committee members, as the case may be, of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Liability</U><I>. </I>No officer, director or employee of the Corporation acting in accordance with the provisions of this Article&nbsp;XI
shall be liable except for willful misconduct.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Amendments</U><I>. </I>At any meeting called in accordance with Section&nbsp;2 of this Article&nbsp;XI, the Board of Directors,
or any committee thereof, as the case may be, may modify, amend or add to the provisions of this Article&nbsp;XI as it deems it to be
in the best interests of the Corporation so as to make any provision that may be practical or necessary for the circumstances of the Emergency.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Section&nbsp;6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Repeal or Change</U><I>. </I>The provisions of this Article&nbsp;XI shall be subject to repeal or change by further action of
the Board of Directors or by action of the shareholders, but no such repeal or change shall modify the provisions of Section&nbsp;4 of
this Article&nbsp;XI with regard to action taken prior to the time of such repeal or change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">February 13, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<!-- Field: Page; Sequence: 45; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; width: 34%; vertical-align: middle">-&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>ci-20230213.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 8aU5o7xRiXhun8uBZHFcSaKLicOdyZx9aZkxtmxzbSm6nysisWgqhSfuPxXmcWcD -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/srt-sup/2022q3" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:CI="http://cigna.com/20230213" elementFormDefault="qualified" targetNamespace="http://cigna.com/20230213">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://cigna.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="ci-20230213_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="ci-20230213_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap-sup/2022q3" schemaLocation="https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd" />
    <import namespace="http://fasb.org/srt-sup/2022q3" schemaLocation="https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd" />
    <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
    <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
    <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>ci-20230213_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInformationFormerLegalOrRegisteredName" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName_lbl" xml:lang="en-US">Entity Information, Former Legal or Registered Name</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>ci-20230213_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://cigna.com/role/Cover" xlink:href="ci-20230213.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://cigna.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="loc_deiEntityInformationFormerLegalOrRegisteredName" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInformationFormerLegalOrRegisteredName" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140586394079872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Feb. 13, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 13,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38769<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">The Cigna Group<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001739940<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">82-4991898<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">900 Cottage Grove Road<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Bloomfield<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">06002<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">860<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">226-6000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, Par Value $0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CI<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationFormerLegalOrRegisteredName', window );">Entity Information, Former Legal or Registered Name</a></td>
<td class="text">Cigna Corporation<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationFormerLegalOrRegisteredName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Former Legal or Registered Name of an entity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationFormerLegalOrRegisteredName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>cigna8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ci-20230213.xsd" xlink:type="simple"/>
    <context id="From2023-02-13to2023-02-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001739940</identifier>
        </entity>
        <period>
            <startDate>2023-02-13</startDate>
            <endDate>2023-02-13</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2023-02-13to2023-02-13">0001739940</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2023-02-13to2023-02-13">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2023-02-13to2023-02-13">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentType contextRef="From2023-02-13to2023-02-13">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2023-02-13to2023-02-13">2023-02-13</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2023-02-13to2023-02-13">The Cigna Group</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-02-13to2023-02-13">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2023-02-13to2023-02-13">001-38769</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2023-02-13to2023-02-13">82-4991898</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2023-02-13to2023-02-13">900 Cottage Grove Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2023-02-13to2023-02-13">Bloomfield</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2023-02-13to2023-02-13">CT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2023-02-13to2023-02-13">06002</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2023-02-13to2023-02-13">860</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2023-02-13to2023-02-13">226-6000</dei:LocalPhoneNumber>
    <dei:EntityInformationFormerLegalOrRegisteredName contextRef="From2023-02-13to2023-02-13">Cigna Corporation</dei:EntityInformationFormerLegalOrRegisteredName>
    <dei:WrittenCommunications contextRef="From2023-02-13to2023-02-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2023-02-13to2023-02-13">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2023-02-13to2023-02-13">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2023-02-13to2023-02-13">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2023-02-13to2023-02-13">Common Stock, Par Value $0.01</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-02-13to2023-02-13">CI</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-02-13to2023-02-13">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-02-13to2023-02-13">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M/[&\UDX:?^:+X3]>?P%02P$"% ,4    " #H,4U6!T%-8H$   "Q    $
M            @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( .@Q
M3580>7+B[0   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E
M+GAM;%!+ 0(4 Q0    ( .@Q35:97)PC$ 8  )PG   3              "
M <L!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ Z#%-5I:%Z*2"
M!   Q!$  !@              ("!# @  'AL+W=O<FMS:&5E=',O<VAE970Q
M+GAM;%!+ 0(4 Q0    ( .@Q35:?H!OPL0(  .(,   -              "
M <0,  !X;"]S='EL97,N>&UL4$L! A0#%     @ Z#%-5I>*NQS     $P(
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9>&UL4$L%!@     )  D /@(  !@4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="cigna8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cigna.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="cigna8k.htm">cigna8k.htm</File>
    <File>ci-20230213.xsd</File>
    <File>ci-20230213_lab.xml</File>
    <File>ci-20230213_pre.xml</File>
    <File>ex3-1.htm</File>
    <File>ex3-2.htm</File>
    <File>ex3-3.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "cigna8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 24
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "cigna8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ci-20230213_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ci-20230213_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "ci-20230213.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 60,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 24,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "CI",
   "nsuri": "http://cigna.com/20230213",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "cigna8k.htm",
      "contextRef": "From2023-02-13to2023-02-13",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://cigna.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "cigna8k.htm",
      "contextRef": "From2023-02-13to2023-02-13",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Former Legal or Registered Name of an entity",
        "label": "Entity Information, Former Legal or Registered Name"
       }
      }
     },
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cigna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0000950159-23-000019-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950159-23-000019-xbrl.zip
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M('2Z'0($B2#4C/()TA6-&']FM<<=YFPK!L"W.8OA%4I/E%NH!C6AB59G2$"
M#?$)8-8(/5#/I" FW^,I*D"R!B_$G<>Q.%!9^<]U0LD4;+]5ZY:N#KM-IBS"
M@$B"W0'\E,H#_0')&'1+0X%F]HZFSOQ#,QL*S2QH:&8?@6;YR@*!YO@=33WV
M#\WQ4&B.@X;F^$/0B([W.M;,Q<=;OF2OMH>S0:479-I6K<#L9>'ATO+6!XL,
MD.L9&>(3DV)A=<OO.'M): 0OF2&Y%V  TU9J#&UXZ-@-]O%3+8AUG->Q1BW*
M>[\D6N9GE&F:M \Q2A,>)$UCO8.+4OM$XHYE.4[_G3QWGHC;Q5[PL!JV0M)0
MAH>*S5X?,"H&B2 ?)]8EKO*&AO55,J/<W2O %EO[5X!KA4% 8'/4?@5873U1
M(M?=+!GE! ,C0K/862=;3%5]7"L+HXO;AEH]7'ROA<;'%UEF=TGO'AF%'Q!H
M2USU-&1.][99'D2/ Z;,7B]DJ-!YNAHO,TQD]N&[5N9L9C?M5!.Y+@BB=TTW
MK6E:ESONS5]YDHL]S]EFLZ7E71[;<X. SE4O=]K4/6X5!='[7<Y,$DHM:HH=
M8[%@:1(E>4+7OXB33YY@6ZML(E= P 8U#6U%$"B MDP.]D*DE8XAN.-$0DA$
M1Q0O <K$0OSVX<$ZVW>)74'1;UC# 2N#@*37G@F+"!A'M0BD0E 1XQ>;JRS;
M$OXN>"PAGA "S0,@M?0AX@29[(5*!?ID:T&BK9@?WZ:SU3+)4]O)95OB;$X"
MS%4SDE$>!!N *9.%H@RQ!S2=_67U5Z2C''?_#5MR+)/'+MXV*Y8"V:>L*E<0
M=%C4'%@D0:  ^S)IN&&HE"*E]9&=JF'6TARCW!4 5ENZZQN%072ZS5'KR]_H
M:T]#_L4N>A2F"/!"@EWF>NBWF32'_[HF" 0ZC+5.2DHITEH?+R3LIZQU_R)@
M[6T1L.Y9!*Q#7 2LARX"UMX6 7JW*D6(&)=N5VFRQD!RPDZU:R@Z+)M\6*1!
MH0+[ \>,*@3M8UQGM"Q2G,GT_'Q3[/]2?+"T$M YRVG99;-*:FD3!<%(E[-6
M6DN5=*XF1E+MFHMMG.0D5F8N$XIIE."T2H]HNR+>'^*,EH'F*W!Z]&$P-,QD
M"R<5IG,95H'[5)>N+Z6K!S!^)6GZ,V6O=$%PQBB)U;44VYVB;KW;)V9Z;#<?
MF@'$0> TQ"'PZ(P,&C_)**3#RBMA7DCZQM(MS3$OWB7GMI$)T+DE![#9),80
M!42*W1E 2"5&2NWG!6V5/:):9*G?'0(;",D=OZ[=:=IX:]NJ#8B93H/0.]QE
MSH_]VEA%>7K%,B?R]R*2%_(%Y[CT!K87DKM^J;++M/DVI4T;$$*=!L'W)ZL8
MF2H&:Z:\I8SA<['46K..I\0-E?O$,2V+[=PQE20@/&R^.C+(<*2U7EA8;'":
M?MYF"249/!$9*K<L6"TV66A( F+!Y@M@H9 BK?7"PL6&\+68WG[B[#5_+/.S
M@FT#U&[9Z+3<9,0J#8B5+G\ ,SH$J1B=4M<//+M]0G&591%NJ47J&!O0K,%,
M2Q<2,)"Y%BTIB>3UEAN6HR5#7S."\D>"+LJ?H:MG@E?U^/JED2B2+T2H53F-
M,;<AU"5V_JLCH.'6;X^TE$& U&L/_AV2*@+I$,?4W J&>?T\KC!QE9,-^+9#
M?X@K@H::UQSUZ8.@::!)DZDBK'ER700B&>DSFU$]N3V\Q&N('*^,+0:-A7%-
M$00CH"UH65S_K0 _N?.VJS2)+E.&X:LL#8WCC'EM>T:RO+T@( +:KJ 4>840
M%4HO_?\9TR>^?<ZCMSO.(D+D4U99-5KU77\;&.V6F7<UJ4G3H-" .'N/7X#
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M(U^0O[\!I<?3!3I?0E8V_P9TO;A@EK;2Y)@SZ%Q-D=I(,?IFR$V,WP_Y7F!
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M5/MF/=S9VK^5GX;^X]OIZ5.MP-7N3>Z^<WMTQ_NZ]\-1_P]02P,$%     @
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MT42&'?ZB(RY4[(_?P(OPZIEY;R+C*S]\+WIO=O\:#I/IAYVW9Z5'4G67KLG
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MJ;4:+L'.]-=[[\1I+,,K?"!6*C6/'_@I\;_?_& "NY-&,..#* OIVW8+U^$
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MP$<I7,N_6<6.ELHB4/='XH;9+;5=Q/N^/N7N J7,\_&KJ;R7PX!P?\X'=-O
MBNJ&D4:=1B0*"[C@++D3:]0DLZ@H7.Y D5!S@C K$[%&Q/R.H"Z2A 7;<?XK
M0$:B82(XH%]#<(WFGD:-QDC[I[EM-M6F1 \.NN4_8R2DF']<Z+$D:0T3L+"E
M %IA7?]C;4U\]%7@O1=GH!]^ *#P1X8T GA"K*UIK_;.X?'_%'W$KM\6\5\C
M5%H"@ A.$3K. VOL ?X@"L\;'%3&7SMO88P5PQW&2GY;&RK@F3"G*<W1Q;>O
M<OS.KKS%;>&=>!KDTW@/%-K>0MRW .$!/8)4'A)!6AL=GI>T&0Y"&=Z$OY54
MV@]X&INTO^+?K#;#6<!!26%A%@F,I&D7ZFYTC58N8B%->@+ZZ[@Z9QW/J8<&
MEILR\(WB9ERZ6:,P+-A1'%<S=L5"79- (EEDU\Y-F''/FG8+ IZX'$MX:E/_
M1K(47S8[0&*._+O:!H@T/(&C!WP:,6*3W93U=&MF:^Q@&G."3.4AS4.'/XT$
M3S82]+K;=68"$Z70V%*P_SR6@H/37W\]/7F=9H+OX^-;EGMO8VL1!6POM$CT
MNPTV?)X/$ 3F>A-K[O^P,GY.V*U+?JRCNY&"W9)&>6,M+$!M*T:]R4]JO8H=
MME9<1X'']F#7O-I,1*"6W(B1HYT8%12%1@52%X"/35$[0U:+PV"#K>'?XAK0
M"<[FVI_@EZ!P16CP8< ZC*)O5?XD:^!1@0ZH@&<\J^(B)T=$@6Q[(O&P-;6K
M#%G);:8&U"-Q*Q/JE0_'4D.KTFB<N'*\G<FB=UP,U*1M9Y6[]=SGN_"# ;F%
ME\84?ND.&C"%QT45K6]0TU]W#XVNR*?Y(C=7<( 0J].I8Q^;9YPD(Y*S\7,\
M)M:H56'*Z(C;:Q72$?'AS"@ 5'')[E0PMP+ RE)1Q.;\J=UR3R2;1?!H:]8D
M;Z0?$*PE>QOBU@JM6?F$[X!/C&1RW6'[0C2%#;PG#.V'SB0+[JIY(2\OC5GZ
M?:2A)5+D8G_&XV*6U@?=K4U+DM82T!%?_#\RWY,&>/[FA_B:^#IE>CUF7JQN
MT$6N-0['DD#&UD(#M[J!;&KI9CR6?ES%R3OP&_!GX:J"N.ELJ1[/GA Y06<_
M;(5/(^EHE[5]7\?#X'N5!V7F3#E/-3Y$[$_@T<5J(OT0YULX'>XD2;>]O0;9
M#'0@OOEH8K.G T598?;038'!0QOPX+TY&E%LGJ*0UPHG;V$:1K["PQ,R0$\Y
M\BRXYX"("@<+VC;S]<1^:<BSJUI<+U9A%BX&81;L(E%! -L7RS 9XQ2TK^#6
M3V@[,2"AY+I!-X,U4\]T!>-S%$:7Q%(*VK#."-K0>V2!N""\H<"/4->SO"KG
M2 Q3\.4AG"_C4M"#J.N,N^F8P8^BR=!G9XKC@8!U)6T0%Z-JJAP-%B; -HT_
MWE(A>RN<G<(7AS*@"%3=A;M[<W:N"WR.N3 Q]8F*KW@[L-\HL >[(H0*/?MT
MX$%KGK/VH49JIMEQ]8/<EI_R"V0]F&8Q:.:)8F78VO4+I)ZX?O:#8B =+3J:
M"SKY6?:4FO!)A@^RP,9$-1=KMW(V5H5 =>@,/^*C8(OE52RGU]\[;O>I(4D]
M C!HWYO)\*CVZH)*Z8<Z!&]<B$?9OU_[(F\KF8'VHVCW%QP(.(4>!Q[%:JID
MD&,3$")^/&%GBT'+)88DH;W?V7^D?V37)A 3^C;M@2J$O5113Y8FJ60I1AY!
M1P10UWRZPKDLE E.!G!8;>0,#8&$$\U6SS6?*9][$RYNAE6S=L:+AN^Y"U)6
M#TKO+8I::QY3R-#'"2QL2"F#+0URONY>^'<8V?QU]WV[=:25N:2HS84*%CZ,
M4J03((7;&%6T$!E= %]F88!!; N6BO<CER]:CUY*$!G&[K%%_*&+L&X6@;"5
M.3$G48H[ZQ!@!5D\W/T:1A2?EY^Y5'[#9;POTHLF*E">@66KM."NG<8^>3E3
M])L:<RE1(-%?QVR&)-&!XA2D#^X73@-D-/T+C%/GT.CAP!GAH>2^>$X1XW-?
M4'CP 7S5/: F>"T2MU&&8$?-/Z_-/%;K/SU6/Z+':I"'8/[2-%)I0YL%O^X>
MH19ESNAOH$,3F$=2GV"(K,] 1<84M$Q8TD\8L"=(RRJ]52IDC%#P5: B#NAU
M!!#')WYG\"*[/.@\3_"QM_##O&8X/@G;*3+_BJ8Z&HUF##"!Z/V4%)'?L]A/
M/ Z2H9,]-T ;&$C'F.CD=!KHN!LX[<@VDFPRP<2X6WEO45$1_UMTIN>,7SGC
MMM@5?YGM1;^L07#, I3_3O#!"/,D/!/=4NH\#SB>DYCUKD_II\@^Q/9,CM9!
MY*GYPR+HKQ0F*+K0DCQ0S48M'C?H7]XU&+2'Z,-R=8N%7+JSA&*_[1C*J\06
MSANSH*,X"8JV8O"5*%8 A\IH[T@R4>BXPN TAWBZ$NT/]#U-L0P+DF[1YHH\
M82WQ_Z68,;S9/;9>2@<20N-:70; Q:FHA W3ZUBIM3%%4=/>V6#=%UT@V)Q\
MA819(% FE#*Z[7Q>H\,3F<1T?+VCMY693L(2F@6>U6;SYHEDG?8[[C[4CL$\
M5AH%R78RVB2@GN)7.;#GG871YP'HU(1SN@ $P)B'R/HFTH-E02RHS4PX'PT+
M&N]5Z%IP&FU9QRQDP>Q9H.I\S]# @]@_FN742\I;Z+^@(L@>8_9?/3A]R #]
M$S\LZ(0N.>)9C&\4KR19*XF643V"Q0P 2G2$=M+/TY: G%/I:Q;2P".&HHK,
M$LQHP@A]:91HQ_9(Y ^CV!\RE:*C/DOMSEH[/?2JC8D41E4@)&P+LV2  5_!
M&4'FGKB6?S_1\UXF60Q>*)ME@/FOCTHEX\PD1]WI R\GKR>;0G';8"/%ODE/
M.LCM9HDU2*-EVYA!D1"J; ,%NX -(,DC30I6@,H4P1C!4>QZ6V=("TBB<JAB
M11H2T 9N-4;R7&5CF0F\DQHAPC"@#RG.,6 1P<L9C+RN%=:5]  ;FT=2H 69
MI'/M),*:28@]YDI6NZ7=TFSKG3NL*@._;CJ-KA19_20JB+!B5P!6:%NZXH(B
M;DH3<(*SS4:T6V%).<;>QIA^1D'"H5;WM(9K7NOPSF$4L4 %%<^WBE%)00U#
M/TPAZF,?GW:W6YMW7IYMOWCLS5*SJ1MZ5IO%VZP_,>ZB9_@.JFV"6,TQK$J4
MPGEC"NG:?.$BPJ;COH=S!F)E<F1+%( U1B?DX(SP(%,.1!;(N)(A.&D5E?RB
M>*"C,-#A[C/'6E(&3'XBC+L5)9.UK)?L165Q&"^PE[%W+4=(>8!X?DQ,"BAE
MRXQ9FG):'Y[+,V,&3\3*WFI'K.RO8K<K!ZLD$2<J_4XIZ7_N8[4]6. >UJ':
MS<X5[,S3#I8!=WM3)#@68M8(GI^I2H*W@%[2RRQEV9!(PK@HHPS"/XA0:<N0
MQ')K^SQQ]&%A8#OQ*!OY^L)A=M^;,I=(E+VZRAFH!3R$*O>?1)4#76L#R-(E
M-X)=%]DP\3U?QO<+B!,89A(%*K@W%C?F;V7#'1J[3(N5@<BU+-^+8*M0G%@7
M$5LW..Y%_\VE8M!ZSI;S=LL/<^XJ!K!:*S>K,[**$/8'"NI>/DV_9A3S2CGM
MP1,YK56=SF+C?#F+HY'R,O8"&?E< #)L>JZDO5L_""@&'>U :+!%_=0:?='D
M=*\D6B:)H1)M2O:C&!U%:!5EJ$88KB_+WZ_@LUQQ[5"EF#ZHNSZ$I_C[5:-/
M6^TK!Q .Y*#CP;:?N;"AWJ$S^.G0>74.G>\4/KJQ1#36[[_3/MSE"#[_:4S"
M5)B25U>QNL+CRL%R*!Q6[E8IGHE.W,K]JL" /%R&;R!8V-Z-*$H?0T]:^T&[
M93F$&Y50P5-("!5CE2(=5B1-,!6;^VW\4E[ (X]) N%774>C&&]J/ 65W WC
MR;79P_B2K"W!&D$4)HWKJ+;E2\D!%_1A-(*6LLU-+M13F29W#7NH8$SY@G!R
M\HI-FD8/'Z"1./H&BWN%?'LR\9.$DW9M$%TJ[W22,T9NC=CS[F$839S\38R5
M2E:!;GQK>B_Q[/%,C03V"Q2-9\2MV>LN1[F%S(?)F?R$#IM;0(O4H64K<I6M
M46:BLS&=16J0CJ6N3 _&5<"@K+S3LU$ ?D4$ZTT40)^$VQ!MY1^=,+!.,6/6
MQH2MS42V5IH/&R7]K.!1C;U %\ZZO58F%*^:M&V%)BNU-<_ KV"^68H;Q*:#
MD*?,FO>PN &QPDA2-$H#<22:W/(=F$,)\_=$IS_S*-&JJD891G[@:&R*G8T3
M=QO#NE*Q]'0X(Y ,0F+]C6Z5'C>M=*KG,0HB-"J*(5 WH@M>KGQ&7)+39*-@
MD&WUU)A63LP\]H  1KYE?A=V6N*0CQ67EA5[&4@2VH__MIU?W">IFFA_,<V#
MOX .0L+Q68(&9([@HCH%.=R:A[+R+)[B]K@1G1U<4Y !,C7<E^FA)!=L[#,?
MZ/K]-?8I'?\<FD-KBZ'P^UR-J8K%V@&A-)*&)I=D5]W\-]!(%J.-&:A1\HM_
M$#788PG@H]XG?SD3REQ" X[4)@&06U0!A,SZ;]P8L/G8P<I]'="MDTI2DV8,
M]#LQ3MS2F;NFA#MUXT<9EAI"N<E1)?7BT7J.C=5:'(\7A"O,ZQPE=;%#&\Y#
M'OI2AVSDN $II@/M)LD,)NMH/2N>S,*U*]@&!@&U\S+K9^03 K.R(7MH4WO,
MHMMNLX0#\S1VH!]@CZ^0FU>E,]2/)=\@0$@%-+(@?>W/E$/]_=)FEZ[B/)7/
M=(G3G$3BZ XP0A3#KXC:C@C;S?=+CD!LN]:,@DFBW3HDJ8AU;BC$54NL6LVG
M$;IS#L9SDN._0SGO9Q9_-TMQA=1R^3U4C^ZTPH&L4#-,C*^D "J/8TZ,7]M8
M\-JM2DT R16#L0+B]O9F NT9I,H5-AP\1ZU'!HOO<4ZVGG7_W6"CLT!*2>#T
M.C^C8X.]XBRP]>"N,BZWI'4Q#EM<,9I$-N2 L]3UL0)\#V@SF,W#H#JZ28KT
ML2VN(J2=2)^#NC$Y: CZ[:)4AQR)#GI8.#VI/]_S#0HK1B_C^'=37@1VD^1P
M]78Z;EI,$THR&;+BH6=*XJQJ55;K>46]K7/CIZWSA[1U/LS,N=18CJWZRO@/
M](4,'A#-P6X\'1)VB-+<=7-\=$M7ESU@C>2S"41[[CH'#]N\'S5@8,"W9NQI
MM]"4-!U]*0^K#1,EV5*"AK8;W\MDT!$8 -,I)(N64GFYDIT45W15%!""VWZB
M.\!L(XP6CCFDFD/2J'*YC4S3>HV.";4N5_S^'&22Z ^\M4TG&K]"K+9;6JZR
M0*7+BHP/%P:^!_(G +C0P9KTF\^2(OK"SMGOIYH :2]3,WE:U,&&[@R-'*A9
M:!*L A/5!#_C "6;/J?(8<U/JMI!DLF45-<F_%)JS:*0!,2)G>KXT\Z,$W=>
MC-:2"*=IIJDMM/'C^NYT9ZF3*=\@ =^!UG-W_ ,RQU<BVG2J[#+W<*,>F3S(
M-/'$+=PR.X@NE0XI'O!/[K:8@##!RS,Z8@IJ##DRRL4O=.$+CFU?P20%78S<
M=8>YG&'5& 7KZFTL)A*,L>!<8\=+X+B(VRWG H->3TS\(-!M8YGTGX%&KX@1
M+<?"A@2"=<&IF BJS(94YXB=1136;JWDI?5KJ3GW'#:CY@6DZUR]L6D)EP#C
M#T2YW_GNM*73\%.M<=N&A*G4ALD:!KXK0WVG$8,>4\6E5/NE6"C[(1+UA;*W
M?F!N]P R>2J5]"SFBA4YF.P5$B4^E(?A !'%F/B?Z+11D4P#/UWM8 N<3Z8S
M7CL<..7 -[>>L</T9FR+%(S"+*T$QU=U],2U]E?.#Q>.L/#3* 8$HC.<BQE>
M'5'J,R7MXD[%(S_!E)8.GY>23U)G?"S*I9O/MC$PI0ZJ/A,S?LT5CU^:#S_(
MW'/S5"C1,Q<'L-&%4\DQ5S?65\;Q<7"SR.W]))J\@WN7P-'-:V*3K,H,0C^"
M%[YWQ:T_-^V\JH#W@;E?MV!-*;*C:CO*5$>?.Z&GY>0V+E)2IPV9(GQQ-/93
M"D6@.DAJ,@VB>V58?W0;0F?7_M2Q1YHGABI4^"XCCLH>,&FNX4!T81'!-5'&
MOI>-Z UR^CDA;396CKK5%D\3*0L\&G8IO5_5L9FN#-%>+"U$>/!T81/-D?SJ
MVI=>,(8.R/'7U#8J'-,H(7VZ88NW2(4F)1<4A7[O+S:5V(WR*>0@5V4MFB3(
MO3%>[JY3'4T$G[)!<W0O3A/W !/3*PDD>;9^; \U7L7-6J^B<<G-\*)'N.F&
M5*EF;10%@9PFT+7YJ^"1^R!FW-/U3*]RXK-<;E#R]<T^L;'PB7(;2_)WSEG<
ML^)>P&9/"[3S[.6U7@<1OPJE^K5F5!XN!<:5I'%%*FZU2)XH$]1GRRF0\,L3
M>+%XG\^YD-*P;GT9RXP20G4'L=@?U9&H;CO/#6ZW_,E$>=@@AG"ZT1\4<$VB
ML'E6FQ4Q%&(_4B!:8D[_KUB-NFE5=$G1[PG=@##155 Y6&2$!3 K>Z#L_V*B
M=&6"- Y$<JAEJ)<LF;]FSX"C[26A/:.CS+LOZF>9C24SBMY#&,714]-42?80
M%[ 8S/C?@;SU+P:0%=B%38+.:Y03"X$.,.[,5&,R\5/(B)(<C*X/U]:;H\]G
MT13_C833,A7%CT\DN?4*T501&SPCFKAT&^M,56YZ+JDYR_XK7/649958M8KX
M?:&H1;F21163?F9?^\.(Y1D<M:_)V;YIS5)CZ0=93"5\]%THYKI3H8$!!Z'&
M-O^=KP>@=_&.BC\R&<,HT2YE;C>9L>BZ=\*6JHN7TE6>RP+ZFJU8KY;(GDIE
M T-DL+W9R&0MDU<J##$Q+M9&"?=:'-]>?E6X76-%T1U@5",T5 @\D;/1C21C
M+)MNG*+85%)P6^6-K#X;=?TDKI?VT@]T2&Z)AVFGCWH<E=53UXR/S/6*T>^-
M_&(S]6FU0]^?^,AF'<\8^JUD:KU=N6N+SI/)DLA3Q@I%X6WZ6'F2/XC'_Y6>
M@I=S\IL3H-VWRH<UJ:QJT)F7]D65:+2GT[I2,2^[8 9/#>]U;E]B:P(7LLPS
M4%;%.(XF1,U!).DR=>\&XV?@KRN "5@$%O_FZ*\D]QJ,84 AF=OQ?"$-ZVMK
MR?8O[W0%8^<-_)(:QPJ6Q6LA'Q.<D_N#R<4+Q.!/C1]<NP;0:Q>JO#C\_ H%
M\'@CX[J]C>,Y[>O]'_]0+MM8^&DIQW*OD=)3UOVY_BP(GHG\QK>L>>Z)3=JM
MLLMKMNH9%G?6<BF_NB0 \9(Z"=!NU)DN#1M7TW/"+^AD F-*:[>*3$8_Q44<
M4G,;XH.LBJ135L6MY>&=G4)PG&8&[59^8Z)Q@)&)I+AT-L'-*RT^EQ.!%4NX
MLH/7[/CJ\NNO\9)0)&4_?*7VCL]+.5XE@X?K&:TPPA>+.5>"(V+SU867"N)D
MYFJ=*[Z)*+CGF[(D7<U'M7U&IC)N?FLA-%APXIJJ(F,^]3PP+/9_8U-"BV\7
M$9^>B#NF(=7B3^=8^.J=G%L_4R=_R-3)1Y2)>[?<6MBUH'F3@UV:\8^-)]7"
M?F<R.;]2"06;E_;1AI2<%F^Y+$DYSKL\B;!.Y%5^Z0(5,YJ5Q 4!DZ1Q9BY1
M#7QUP]=5E@N0&0"=Q[CDUVX*?Z(O4Z*2U\]BQ'^Y"Q1,7;@'WZYX%!2NB[MD
M;R8:([&""KRCN)8:7V5N5(*'7AB7W[T#@$7=@59"B .+Y>>W9& Y/5T0 $OS
M6VA1)3@L+02^*9I>H:K,7&$UID#]4%%M-D].2-_!+Y'-X0VL8X=6O"R])R.&
MM$/IBCVR3="=(=265XCRY4(+H#^R9$0&AH(KK_4.:A::-0*Z9,+:0NB2$HXD
M3_,KZ/-N><FX;E^:0\/(7EY;-9YE73+P0C3<XWO4D(BW&005NV1I #1[O/N_
M%_"-3-%*A0*I&<)D!TOR?Y;A'5OW<+T<_^6G'']U<GPYP0,S-(9D7<TICT\
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M.SF=C&ZE!H=2 Y6=W!FX<7N\U\RFDX_>X('*^XC]I=2UPE,TE0[_0-O\JA$
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MK6G)7:1WW%ZJ)8\%I\F5P[,TIK-7@50F1I5*A6RM5X]3(=+^:#A9E4X_&KV
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MT;9RUZ<Q R0]%T7ETCH:#N/(^;P$R[7E+M1VU&>;W7Z[PVQ=@14QSWV5P@%
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M#/UTCY,AURZX84M#9C8(5+A40WQ13B?NICRJ%A1&</A39Z$1=&+TV2J<ICD
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MWGGR>T9+TV;:A[OI27S&U]1*BO,SXB!C2TS*Y&-G@.H?>JJIX?90#O#PG5+
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M?E5L""/DE%??HP:E<1^TX0LX;%6I) O2MT^[':-DVN%O5Z5Z!1C_ U;S,"!
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MT-F*S0M^I'L3_.?^0J\<K>^O[2T^?G14,BDB>_Z!!/0U>O3_(,-N4>Z,+SY
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M2P$"% ,4    " #H,4U6R@B9G4D#  "J#   #P              @ $
M8VDM,C R,S R,3,N>'-D4$L! A0#%     @ Z#%-5D0(52$X"P  )XD  !,
M             ( !=@,  &-I+3(P,C,P,C$S7VQA8BYX;6Q02P$"% ,4
M" #H,4U6%C$P/','  !]60  $P              @ '?#@  8VDM,C R,S R
M,3-?<')E+GAM;%!+ 0(4 Q0    ( .@Q359+W\6]U!,  )9P   +
M      "  8,6  !C:6=N83AK+FAT;5!+ 0(4 Q0    ( .@Q35;U]$,Q+04
M /88   )              "  8 J  !E>#,M,2YH=&U02P$"% ,4    " #H
M,4U6 B3Q7!8@  !@M   "0              @ '4+P  97@S+3(N:'1M4$L!
M A0#%     @ Z#%-5M1;/(C?I0  7?(#  D              ( !$5   &5X
=,RTS+FAT;5!+!08     !P ' )T!   7]@     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
